disease,drug,phase,status,target,num_ev_strings
breast carcinoma,PACLITAXEL,2,Completed,TUBB3,110
breast carcinoma,PACLITAXEL,2,Completed,TUBB8,110
breast carcinoma,PACLITAXEL,2,Completed,TUBB1,110
breast carcinoma,PACLITAXEL,2,Completed,TUBB2A,110
breast carcinoma,PACLITAXEL,2,Completed,TUBB2B,110
breast carcinoma,PACLITAXEL,2,Completed,TUBB,110
breast carcinoma,PACLITAXEL,2,Completed,TUBB4A,110
breast carcinoma,PACLITAXEL,2,Completed,TUBB4B,110
breast carcinoma,PACLITAXEL,2,Completed,TUBB6,110
breast carcinoma,TRASTUZUMAB,2,Completed,ERBB2,103
breast carcinoma,DOCETAXEL,2,Completed,TUBB4B,102
breast carcinoma,DOCETAXEL,2,Completed,TUBB6,102
breast carcinoma,DOCETAXEL,2,Completed,TUBB8,102
breast carcinoma,DOCETAXEL,2,Completed,TUBB4A,102
breast carcinoma,DOCETAXEL,2,Completed,TUBB3,102
breast carcinoma,DOCETAXEL,2,Completed,TUBB2B,102
breast carcinoma,DOCETAXEL,2,Completed,TUBB2A,102
breast carcinoma,DOCETAXEL,2,Completed,TUBB1,102
breast carcinoma,DOCETAXEL,2,Completed,TUBB,102
breast carcinoma,DOXORUBICIN,2,Completed,TOP2A,73
breast carcinoma,BEVACIZUMAB,2,Completed,VEGFA,62
breast carcinoma,CAPECITABINE,2,Completed,TYMS,53
breast carcinoma,DOCETAXEL,3,Completed,TUBB1,52
breast carcinoma,DOCETAXEL,3,Completed,TUBB,52
breast carcinoma,DOCETAXEL,3,Completed,TUBB2B,52
breast carcinoma,DOCETAXEL,3,Completed,TUBB4A,52
breast carcinoma,DOCETAXEL,3,Completed,TUBB6,52
breast carcinoma,DOCETAXEL,3,Completed,TUBB4B,52
breast carcinoma,DOCETAXEL,3,Completed,TUBB3,52
breast carcinoma,DOCETAXEL,3,Completed,TUBB8,52
breast carcinoma,DOCETAXEL,3,Completed,TUBB2A,52
breast carcinoma,GEMCITABINE,2,Completed,PRIM2,50
breast carcinoma,GEMCITABINE,2,Completed,POLD2,50
breast carcinoma,GEMCITABINE,2,Completed,POLD1,50
breast carcinoma,GEMCITABINE,2,Completed,POLE,50
breast carcinoma,GEMCITABINE,2,Completed,POLD3,50
breast carcinoma,GEMCITABINE,2,Completed,POLD4,50
breast carcinoma,GEMCITABINE,2,Completed,PRIM1,50
breast carcinoma,GEMCITABINE,2,Completed,POLA2,50
breast carcinoma,GEMCITABINE,2,Completed,POLE2,50
breast carcinoma,GEMCITABINE,2,Completed,POLE3,50
breast carcinoma,GEMCITABINE,2,Completed,RRM1,50
breast carcinoma,GEMCITABINE,2,Completed,POLA1,50
breast carcinoma,PACLITAXEL,1,Completed,TUBB8,48
breast carcinoma,PACLITAXEL,1,Completed,TUBB6,48
breast carcinoma,PACLITAXEL,1,Completed,TUBB4B,48
breast carcinoma,PACLITAXEL,1,Completed,TUBB4A,48
breast carcinoma,PACLITAXEL,1,Completed,TUBB3,48
breast carcinoma,PACLITAXEL,1,Completed,TUBB2B,48
breast carcinoma,PACLITAXEL,1,Completed,TUBB2A,48
breast carcinoma,PACLITAXEL,1,Completed,TUBB1,48
breast carcinoma,PACLITAXEL,1,Completed,TUBB,48
breast carcinoma,PALBOCICLIB,2,Recruiting,CCND1,48
breast carcinoma,PACLITAXEL,3,Completed,TUBB8,44
breast carcinoma,PACLITAXEL,3,Completed,TUBB,44
breast carcinoma,PACLITAXEL,3,Completed,TUBB6,44
breast carcinoma,PACLITAXEL,3,Completed,TUBB2B,44
breast carcinoma,PACLITAXEL,3,Completed,TUBB4A,44
breast carcinoma,PACLITAXEL,3,Completed,TUBB3,44
breast carcinoma,PACLITAXEL,3,Completed,TUBB4B,44
breast carcinoma,PACLITAXEL,3,Completed,TUBB1,44
breast carcinoma,PACLITAXEL,3,Completed,TUBB2A,44
breast carcinoma,TAMOXIFEN,3,Completed,ESR1,41
breast carcinoma,PACLITAXEL,2,Recruiting,TUBB1,39
breast carcinoma,PACLITAXEL,2,Recruiting,TUBB2A,39
breast carcinoma,PACLITAXEL,2,Recruiting,TUBB4B,39
breast carcinoma,FLUOROURACIL,3,Completed,TYMS,39
breast carcinoma,PACLITAXEL,2,Recruiting,TUBB8,39
breast carcinoma,PACLITAXEL,2,Recruiting,TUBB4A,39
breast carcinoma,PACLITAXEL,2,Recruiting,TUBB3,39
breast carcinoma,PACLITAXEL,2,Recruiting,TUBB2B,39
breast carcinoma,PACLITAXEL,2,Recruiting,TUBB6,39
breast carcinoma,PACLITAXEL,2,Recruiting,TUBB,39
breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,37
breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2B,37
breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB1,37
breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB8,37
breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB6,37
breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4B,37
breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4A,37
breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2A,37
breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB3,37
breast carcinoma,TRASTUZUMAB,3,Completed,ERBB2,34
breast carcinoma,TRASTUZUMAB,2,"Active, not recruiting",ERBB2,34
breast carcinoma,DOXORUBICIN,3,Completed,TOP2A,33
breast carcinoma,ANASTROZOLE,4,n/a,CYP19A1,33
breast carcinoma,TRASTUZUMAB,1,Completed,ERBB2,32
breast carcinoma,LETROZOLE,2,Completed,CYP19A1,31
breast carcinoma,PALBOCICLIB,1,Recruiting,CCND1,30
breast carcinoma,CAPECITABINE,3,Completed,TYMS,30
breast carcinoma,TRASTUZUMAB,2,Recruiting,ERBB2,29
breast carcinoma,CAPECITABINE,2,Terminated,TYMS,28
breast carcinoma,FULVESTRANT,2,Completed,ESR2,28
breast carcinoma,FULVESTRANT,2,Completed,ESR1,28
breast carcinoma,FULVESTRANT,2,Recruiting,ESR1,25
breast carcinoma,FULVESTRANT,2,Recruiting,ESR2,25
breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,24
breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB1,24
breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB2A,24
breast carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB2A,24
breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB2B,24
breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB3,24
breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB4B,24
breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB6,24
breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB8,24
breast carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB8,24
breast carcinoma,LETROZOLE,2,Recruiting,CYP19A1,24
breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB4A,24
breast carcinoma,PALBOCICLIB,2,Recruiting,CDK4,24
breast carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB6,24
breast carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB4B,24
breast carcinoma,PALBOCICLIB,2,Recruiting,CDK6,24
breast carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB1,24
breast carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,24
breast carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB4A,24
breast carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB2B,24
breast carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB3,24
breast carcinoma,VINORELBINE,2,Completed,TUBB3,23
breast carcinoma,VINORELBINE,2,Completed,TUBB4A,23
breast carcinoma,VINORELBINE,2,Completed,TUBB8,23
breast carcinoma,VINORELBINE,2,Completed,TUBB2B,23
breast carcinoma,VINORELBINE,2,Completed,TUBB6,23
breast carcinoma,VINORELBINE,2,Completed,TUBB1,23
breast carcinoma,VINORELBINE,2,Completed,TUBB,23
breast carcinoma,VINORELBINE,2,Completed,TUBB4B,23
breast carcinoma,VINORELBINE,2,Completed,TUBB2A,23
breast carcinoma,ANASTROZOLE,2,Completed,CYP19A1,23
breast carcinoma,PALBOCICLIB,2,"Active, not recruiting",CCND1,22
breast carcinoma,CAPECITABINE,1,Completed,TYMS,22
breast carcinoma,TAMOXIFEN,2,Completed,ESR1,22
breast carcinoma,TRASTUZUMAB,2,Terminated,ERBB2,22
breast carcinoma,TRASTUZUMAB,3,"Active, not recruiting",ERBB2,22
breast carcinoma,PACLITAXEL,2,Terminated,TUBB6,21
breast carcinoma,DOCETAXEL,2,Terminated,TUBB6,21
breast carcinoma,DOCETAXEL,2,Terminated,TUBB8,21
breast carcinoma,DOCETAXEL,2,Unknown status,TUBB,21
breast carcinoma,DOCETAXEL,2,Unknown status,TUBB1,21
breast carcinoma,DOCETAXEL,2,Unknown status,TUBB2A,21
breast carcinoma,DOCETAXEL,2,Unknown status,TUBB2B,21
breast carcinoma,DOCETAXEL,2,Terminated,TUBB1,21
breast carcinoma,DOCETAXEL,2,Terminated,TUBB,21
breast carcinoma,DOCETAXEL,2,Unknown status,TUBB3,21
breast carcinoma,PACLITAXEL,2,Terminated,TUBB8,21
breast carcinoma,PACLITAXEL,2,Terminated,TUBB4B,21
breast carcinoma,METHOTREXATE,3,Completed,DHFR,21
breast carcinoma,PACLITAXEL,2,Terminated,TUBB4A,21
breast carcinoma,PACLITAXEL,2,Terminated,TUBB3,21
breast carcinoma,PACLITAXEL,2,Terminated,TUBB2B,21
breast carcinoma,PACLITAXEL,2,Terminated,TUBB2A,21
breast carcinoma,PACLITAXEL,2,Terminated,TUBB1,21
breast carcinoma,PACLITAXEL,2,Terminated,TUBB,21
breast carcinoma,DOCETAXEL,2,Unknown status,TUBB4A,21
breast carcinoma,DOCETAXEL,2,Unknown status,TUBB4B,21
breast carcinoma,DOCETAXEL,2,Unknown status,TUBB6,21
breast carcinoma,DOCETAXEL,2,Unknown status,TUBB8,21
breast carcinoma,FILGRASTIM,2,Completed,CSF3R,21
breast carcinoma,DOCETAXEL,2,Terminated,TUBB4B,21
breast carcinoma,DOCETAXEL,1,Completed,TUBB1,21
breast carcinoma,DOCETAXEL,1,Completed,TUBB4A,21
breast carcinoma,DOCETAXEL,1,Completed,TUBB8,21
breast carcinoma,DOCETAXEL,1,Completed,TUBB2B,21
breast carcinoma,DOCETAXEL,1,Completed,TUBB2A,21
breast carcinoma,DOCETAXEL,1,Completed,TUBB3,21
breast carcinoma,DOCETAXEL,1,Completed,TUBB,21
breast carcinoma,DOCETAXEL,2,Terminated,TUBB4A,21
breast carcinoma,DOCETAXEL,1,Completed,TUBB4B,21
breast carcinoma,DOCETAXEL,1,Completed,TUBB6,21
breast carcinoma,LETROZOLE,4,n/a,CYP19A1,21
breast carcinoma,DOCETAXEL,2,Terminated,TUBB2A,21
breast carcinoma,DOCETAXEL,2,Terminated,TUBB2B,21
breast carcinoma,DOCETAXEL,2,Terminated,TUBB3,21
breast carcinoma,LAPATINIB,2,Completed,EGFR,20
breast carcinoma,LAPATINIB,2,Completed,ERBB2,20
breast carcinoma,EXEMESTANE,2,Completed,CYP19A1,19
breast carcinoma,DOXORUBICIN,2,Unknown status,TOP2A,19
breast carcinoma,PACLITAXEL,1,Recruiting,TUBB2A,18
breast carcinoma,PACLITAXEL,1,Recruiting,TUBB4B,18
breast carcinoma,FULVESTRANT,2,"Active, not recruiting",ESR1,18
breast carcinoma,PACLITAXEL,1,Recruiting,TUBB4A,18
breast carcinoma,PACLITAXEL,1,Recruiting,TUBB1,18
breast carcinoma,PACLITAXEL,1,Recruiting,TUBB3,18
breast carcinoma,PACLITAXEL,1,Recruiting,TUBB6,18
breast carcinoma,PACLITAXEL,1,Recruiting,TUBB,18
breast carcinoma,FULVESTRANT,2,"Active, not recruiting",ESR2,18
breast carcinoma,PACLITAXEL,1,Recruiting,TUBB8,18
breast carcinoma,PACLITAXEL,1,Recruiting,TUBB2B,18
breast carcinoma,PACLITAXEL,2,Unknown status,TUBB2A,18
breast carcinoma,PACLITAXEL,2,Unknown status,TUBB3,18
breast carcinoma,PACLITAXEL,2,Unknown status,TUBB2B,18
breast carcinoma,PACLITAXEL,2,Unknown status,TUBB4B,18
breast carcinoma,PACLITAXEL,2,Unknown status,TUBB6,18
breast carcinoma,PACLITAXEL,2,Unknown status,TUBB1,18
breast carcinoma,PACLITAXEL,2,Unknown status,TUBB8,18
breast carcinoma,CAPECITABINE,2,Recruiting,TYMS,18
breast carcinoma,PACLITAXEL,2,Unknown status,TUBB,18
breast carcinoma,PACLITAXEL,2,Unknown status,TUBB4A,18
breast carcinoma,IXABEPILONE,2,Completed,TUBB,17
breast carcinoma,ANASTROZOLE,3,Completed,CYP19A1,17
breast carcinoma,IXABEPILONE,2,Completed,TUBB1,17
breast carcinoma,IXABEPILONE,2,Completed,TUBB2B,17
breast carcinoma,IXABEPILONE,2,Completed,TUBB3,17
breast carcinoma,IXABEPILONE,2,Completed,TUBB4A,17
breast carcinoma,DOXORUBICIN,2,Terminated,TOP2A,17
breast carcinoma,IXABEPILONE,2,Completed,TUBB4B,17
breast carcinoma,IXABEPILONE,2,Completed,TUBB6,17
breast carcinoma,IXABEPILONE,2,Completed,TUBB2A,17
breast carcinoma,IXABEPILONE,2,Completed,TUBB8,17
breast carcinoma,DOXORUBICIN,1,Completed,TOP2A,16
breast carcinoma,PERTUZUMAB,2,"Active, not recruiting",ERBB2,16
breast carcinoma,DOXORUBICIN,2,Recruiting,TOP2A,16
breast carcinoma,DOXORUBICIN,2,"Active, not recruiting",TOP2A,16
breast carcinoma,PEMBROLIZUMAB,2,Recruiting,PDCD1,16
breast carcinoma,LETROZOLE,2,"Active, not recruiting",CYP19A1,15
breast carcinoma,PEGFILGRASTIM,2,Completed,CSF3R,15
breast carcinoma,LAPATINIB,1,Completed,EGFR,15
breast carcinoma,PALBOCICLIB,1,Recruiting,CDK4,15
breast carcinoma,PALBOCICLIB,1,Recruiting,CDK6,15
breast carcinoma,LAPATINIB,1,Completed,ERBB2,15
breast carcinoma,TRASTUZUMAB,1,Terminated,ERBB2,15
breast carcinoma,VINORELBINE,2,Terminated,TUBB2B,14
breast carcinoma,VINORELBINE,2,Terminated,TUBB8,14
breast carcinoma,ERIBULIN,2,Completed,TUBB1,14
breast carcinoma,ERIBULIN,2,Completed,TUBB,14
breast carcinoma,ERIBULIN,2,Completed,TUBB2B,14
breast carcinoma,VINORELBINE,2,Terminated,TUBB6,14
breast carcinoma,VINORELBINE,2,Terminated,TUBB4B,14
breast carcinoma,VINORELBINE,2,Terminated,TUBB4A,14
breast carcinoma,GEFITINIB,2,Completed,EGFR,14
breast carcinoma,VINORELBINE,2,Terminated,TUBB3,14
breast carcinoma,ERIBULIN,2,Completed,TUBB4A,14
breast carcinoma,VINORELBINE,2,Terminated,TUBB2A,14
breast carcinoma,VINORELBINE,2,Terminated,TUBB,14
breast carcinoma,ERIBULIN,2,Completed,TUBB3,14
breast carcinoma,NERATINIB,2,Recruiting,ERBB2,14
breast carcinoma,TAMOXIFEN,3,Unknown status,ESR1,14
breast carcinoma,TAMOXIFEN,2,Recruiting,ESR1,14
breast carcinoma,LETROZOLE,3,"Active, not recruiting",CYP19A1,14
breast carcinoma,PERTUZUMAB,2,Recruiting,ERBB2,14
breast carcinoma,ERIBULIN,2,Completed,TUBB2A,14
breast carcinoma,NERATINIB,1,Completed,EGFR,14
breast carcinoma,NERATINIB,1,Completed,ERBB2,14
breast carcinoma,ERIBULIN,2,Completed,TUBB6,14
breast carcinoma,ERIBULIN,2,Completed,TUBB4B,14
breast carcinoma,NERATINIB,2,Recruiting,EGFR,14
breast carcinoma,VINORELBINE,2,Terminated,TUBB1,14
breast carcinoma,DOCETAXEL,2,Recruiting,TUBB4B,14
breast carcinoma,PACLITAXEL,3,Recruiting,TUBB8,14
breast carcinoma,PACLITAXEL,3,Recruiting,TUBB,14
breast carcinoma,PACLITAXEL,3,Recruiting,TUBB1,14
breast carcinoma,PACLITAXEL,3,Recruiting,TUBB2A,14
breast carcinoma,PACLITAXEL,3,Recruiting,TUBB2B,14
breast carcinoma,PACLITAXEL,3,Recruiting,TUBB6,14
breast carcinoma,DOCETAXEL,2,Recruiting,TUBB,14
breast carcinoma,ERIBULIN,2,Completed,TUBB8,14
breast carcinoma,PACLITAXEL,3,Recruiting,TUBB3,14
breast carcinoma,DOCETAXEL,2,Recruiting,TUBB8,14
breast carcinoma,DOCETAXEL,2,Recruiting,TUBB6,14
breast carcinoma,DOCETAXEL,2,Recruiting,TUBB1,14
breast carcinoma,DOCETAXEL,2,Recruiting,TUBB2A,14
breast carcinoma,DOCETAXEL,2,Recruiting,TUBB2B,14
breast carcinoma,DOXORUBICIN,3,"Active, not recruiting",TOP2A,14
breast carcinoma,PACLITAXEL,3,Recruiting,TUBB4A,14
breast carcinoma,DOCETAXEL,2,Recruiting,TUBB3,14
breast carcinoma,BEVACIZUMAB,3,Completed,VEGFA,14
breast carcinoma,PACLITAXEL,3,Recruiting,TUBB4B,14
breast carcinoma,DOCETAXEL,2,Recruiting,TUBB4A,14
breast carcinoma,TRASTUZUMAB,3,Recruiting,ERBB2,14
breast carcinoma,LAPATINIB,2,Terminated,EGFR,13
breast carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB2A,13
breast carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB8,13
breast carcinoma,CAPECITABINE,3,"Active, not recruiting",TYMS,13
breast carcinoma,LAPATINIB,2,Terminated,ERBB2,13
breast carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB6,13
breast carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB4B,13
breast carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB4A,13
breast carcinoma,TRASTUZUMAB,1,"Active, not recruiting",ERBB2,13
breast carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB3,13
breast carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB2B,13
breast carcinoma,LETROZOLE,2,Terminated,CYP19A1,13
breast carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,13
breast carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB1,13
breast carcinoma,LETROZOLE,1,Recruiting,CYP19A1,12
breast carcinoma,PALBOCICLIB,3,"Active, not recruiting",CCND1,12
breast carcinoma,CAPECITABINE,2,Unknown status,TYMS,12
breast carcinoma,EVEROLIMUS,2,Completed,FKBP1A,12
breast carcinoma,BEVACIZUMAB,2,Terminated,VEGFA,12
breast carcinoma,TRASTUZUMAB,2,Unknown status,ERBB2,12
breast carcinoma,PACLITAXEL,3,Unknown status,TUBB8,12
breast carcinoma,LETROZOLE,3,Completed,CYP19A1,12
breast carcinoma,PACLITAXEL,4,n/a,TUBB,12
breast carcinoma,TRASTUZUMAB,1,Recruiting,ERBB2,12
breast carcinoma,PACLITAXEL,4,n/a,TUBB2A,12
breast carcinoma,PACLITAXEL,4,n/a,TUBB2B,12
breast carcinoma,PACLITAXEL,4,n/a,TUBB3,12
breast carcinoma,PACLITAXEL,4,n/a,TUBB4A,12
breast carcinoma,PACLITAXEL,4,n/a,TUBB4B,12
breast carcinoma,PACLITAXEL,4,n/a,TUBB6,12
breast carcinoma,PACLITAXEL,4,n/a,TUBB8,12
breast carcinoma,PACLITAXEL,4,n/a,TUBB1,12
breast carcinoma,PACLITAXEL,3,Unknown status,TUBB6,12
breast carcinoma,PACLITAXEL,3,Unknown status,TUBB4B,12
breast carcinoma,PACLITAXEL,3,Unknown status,TUBB4A,12
breast carcinoma,PACLITAXEL,3,Unknown status,TUBB3,12
breast carcinoma,PACLITAXEL,3,Unknown status,TUBB2B,12
breast carcinoma,PACLITAXEL,3,Unknown status,TUBB,12
breast carcinoma,PACLITAXEL,3,Unknown status,TUBB2A,12
breast carcinoma,PACLITAXEL,3,Unknown status,TUBB1,12
breast carcinoma,GEMCITABINE,3,Completed,RRM1,11
breast carcinoma,DOCETAXEL,3,Unknown status,TUBB3,11
breast carcinoma,DOCETAXEL,3,Unknown status,TUBB1,11
breast carcinoma,DOCETAXEL,3,Unknown status,TUBB2A,11
breast carcinoma,DOCETAXEL,3,Unknown status,TUBB2B,11
breast carcinoma,DOCETAXEL,3,Unknown status,TUBB8,11
breast carcinoma,DOCETAXEL,3,Unknown status,TUBB4B,11
breast carcinoma,DOCETAXEL,3,Unknown status,TUBB6,11
breast carcinoma,FILGRASTIM,3,Completed,CSF3R,11
breast carcinoma,DOCETAXEL,3,Unknown status,TUBB,11
breast carcinoma,GEMCITABINE,3,Completed,POLD1,11
breast carcinoma,GEMCITABINE,3,Completed,POLA1,11
breast carcinoma,GEMCITABINE,3,Completed,POLA2,11
breast carcinoma,GEMCITABINE,3,Completed,PRIM2,11
breast carcinoma,GEMCITABINE,3,Completed,POLD2,11
breast carcinoma,GEMCITABINE,3,Completed,POLD3,11
breast carcinoma,EXEMESTANE,2,Recruiting,CYP19A1,11
breast carcinoma,GEMCITABINE,3,Completed,POLD4,11
breast carcinoma,GEMCITABINE,3,Completed,POLE,11
breast carcinoma,EXEMESTANE,2,"Active, not recruiting",CYP19A1,11
breast carcinoma,GEMCITABINE,3,Completed,POLE3,11
breast carcinoma,GEMCITABINE,3,Completed,PRIM1,11
breast carcinoma,GEMCITABINE,3,Completed,POLE2,11
breast carcinoma,DOCETAXEL,3,Unknown status,TUBB4A,11
breast carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB3,11
breast carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB6,11
breast carcinoma,ANASTROZOLE,2,Terminated,CYP19A1,11
breast carcinoma,FULVESTRANT,3,"Active, not recruiting",ESR2,11
breast carcinoma,FULVESTRANT,3,"Active, not recruiting",ESR1,11
breast carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB2A,11
breast carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB8,11
breast carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB2B,11
breast carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB4A,11
breast carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB1,11
breast carcinoma,PALBOCICLIB,2,"Active, not recruiting",CDK6,11
breast carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,11
breast carcinoma,FULVESTRANT,1,Recruiting,ESR2,11
breast carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB4B,11
breast carcinoma,FULVESTRANT,1,Recruiting,ESR1,11
breast carcinoma,PALBOCICLIB,2,"Active, not recruiting",CDK4,11
breast carcinoma,PACLITAXEL,1,Terminated,TUBB3,10
breast carcinoma,PACLITAXEL,1,Terminated,TUBB2A,10
breast carcinoma,PACLITAXEL,1,Terminated,TUBB2B,10
breast carcinoma,PEMBROLIZUMAB,1,Recruiting,PDCD1,10
breast carcinoma,EXEMESTANE,3,Completed,CYP19A1,10
breast carcinoma,PACLITAXEL,1,Terminated,TUBB4A,10
breast carcinoma,PERTUZUMAB,2,Completed,ERBB2,10
breast carcinoma,PACLITAXEL,1,Terminated,TUBB4B,10
breast carcinoma,PACLITAXEL,1,Terminated,TUBB8,10
breast carcinoma,PACLITAXEL,1,Terminated,TUBB6,10
breast carcinoma,PACLITAXEL,1,Terminated,TUBB1,10
breast carcinoma,PACLITAXEL,1,Terminated,TUBB,10
breast carcinoma,TAMOXIFEN,2,"Active, not recruiting",ESR1,10
breast carcinoma,TAMOXIFEN,3,"Active, not recruiting",ESR1,10
breast carcinoma,CAPECITABINE,3,Recruiting,TYMS,10
breast carcinoma,ANASTROZOLE,3,"Active, not recruiting",CYP19A1,10
breast carcinoma,ZOLEDRONIC ACID,3,Completed,FDPS,10
breast carcinoma,OLAPARIB,2,Recruiting,PARP3,9
breast carcinoma,ATEZOLIZUMAB,2,Recruiting,CD274,9
breast carcinoma,DOCETAXEL,4,n/a,TUBB6,9
breast carcinoma,DOCETAXEL,4,n/a,TUBB8,9
breast carcinoma,DOCETAXEL,4,n/a,TUBB,9
breast carcinoma,DOCETAXEL,4,n/a,TUBB1,9
breast carcinoma,DOXORUBICIN,3,Unknown status,TOP2A,9
breast carcinoma,FLUOROURACIL,2,Completed,TYMS,9
breast carcinoma,DOCETAXEL,4,n/a,TUBB2A,9
breast carcinoma,OLAPARIB,2,Recruiting,PARP2,9
breast carcinoma,OLAPARIB,2,Recruiting,PARP1,9
breast carcinoma,DOCETAXEL,4,n/a,TUBB2B,9
breast carcinoma,DOCETAXEL,4,n/a,TUBB3,9
breast carcinoma,ANASTROZOLE,2,Recruiting,CYP19A1,9
breast carcinoma,GOSERELIN,3,Completed,GNRHR,9
breast carcinoma,DOCETAXEL,4,n/a,TUBB4A,9
breast carcinoma,DOCETAXEL,4,n/a,TUBB4B,9
breast carcinoma,FLUOROURACIL,2,Unknown status,TYMS,9
breast carcinoma,SARGRAMOSTIM,2,Completed,CSF2RA,9
breast carcinoma,BEVACIZUMAB,2,Unknown status,VEGFA,8
breast carcinoma,PACLITAXEL,1,Unknown status,TUBB,8
breast carcinoma,PACLITAXEL,1,Unknown status,TUBB1,8
breast carcinoma,GEMCITABINE,2,Terminated,POLD2,8
breast carcinoma,PACLITAXEL,1,Unknown status,TUBB2A,8
breast carcinoma,FILGRASTIM,1,Completed,CSF3R,8
breast carcinoma,GEMCITABINE,2,Terminated,POLA2,8
breast carcinoma,PACLITAXEL,1,Unknown status,TUBB2B,8
breast carcinoma,TRASTUZUMAB EMTANSINE,2,"Active, not recruiting",TUBB4A,8
breast carcinoma,VINORELBINE,1,Completed,TUBB4B,8
breast carcinoma,VINORELBINE,1,Completed,TUBB4A,8
breast carcinoma,VINORELBINE,1,Completed,TUBB3,8
breast carcinoma,VINORELBINE,1,Completed,TUBB2B,8
breast carcinoma,VINORELBINE,1,Completed,TUBB2A,8
breast carcinoma,TRASTUZUMAB EMTANSINE,2,"Active, not recruiting",TUBB3,8
breast carcinoma,TRASTUZUMAB EMTANSINE,2,"Active, not recruiting",TUBB4B,8
breast carcinoma,GEMCITABINE,2,Terminated,POLD1,8
breast carcinoma,TRASTUZUMAB EMTANSINE,2,"Active, not recruiting",TUBB6,8
breast carcinoma,TRASTUZUMAB EMTANSINE,2,"Active, not recruiting",TUBB8,8
breast carcinoma,VINORELBINE,1,Completed,TUBB1,8
breast carcinoma,LETROZOLE,3,Recruiting,CYP19A1,8
breast carcinoma,VINORELBINE,1,Completed,TUBB,8
breast carcinoma,PALBOCICLIB,2,Not yet recruiting,CCND1,8
breast carcinoma,VINORELBINE,1,Completed,TUBB6,8
breast carcinoma,VINORELBINE,1,Completed,TUBB8,8
breast carcinoma,TRASTUZUMAB EMTANSINE,2,"Active, not recruiting",TUBB2B,8
breast carcinoma,TRASTUZUMAB EMTANSINE,2,"Active, not recruiting",TUBB2A,8
breast carcinoma,TRASTUZUMAB EMTANSINE,2,"Active, not recruiting",TUBB1,8
breast carcinoma,TRASTUZUMAB EMTANSINE,2,"Active, not recruiting",TUBB,8
breast carcinoma,LAPATINIB,1,Terminated,EGFR,8
breast carcinoma,LAPATINIB,1,Terminated,ERBB2,8
breast carcinoma,LAPATINIB,2,"Active, not recruiting",EGFR,8
breast carcinoma,LAPATINIB,2,"Active, not recruiting",ERBB2,8
breast carcinoma,PACLITAXEL,1,Unknown status,TUBB8,8
breast carcinoma,PACLITAXEL,1,Unknown status,TUBB6,8
breast carcinoma,PACLITAXEL,1,Unknown status,TUBB4B,8
breast carcinoma,FULVESTRANT,2,Terminated,ESR2,8
breast carcinoma,FULVESTRANT,2,Terminated,ESR1,8
breast carcinoma,PACLITAXEL,1,Unknown status,TUBB4A,8
breast carcinoma,PACLITAXEL,1,Unknown status,TUBB3,8
breast carcinoma,GEMCITABINE,2,Terminated,POLA1,8
breast carcinoma,TRASTUZUMAB EMTANSINE,2,"Active, not recruiting",ERBB2,8
breast carcinoma,FULVESTRANT,1,Completed,ESR1,8
breast carcinoma,GEMCITABINE,2,Terminated,RRM1,8
breast carcinoma,GEMCITABINE,2,Terminated,POLD3,8
breast carcinoma,GEMCITABINE,2,Terminated,POLD4,8
breast carcinoma,GEMCITABINE,2,Terminated,POLE,8
breast carcinoma,GEMCITABINE,2,Terminated,POLE2,8
breast carcinoma,GEMCITABINE,2,Terminated,POLE3,8
breast carcinoma,FLUOROURACIL,2,"Active, not recruiting",TYMS,8
breast carcinoma,GEMCITABINE,2,Terminated,PRIM1,8
breast carcinoma,FULVESTRANT,1,Completed,ESR2,8
breast carcinoma,FLUOROURACIL,3,Unknown status,TYMS,8
breast carcinoma,GEMCITABINE,2,Terminated,PRIM2,8
breast carcinoma,PERTUZUMAB,3,"Active, not recruiting",ERBB2,8
breast carcinoma,VINORELBINE,2,Unknown status,TUBB3,7
breast carcinoma,DOCETAXEL,1,Terminated,TUBB8,7
breast carcinoma,NERATINIB,2,Recruiting,ERBB3,7
breast carcinoma,NERATINIB,2,Recruiting,ERBB4,7
breast carcinoma,CAPECITABINE,2,Not yet recruiting,TYMS,7
breast carcinoma,DOCETAXEL,1,Terminated,TUBB,7
breast carcinoma,DOCETAXEL,1,Terminated,TUBB2B,7
breast carcinoma,LETROZOLE,4,Completed,CYP19A1,7
breast carcinoma,DOCETAXEL,1,Terminated,TUBB3,7
breast carcinoma,EVEROLIMUS,2,"Active, not recruiting",FKBP1A,7
breast carcinoma,DOCETAXEL,1,Terminated,TUBB4A,7
breast carcinoma,EXEMESTANE,3,"Active, not recruiting",CYP19A1,7
breast carcinoma,EVEROLIMUS,2,Recruiting,FKBP1A,7
breast carcinoma,ANASTROZOLE,2,"Active, not recruiting",CYP19A1,7
breast carcinoma,VINORELBINE,2,Unknown status,TUBB8,7
breast carcinoma,PEMETREXED,2,Completed,TYMS,7
breast carcinoma,GOSERELIN,2,Completed,GNRHR,7
breast carcinoma,FULVESTRANT,3,Completed,ESR1,7
breast carcinoma,FULVESTRANT,3,Completed,ESR2,7
breast carcinoma,PEMETREXED,2,Completed,GART,7
breast carcinoma,PEMETREXED,2,Completed,DHFR,7
breast carcinoma,VINORELBINE,2,Unknown status,TUBB6,7
breast carcinoma,VINORELBINE,2,Unknown status,TUBB4B,7
breast carcinoma,DOCETAXEL,1,Terminated,TUBB6,7
breast carcinoma,DOCETAXEL,1,Terminated,TUBB4B,7
breast carcinoma,VINORELBINE,2,Unknown status,TUBB,7
breast carcinoma,VINORELBINE,2,Unknown status,TUBB1,7
breast carcinoma,VINORELBINE,2,Unknown status,TUBB4A,7
breast carcinoma,VINORELBINE,2,Unknown status,TUBB2A,7
breast carcinoma,VINORELBINE,2,Unknown status,TUBB2B,7
breast carcinoma,DOCETAXEL,1,Terminated,TUBB2A,7
breast carcinoma,DOCETAXEL,1,Terminated,TUBB1,7
breast carcinoma,DOCETAXEL,3,Recruiting,TUBB,7
breast carcinoma,NERATINIB,1,Completed,ERBB3,7
breast carcinoma,DOCETAXEL,3,Recruiting,TUBB6,7
breast carcinoma,DOCETAXEL,3,Recruiting,TUBB1,7
male breast carcinoma,PACLITAXEL,1,Completed,TUBB4B,7
breast carcinoma,CAPECITABINE,4,n/a,TYMS,7
breast carcinoma,ALPELISIB,1,"Active, not recruiting",PIK3CA,7
breast carcinoma,FLUOROURACIL,3,"Active, not recruiting",TYMS,7
male breast carcinoma,PACLITAXEL,1,Completed,TUBB6,7
breast carcinoma,DOCETAXEL,3,Recruiting,TUBB4B,7
breast carcinoma,BEVACIZUMAB,2,"Active, not recruiting",VEGFA,7
male breast carcinoma,PACLITAXEL,1,Completed,TUBB8,7
breast carcinoma,BEVACIZUMAB,1,Completed,VEGFA,7
breast carcinoma,DOCETAXEL,3,Recruiting,TUBB4A,7
breast carcinoma,DOCETAXEL,3,Recruiting,TUBB2A,7
breast carcinoma,DOCETAXEL,3,Recruiting,TUBB3,7
breast carcinoma,DOCETAXEL,3,Recruiting,TUBB2B,7
male breast carcinoma,PACLITAXEL,1,Completed,TUBB4A,7
breast carcinoma,NERATINIB,1,Completed,ERBB4,7
breast carcinoma,TAMOXIFEN,2,Terminated,ESR1,7
male breast carcinoma,PACLITAXEL,1,Completed,TUBB,7
breast carcinoma,LETROZOLE,1,Completed,CYP19A1,7
breast carcinoma,TRASTUZUMAB,3,Unknown status,ERBB2,7
breast carcinoma,ANASTROZOLE,3,Recruiting,CYP19A1,7
breast carcinoma,TRASTUZUMAB,2,Withdrawn,ERBB2,7
breast carcinoma,DOCETAXEL,3,Recruiting,TUBB8,7
male breast carcinoma,PACLITAXEL,1,Completed,TUBB1,7
male breast carcinoma,PACLITAXEL,1,Completed,TUBB2A,7
male breast carcinoma,PACLITAXEL,1,Completed,TUBB2B,7
breast carcinoma,PERTUZUMAB,3,Recruiting,ERBB2,7
breast carcinoma,ANASTROZOLE,4,Completed,CYP19A1,7
male breast carcinoma,PACLITAXEL,1,Completed,TUBB3,7
breast carcinoma,VINORELBINE,3,Completed,TUBB2B,6
breast carcinoma,VINORELBINE,3,Completed,TUBB3,6
breast carcinoma,VINORELBINE,3,Completed,TUBB4A,6
breast carcinoma,VINORELBINE,3,Completed,TUBB,6
breast carcinoma,APATINIB,2,Recruiting,KDR,6
breast carcinoma,ANASTROZOLE,2,Unknown status,CYP19A1,6
breast carcinoma,VINORELBINE,3,Completed,TUBB1,6
breast carcinoma,VINORELBINE,3,Completed,TUBB2A,6
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Recruiting,TUBB,6
breast carcinoma,ERLOTINIB,2,Completed,EGFR,6
breast carcinoma,VINORELBINE,1,Terminated,TUBB6,6
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Recruiting,TUBB1,6
breast carcinoma,LETROZOLE,2,Unknown status,CYP19A1,6
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Recruiting,TUBB2A,6
breast carcinoma,VINORELBINE,1,Terminated,TUBB8,6
breast carcinoma,VINORELBINE,1,Terminated,TUBB2A,6
breast carcinoma,VINORELBINE,2,Recruiting,TUBB4A,6
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Recruiting,ERBB2,6
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Recruiting,TUBB2B,6
breast carcinoma,SORAFENIB,2,Terminated,RET,6
breast carcinoma,CELECOXIB,2,Completed,PTGS2,6
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Recruiting,TUBB8,6
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Recruiting,TUBB6,6
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Recruiting,TUBB4B,6
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Recruiting,TUBB4A,6
breast carcinoma,DOCETAXEL,4,Completed,TUBB1,6
breast carcinoma,PALBOCICLIB,3,"Active, not recruiting",CDK6,6
breast carcinoma,PALBOCICLIB,3,"Active, not recruiting",CDK4,6
breast carcinoma,DOCETAXEL,4,Completed,TUBB,6
breast carcinoma,VINORELBINE,2,Recruiting,TUBB,6
breast carcinoma,VINORELBINE,2,Recruiting,TUBB1,6
breast carcinoma,TAMOXIFEN,3,Recruiting,ESR1,6
breast carcinoma,VINORELBINE,2,Recruiting,TUBB2A,6
breast carcinoma,DOCETAXEL,4,Completed,TUBB3,6
breast carcinoma,LAPATINIB,3,"Active, not recruiting",EGFR,6
breast carcinoma,VINORELBINE,2,Recruiting,TUBB2B,6
breast carcinoma,VINORELBINE,2,Recruiting,TUBB3,6
breast carcinoma,CAPECITABINE,1,Recruiting,TYMS,6
breast carcinoma,VINORELBINE,3,Completed,TUBB6,6
breast carcinoma,LAPATINIB,3,"Active, not recruiting",ERBB2,6
breast carcinoma,ZOLEDRONIC ACID,2,Completed,FDPS,6
breast carcinoma,VINORELBINE,2,Recruiting,TUBB4B,6
breast carcinoma,VINORELBINE,2,Recruiting,TUBB6,6
breast carcinoma,VINORELBINE,2,Recruiting,TUBB8,6
breast carcinoma,PALBOCICLIB,1,"Active, not recruiting",CCND1,6
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Recruiting,TUBB3,6
breast carcinoma,VINORELBINE,3,Completed,TUBB4B,6
breast carcinoma,BUPARLISIB,2,Completed,PIK3R1,6
breast carcinoma,VINORELBINE,3,Completed,TUBB8,6
breast carcinoma,SORAFENIB,2,Terminated,KIT,6
breast carcinoma,DOCETAXEL,4,Completed,TUBB8,6
breast carcinoma,EXEMESTANE,3,Unknown status,CYP19A1,6
breast carcinoma,EXEMESTANE,3,Recruiting,CYP19A1,6
breast carcinoma,EXEMESTANE,2,Withdrawn,CYP19A1,6
breast carcinoma,SORAFENIB,2,Terminated,PDGFRB,6
breast carcinoma,DOCETAXEL,4,Completed,TUBB2A,6
breast carcinoma,SORAFENIB,2,Terminated,KDR,6
breast carcinoma,DOCETAXEL,2,Withdrawn,TUBB,6
breast carcinoma,METHOTREXATE,2,Unknown status,DHFR,6
breast carcinoma,SORAFENIB,2,Terminated,FLT4,6
breast carcinoma,SORAFENIB,2,Terminated,FLT3,6
breast carcinoma,SORAFENIB,2,Terminated,FLT1,6
breast carcinoma,DOCETAXEL,4,Completed,TUBB4A,6
breast carcinoma,RIBOCICLIB,1,"Active, not recruiting",CDK4,6
breast carcinoma,SORAFENIB,2,Terminated,RAF1,6
breast carcinoma,FILGRASTIM,1,Unknown status,CSF3R,6
breast carcinoma,GOSERELIN,2,Recruiting,GNRHR,6
breast carcinoma,DOCETAXEL,2,Withdrawn,TUBB4B,6
breast carcinoma,LETROZOLE,1,"Active, not recruiting",CYP19A1,6
breast carcinoma,VINORELBINE,1,Terminated,TUBB3,6
breast carcinoma,VINORELBINE,1,Terminated,TUBB4A,6
breast carcinoma,VINORELBINE,1,Terminated,TUBB4B,6
breast carcinoma,DOCETAXEL,2,Withdrawn,TUBB8,6
breast carcinoma,DOCETAXEL,2,Withdrawn,TUBB6,6
breast carcinoma,NERATINIB,2,Completed,EGFR,6
breast carcinoma,DOCETAXEL,2,Withdrawn,TUBB1,6
breast carcinoma,NERATINIB,2,Completed,ERBB2,6
breast carcinoma,BEVACIZUMAB,3,"Active, not recruiting",VEGFA,6
breast carcinoma,DOCETAXEL,2,Withdrawn,TUBB4A,6
breast carcinoma,DOCETAXEL,2,Withdrawn,TUBB3,6
breast carcinoma,DOCETAXEL,2,Withdrawn,TUBB2B,6
breast carcinoma,DOCETAXEL,2,Withdrawn,TUBB2A,6
breast carcinoma,RIBOCICLIB,1,"Active, not recruiting",CDK6,6
breast carcinoma,DOCETAXEL,4,Completed,TUBB6,6
breast carcinoma,DOCETAXEL,4,Completed,TUBB2B,6
breast carcinoma,BUPARLISIB,1,Completed,PIK3CD,6
breast carcinoma,BUPARLISIB,2,Completed,PIK3CA,6
breast carcinoma,BUPARLISIB,2,Completed,PIK3CG,6
breast carcinoma,VINORELBINE,1,Terminated,TUBB2B,6
breast carcinoma,BUPARLISIB,2,Completed,PIK3R2,6
breast carcinoma,BUPARLISIB,2,Completed,PIK3R3,6
breast carcinoma,BUPARLISIB,2,Completed,PIK3R5,6
breast carcinoma,DOCETAXEL,4,Completed,TUBB4B,6
breast carcinoma,RIBOCICLIB,2,Recruiting,CDK6,6
breast carcinoma,BUPARLISIB,1,Completed,PIK3R5,6
breast carcinoma,BUPARLISIB,1,Completed,PIK3R3,6
breast carcinoma,BUPARLISIB,1,Completed,PIK3R2,6
breast carcinoma,BUPARLISIB,1,Completed,PIK3R1,6
breast carcinoma,BUPARLISIB,2,Completed,PIK3CD,6
breast carcinoma,BUPARLISIB,1,Completed,PIK3CG,6
breast carcinoma,SORAFENIB,2,Terminated,BRAF,6
breast carcinoma,BUPARLISIB,1,Completed,PIK3CB,6
breast carcinoma,VINORELBINE,1,Terminated,TUBB1,6
breast carcinoma,BUPARLISIB,1,Completed,PIK3CA,6
breast carcinoma,NIVOLUMAB,2,Recruiting,PDCD1,6
breast carcinoma,BUPARLISIB,2,Completed,PIK3CB,6
breast carcinoma,VINORELBINE,1,Terminated,TUBB,6
breast carcinoma,RIBOCICLIB,2,Recruiting,CDK4,6
breast carcinoma,DASATINIB,2,Completed,SRMS,5
breast carcinoma,DASATINIB,2,Completed,SRC,5
breast carcinoma,DASATINIB,2,Completed,PDGFRB,5
breast carcinoma,DASATINIB,2,Completed,LYN,5
breast carcinoma,ERIBULIN,2,Terminated,TUBB4B,5
breast carcinoma,ERIBULIN,2,Terminated,TUBB6,5
breast carcinoma,DASATINIB,2,Completed,YES1,5
breast carcinoma,ERIBULIN,2,Terminated,TUBB8,5
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB6,5
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB8,5
breast carcinoma,DASATINIB,2,Completed,LCK,5
breast carcinoma,METFORMIN,2,Completed,GPD2,5
breast carcinoma,ERIBULIN,2,Terminated,TUBB4A,5
breast carcinoma,DASATINIB,2,Completed,EPHA2,5
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,ERBB2,5
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB1,5
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB4A,5
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB4B,5
breast carcinoma,ERIBULIN,2,Terminated,TUBB2B,5
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB2B,5
breast carcinoma,ERIBULIN,2,Terminated,TUBB2A,5
breast carcinoma,ERIBULIN,2,Terminated,TUBB1,5
breast carcinoma,ERIBULIN,2,Terminated,TUBB,5
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB2A,5
breast carcinoma,DASATINIB,2,Completed,FGR,5
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB,5
breast carcinoma,DASATINIB,2,Completed,FRK,5
breast carcinoma,DASATINIB,2,Completed,FYN,5
breast carcinoma,DASATINIB,2,Completed,HCK,5
breast carcinoma,DASATINIB,2,Completed,KIT,5
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB3,5
breast carcinoma,DASATINIB,2,Completed,ABL1,5
breast carcinoma,DASATINIB,2,Completed,BLK,5
breast carcinoma,ERIBULIN,2,Terminated,TUBB3,5
breast carcinoma,IXABEPILONE,1,Completed,TUBB,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFAB1,5
breast carcinoma,IXABEPILONE,1,Completed,TUBB1,5
breast carcinoma,DOXORUBICIN,1,Terminated,TOP2A,5
breast carcinoma,LAPATINIB,1,"Active, not recruiting",ERBB2,5
breast carcinoma,LAPATINIB,1,"Active, not recruiting",EGFR,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Completed,TUBB3,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Completed,TUBB2B,5
breast carcinoma,VINORELBINE,3,Recruiting,TUBB8,5
breast carcinoma,VINORELBINE,3,Recruiting,TUBB6,5
breast carcinoma,VINORELBINE,3,Recruiting,TUBB4B,5
breast carcinoma,VINORELBINE,3,Recruiting,TUBB4A,5
breast carcinoma,VINORELBINE,3,Recruiting,TUBB3,5
breast carcinoma,VINORELBINE,3,Recruiting,TUBB2B,5
breast carcinoma,VINORELBINE,3,Recruiting,TUBB2A,5
breast carcinoma,VINORELBINE,3,Recruiting,TUBB1,5
breast carcinoma,VINORELBINE,3,Recruiting,TUBB,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Completed,TUBB2A,5
breast carcinoma,DOXORUBICIN,2,Withdrawn,TOP2A,5
breast carcinoma,IXABEPILONE,1,Completed,TUBB2A,5
breast carcinoma,DOXORUBICIN,3,Recruiting,TOP2A,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,"Active, not recruiting",ERBB2,5
breast carcinoma,DURVALUMAB,1,Recruiting,CD274,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,"Active, not recruiting",TUBB,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,"Active, not recruiting",TUBB1,5
breast carcinoma,DURVALUMAB,2,Recruiting,CD274,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,"Active, not recruiting",TUBB2A,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,"Active, not recruiting",TUBB2B,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,"Active, not recruiting",TUBB3,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,"Active, not recruiting",TUBB4A,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,"Active, not recruiting",TUBB4B,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Completed,TUBB1,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Completed,TUBB,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Completed,ERBB2,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Completed,TUBB4A,5
breast carcinoma,LAPATINIB,2,Unknown status,EGFR,5
breast carcinoma,LAPATINIB,2,Unknown status,ERBB2,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Completed,TUBB4B,5
breast carcinoma,IXABEPILONE,1,Completed,TUBB2B,5
breast carcinoma,IXABEPILONE,1,Completed,TUBB3,5
breast carcinoma,IXABEPILONE,1,Completed,TUBB4A,5
breast carcinoma,IXABEPILONE,1,Completed,TUBB4B,5
breast carcinoma,IXABEPILONE,1,Completed,TUBB6,5
breast carcinoma,IXABEPILONE,1,Completed,TUBB8,5
breast carcinoma,ERIBULIN,1,"Active, not recruiting",TUBB8,5
breast carcinoma,ERIBULIN,1,"Active, not recruiting",TUBB6,5
breast carcinoma,ERIBULIN,1,"Active, not recruiting",TUBB4B,5
breast carcinoma,ERIBULIN,1,"Active, not recruiting",TUBB4A,5
breast carcinoma,TAMOXIFEN,2,Unknown status,ESR1,5
breast carcinoma,ERIBULIN,1,"Active, not recruiting",TUBB3,5
breast carcinoma,ERIBULIN,1,"Active, not recruiting",TUBB2B,5
breast carcinoma,ERIBULIN,1,"Active, not recruiting",TUBB2A,5
breast carcinoma,ERIBULIN,1,"Active, not recruiting",TUBB1,5
breast carcinoma,ERIBULIN,1,"Active, not recruiting",TUBB,5
breast carcinoma,ENZALUTAMIDE,2,"Active, not recruiting",AR,5
breast carcinoma,DOCETAXEL,3,Terminated,TUBB,5
breast carcinoma,DOCETAXEL,3,Terminated,TUBB1,5
breast carcinoma,DOCETAXEL,3,Terminated,TUBB2A,5
breast carcinoma,DOCETAXEL,3,Terminated,TUBB2B,5
breast carcinoma,DOCETAXEL,3,Terminated,TUBB3,5
breast carcinoma,DOCETAXEL,3,Terminated,TUBB4A,5
breast carcinoma,DOCETAXEL,3,Terminated,TUBB4B,5
breast carcinoma,DOCETAXEL,3,Terminated,TUBB6,5
breast carcinoma,DOCETAXEL,3,Terminated,TUBB8,5
breast carcinoma,METFORMIN,2,Completed,MT-ND2,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Completed,TUBB8,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Completed,TUBB6,5
breast carcinoma,METFORMIN,2,Completed,MT-ND1,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFB11,5
breast carcinoma,METFORMIN,2,Completed,MT-ND3,5
breast carcinoma,CAPECITABINE,1,"Active, not recruiting",TYMS,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFA13,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFA2,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFA3,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFA4,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFA4L2,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFA5,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFA6,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFA7,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFA8,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFA9,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFAF1,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFAF2,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFAF3,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFAF4,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFB1,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFB10,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,"Active, not recruiting",TUBB6,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFB2,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFB3,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFB4,5
breast carcinoma,CAPECITABINE,1,Terminated,TYMS,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFA12,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFA11,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFA10,5
breast carcinoma,METFORMIN,2,Completed,NDUFV2,5
breast carcinoma,METFORMIN,2,Completed,NDUFS1,5
breast carcinoma,METFORMIN,2,Completed,NDUFS2,5
breast carcinoma,METFORMIN,2,Completed,NDUFS3,5
breast carcinoma,METFORMIN,2,Completed,NDUFS4,5
breast carcinoma,METFORMIN,2,Completed,NDUFS5,5
breast carcinoma,METFORMIN,2,Completed,NDUFS6,5
breast carcinoma,METFORMIN,2,Completed,NDUFS7,5
breast carcinoma,METFORMIN,2,Completed,NDUFS8,5
breast carcinoma,METFORMIN,2,Completed,NDUFV1,5
breast carcinoma,METFORMIN,2,Completed,NDUFV3,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFA1,5
breast carcinoma,METFORMIN,2,Recruiting,GPD2,5
breast carcinoma,METFORMIN,2,Recruiting,MT-ND1,5
breast carcinoma,METFORMIN,2,Recruiting,MT-ND2,5
breast carcinoma,CELECOXIB,2,Terminated,PTGS2,5
breast carcinoma,METFORMIN,2,Recruiting,MT-ND3,5
breast carcinoma,METFORMIN,2,Recruiting,MT-ND4,5
breast carcinoma,METFORMIN,2,Recruiting,MT-ND4L,5
breast carcinoma,METFORMIN,2,Recruiting,MT-ND5,5
breast carcinoma,METFORMIN,2,Recruiting,MT-ND6,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFB5,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFB6,5
breast carcinoma,METFORMIN,2,Completed,NDUFC1,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFB7,5
breast carcinoma,EXEMESTANE,1,"Active, not recruiting",CYP19A1,5
breast carcinoma,METHOTREXATE,2,Completed,DHFR,5
breast carcinoma,EXEMESTANE,2,Terminated,CYP19A1,5
breast carcinoma,EXEMESTANE,4,Completed,CYP19A1,5
breast carcinoma,EXEMESTANE,4,n/a,CYP19A1,5
breast carcinoma,PERTUZUMAB,1,Completed,ERBB2,5
breast carcinoma,PEMBROLIZUMAB,2,Not yet recruiting,PDCD1,5
breast carcinoma,PEMBROLIZUMAB,2,"Active, not recruiting",PDCD1,5
breast carcinoma,ANASTROZOLE,3,Unknown status,CYP19A1,5
breast carcinoma,ANASTROZOLE,1,Completed,CYP19A1,5
breast carcinoma,FULVESTRANT,1,"Active, not recruiting",ESR1,5
breast carcinoma,FULVESTRANT,1,"Active, not recruiting",ESR2,5
breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,5
breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB1,5
breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB2A,5
breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB2B,5
breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB3,5
breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB4A,5
breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB4B,5
breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB6,5
breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB8,5
breast carcinoma,EVEROLIMUS,3,Completed,FKBP1A,5
breast carcinoma,RIBOCICLIB,3,"Active, not recruiting",CDK4,5
breast carcinoma,RIBOCICLIB,3,"Active, not recruiting",CDK6,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFS6,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFB8,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFB9,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFC1,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFC2,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFS1,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFS2,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFS3,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFS4,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFS5,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFS7,5
breast carcinoma,METFORMIN,2,Completed,MT-ND4,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFS8,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFV1,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFV2,5
breast carcinoma,METFORMIN,2,Recruiting,NDUFV3,5
breast carcinoma,ERLOTINIB,1,Completed,EGFR,5
breast carcinoma,ERLOTINIB,2,Terminated,EGFR,5
breast carcinoma,ETOPOSIDE,2,Completed,TOP2A,5
breast carcinoma,ETOPOSIDE,2,Completed,TOP2B,5
breast carcinoma,EVEROLIMUS,1,Completed,FKBP1A,5
breast carcinoma,METFORMIN,2,Completed,NDUFC2,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,"Active, not recruiting",TUBB8,5
breast carcinoma,METFORMIN,2,Completed,NDUFB5,5
breast carcinoma,METFORMIN,2,Completed,NDUFA12,5
breast carcinoma,METFORMIN,2,Completed,NDUFB2,5
breast carcinoma,METFORMIN,2,Completed,NDUFB1,5
breast carcinoma,METFORMIN,2,Completed,NDUFAF1,5
breast carcinoma,METFORMIN,2,Completed,NDUFAB1,5
breast carcinoma,METFORMIN,2,Completed,NDUFA9,5
breast carcinoma,METFORMIN,2,Completed,NDUFA8,5
breast carcinoma,METFORMIN,2,Completed,NDUFA7,5
breast carcinoma,METFORMIN,2,Completed,NDUFB7,5
breast carcinoma,METFORMIN,2,Completed,NDUFB8,5
breast carcinoma,METFORMIN,2,Completed,NDUFB9,5
breast carcinoma,METFORMIN,2,Completed,NDUFB6,5
breast carcinoma,METFORMIN,2,Completed,NDUFB3,5
breast carcinoma,METFORMIN,2,Completed,NDUFAF2,5
breast carcinoma,METFORMIN,2,Completed,NDUFA6,5
breast carcinoma,METFORMIN,2,Completed,NDUFA5,5
breast carcinoma,METFORMIN,2,Completed,NDUFB10,5
breast carcinoma,METFORMIN,2,Completed,NDUFB4,5
breast carcinoma,METFORMIN,2,Completed,NDUFAF3,5
breast carcinoma,METFORMIN,2,Completed,NDUFAF4,5
breast carcinoma,METFORMIN,2,Completed,MT-ND4L,5
breast carcinoma,METFORMIN,2,Completed,MT-ND5,5
breast carcinoma,METFORMIN,2,Completed,MT-ND6,5
breast carcinoma,METFORMIN,2,Completed,NDUFA1,5
breast carcinoma,METFORMIN,2,Completed,NDUFA4L2,5
breast carcinoma,METFORMIN,2,Completed,NDUFA4,5
breast carcinoma,METFORMIN,2,Completed,NDUFA3,5
breast carcinoma,METFORMIN,2,Completed,NDUFA2,5
breast carcinoma,METFORMIN,2,Completed,NDUFA13,5
breast carcinoma,METFORMIN,2,Completed,NDUFA10,5
breast carcinoma,METFORMIN,2,Completed,NDUFA11,5
breast carcinoma,METFORMIN,2,Completed,NDUFB11,5
breast carcinoma,SORAFENIB,2,Completed,RET,4
breast carcinoma,FULVESTRANT,2,Unknown status,ESR1,4
male breast carcinoma,TRASTUZUMAB,1,Completed,ERBB2,4
breast carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB6,4
breast carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB4B,4
breast carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB4A,4
breast carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB3,4
breast carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB2B,4
breast carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB8,4
breast carcinoma,TRASTUZUMAB EMTANSINE,3,"Active, not recruiting",TUBB6,4
breast carcinoma,FULVESTRANT,2,Unknown status,ESR2,4
breast carcinoma,GEMCITABINE,2,Recruiting,RRM1,4
breast carcinoma,GEMCITABINE,2,Recruiting,POLE2,4
breast carcinoma,FULVESTRANT,3,Unknown status,ESR2,4
breast carcinoma,FULVESTRANT,3,Unknown status,ESR1,4
breast carcinoma,TRASTUZUMAB,1,Unknown status,ERBB2,4
breast carcinoma,GEMCITABINE,2,Recruiting,POLE3,4
breast carcinoma,GEMCITABINE,2,Recruiting,PRIM1,4
breast carcinoma,TRASTUZUMAB EMTANSINE,3,"Active, not recruiting",TUBB8,4
breast carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB1,4
breast carcinoma,TRASTUZUMAB EMTANSINE,3,"Active, not recruiting",TUBB4B,4
breast carcinoma,TRASTUZUMAB EMTANSINE,3,"Active, not recruiting",TUBB4A,4
breast carcinoma,TRASTUZUMAB EMTANSINE,3,"Active, not recruiting",TUBB3,4
breast carcinoma,ERIBULIN,3,Recruiting,TUBB8,4
breast carcinoma,ERIBULIN,3,Recruiting,TUBB6,4
breast carcinoma,ERIBULIN,3,Recruiting,TUBB4B,4
breast carcinoma,GEMCITABINE,2,Recruiting,PRIM2,4
breast carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB2A,4
breast carcinoma,ERIBULIN,3,Recruiting,TUBB2B,4
breast carcinoma,LAPATINIB,2,Recruiting,EGFR,4
breast carcinoma,GEMCITABINE,3,Recruiting,POLE2,4
breast carcinoma,GEMCITABINE,3,Recruiting,POLA1,4
breast carcinoma,GEMCITABINE,3,Recruiting,POLA2,4
breast carcinoma,GEMCITABINE,3,Recruiting,POLD1,4
breast carcinoma,NERATINIB,1,Recruiting,ERBB2,4
breast carcinoma,NERATINIB,1,Recruiting,EGFR,4
breast carcinoma,GEMCITABINE,3,Recruiting,POLD2,4
breast carcinoma,GEMCITABINE,3,Recruiting,POLD3,4
breast carcinoma,GEMCITABINE,3,Recruiting,POLD4,4
breast carcinoma,PERTUZUMAB,3,Completed,ERBB2,4
breast carcinoma,GEMCITABINE,3,Recruiting,POLE,4
breast carcinoma,GEMCITABINE,3,Recruiting,POLE3,4
breast carcinoma,LAPATINIB,2,Recruiting,ERBB2,4
breast carcinoma,GEMCITABINE,3,Recruiting,PRIM1,4
breast carcinoma,GEMCITABINE,3,Recruiting,PRIM2,4
breast carcinoma,GEMCITABINE,3,Recruiting,RRM1,4
breast carcinoma,AZD-5363,1,"Active, not recruiting",AKT1,4
breast carcinoma,AZD-5363,1,"Active, not recruiting",AKT2,4
breast carcinoma,AZD-5363,1,"Active, not recruiting",AKT3,4
breast carcinoma,SORAFENIB,2,Completed,RAF1,4
breast carcinoma,BEVACIZUMAB,2,Recruiting,VEGFA,4
breast carcinoma,BEVACIZUMAB,3,Terminated,VEGFA,4
breast carcinoma,GEMCITABINE,4,n/a,POLA1,4
breast carcinoma,ATEZOLIZUMAB,3,Recruiting,CD274,4
breast carcinoma,ATEZOLIZUMAB,1,Recruiting,CD274,4
breast carcinoma,NERATINIB,3,"Active, not recruiting",EGFR,4
breast carcinoma,NERATINIB,3,"Active, not recruiting",ERBB2,4
breast carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB,4
breast carcinoma,ERIBULIN,3,Recruiting,TUBB4A,4
breast carcinoma,ERIBULIN,3,Recruiting,TUBB3,4
breast carcinoma,GEMCITABINE,2,Unknown status,POLA1,4
breast carcinoma,GEMCITABINE,2,Unknown status,POLA2,4
breast carcinoma,GEMCITABINE,2,Unknown status,POLD1,4
breast carcinoma,GEMCITABINE,2,Unknown status,POLD2,4
breast carcinoma,GEMCITABINE,2,Unknown status,POLD3,4
breast carcinoma,ERIBULIN,3,Recruiting,TUBB2A,4
breast carcinoma,GEMCITABINE,2,Unknown status,POLD4,4
breast carcinoma,GEMCITABINE,2,Unknown status,POLE,4
breast carcinoma,GEMCITABINE,2,Unknown status,POLE2,4
breast carcinoma,GEMCITABINE,2,Unknown status,POLE3,4
breast carcinoma,GEMCITABINE,2,Unknown status,PRIM1,4
breast carcinoma,GEMCITABINE,2,Unknown status,PRIM2,4
breast carcinoma,GEMCITABINE,2,Unknown status,RRM1,4
breast carcinoma,ERIBULIN,3,Recruiting,TUBB1,4
breast carcinoma,ERIBULIN,3,Recruiting,TUBB,4
breast carcinoma,PERTUZUMAB,1,"Active, not recruiting",ERBB2,4
breast carcinoma,TRASTUZUMAB EMTANSINE,3,"Active, not recruiting",TUBB2B,4
breast carcinoma,PERTUZUMAB,1,Recruiting,ERBB2,4
breast carcinoma,GEMCITABINE,2,Recruiting,POLE,4
breast carcinoma,PACLITAXEL,2,Withdrawn,TUBB4B,4
breast carcinoma,GEMCITABINE,2,Recruiting,POLD4,4
breast carcinoma,GEMCITABINE,1,Completed,POLD2,4
breast carcinoma,GEMCITABINE,1,Completed,RRM1,4
breast carcinoma,GEMCITABINE,1,Completed,PRIM2,4
breast carcinoma,GEMCITABINE,1,Completed,PRIM1,4
breast carcinoma,GEMCITABINE,1,Completed,POLE3,4
breast carcinoma,GEMCITABINE,1,Completed,POLE2,4
breast carcinoma,GEMCITABINE,1,Completed,POLE,4
breast carcinoma,GEMCITABINE,1,Completed,POLD4,4
breast carcinoma,GEMCITABINE,1,Completed,POLD3,4
breast carcinoma,GEMCITABINE,1,Completed,POLD1,4
breast carcinoma,IXABEPILONE,3,Completed,TUBB8,4
breast carcinoma,GEMCITABINE,1,Completed,POLA2,4
breast carcinoma,GEMCITABINE,1,Completed,POLA1,4
breast carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE,4
breast carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE2,4
breast carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE3,4
breast carcinoma,GEMCITABINE,2,"Active, not recruiting",PRIM1,4
breast carcinoma,GEMCITABINE,2,"Active, not recruiting",PRIM2,4
breast carcinoma,GEMCITABINE,2,"Active, not recruiting",RRM1,4
breast carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD4,4
breast carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD3,4
breast carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD2,4
breast carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD1,4
breast carcinoma,PALBOCICLIB,4,n/a,CCND1,4
breast carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB8,4
breast carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB6,4
breast carcinoma,PALBOCICLIB,2,Not yet recruiting,CDK6,4
breast carcinoma,PALBOCICLIB,2,Not yet recruiting,CDK4,4
breast carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB4B,4
breast carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB4A,4
breast carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB3,4
breast carcinoma,IXABEPILONE,3,Completed,TUBB,4
breast carcinoma,IXABEPILONE,3,Completed,TUBB1,4
breast carcinoma,IXABEPILONE,3,Completed,TUBB2A,4
breast carcinoma,IXABEPILONE,3,Completed,TUBB2B,4
breast carcinoma,IXABEPILONE,3,Completed,TUBB3,4
breast carcinoma,IXABEPILONE,3,Completed,TUBB4A,4
breast carcinoma,IXABEPILONE,3,Completed,TUBB4B,4
breast carcinoma,GEMCITABINE,2,"Active, not recruiting",POLA1,4
breast carcinoma,GEMCITABINE,2,"Active, not recruiting",POLA2,4
breast carcinoma,IXABEPILONE,3,Completed,TUBB6,4
breast carcinoma,GEMCITABINE,2,Not yet recruiting,POLA1,4
breast carcinoma,PACLITAXEL,2,Withdrawn,TUBB,4
breast carcinoma,PACLITAXEL,3,Terminated,TUBB1,4
breast carcinoma,PACLITAXEL,3,Terminated,TUBB8,4
breast carcinoma,PACLITAXEL,3,Terminated,TUBB6,4
breast carcinoma,PACLITAXEL,3,Terminated,TUBB4B,4
breast carcinoma,PACLITAXEL,3,Terminated,TUBB4A,4
breast carcinoma,PACLITAXEL,3,Terminated,TUBB3,4
breast carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB,4
breast carcinoma,PACLITAXEL,3,Terminated,TUBB2B,4
breast carcinoma,PACLITAXEL,3,Terminated,TUBB2A,4
breast carcinoma,PACLITAXEL,3,Terminated,TUBB,4
breast carcinoma,GEMCITABINE,2,Not yet recruiting,POLA2,4
breast carcinoma,PACLITAXEL,2,Withdrawn,TUBB8,4
breast carcinoma,PACLITAXEL,2,Withdrawn,TUBB6,4
breast carcinoma,GEMCITABINE,4,n/a,POLD1,4
breast carcinoma,PACLITAXEL,2,Withdrawn,TUBB4A,4
breast carcinoma,PACLITAXEL,2,Withdrawn,TUBB3,4
breast carcinoma,PACLITAXEL,2,Withdrawn,TUBB2B,4
breast carcinoma,PACLITAXEL,2,Withdrawn,TUBB2A,4
breast carcinoma,PACLITAXEL,2,Withdrawn,TUBB1,4
breast carcinoma,GEMCITABINE,2,Recruiting,POLD3,4
breast carcinoma,GEMCITABINE,2,Recruiting,POLD2,4
breast carcinoma,GEMCITABINE,2,Recruiting,POLD1,4
breast carcinoma,GEMCITABINE,2,Recruiting,POLA2,4
breast carcinoma,GEMCITABINE,2,Not yet recruiting,POLD1,4
breast carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB2B,4
breast carcinoma,GEMCITABINE,2,Not yet recruiting,POLD2,4
breast carcinoma,GEMCITABINE,2,Not yet recruiting,POLD3,4
breast carcinoma,DOXORUBICIN,3,Terminated,TOP2A,4
breast carcinoma,GEMCITABINE,2,Not yet recruiting,POLD4,4
breast carcinoma,GEMCITABINE,2,Not yet recruiting,POLE,4
breast carcinoma,GEMCITABINE,2,Not yet recruiting,POLE2,4
breast carcinoma,GEMCITABINE,2,Not yet recruiting,POLE3,4
breast carcinoma,GEMCITABINE,2,Not yet recruiting,PRIM1,4
breast carcinoma,TRASTUZUMAB,3,Terminated,ERBB2,4
breast carcinoma,GEMCITABINE,2,Not yet recruiting,PRIM2,4
breast carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB2A,4
breast carcinoma,GEMCITABINE,2,Not yet recruiting,RRM1,4
breast carcinoma,GEMCITABINE,2,Recruiting,POLA1,4
breast carcinoma,DOXORUBICIN,1,Withdrawn,TOP2A,4
breast carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB1,4
breast carcinoma,GEMCITABINE,4,n/a,POLA2,4
breast carcinoma,RIBOCICLIB,3,Recruiting,CDK6,4
breast carcinoma,GEMCITABINE,4,n/a,POLD2,4
breast carcinoma,TRASTUZUMAB EMTANSINE,3,"Active, not recruiting",TUBB1,4
breast carcinoma,SUNITINIB,1,Completed,FLT4,4
breast carcinoma,SUNITINIB,1,Completed,FLT3,4
breast carcinoma,SUNITINIB,1,Completed,FLT1,4
breast carcinoma,SUNITINIB,1,Completed,CSF1R,4
breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB2B,4
breast carcinoma,EVEROLIMUS,1,Terminated,FKBP1A,4
breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB3,4
breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB4A,4
breast carcinoma,RIBOCICLIB,3,Recruiting,CDK4,4
breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB4B,4
breast carcinoma,TRASTUZUMAB EMTANSINE,3,"Active, not recruiting",ERBB2,4
breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB6,4
breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB8,4
breast carcinoma,GOSERELIN,2,Terminated,GNRHR,4
breast carcinoma,TRASTUZUMAB EMTANSINE,3,"Active, not recruiting",TUBB,4
breast carcinoma,CELECOXIB,1,Completed,PTGS2,4
breast carcinoma,GOSERELIN,2,Not yet recruiting,GNRHR,4
breast carcinoma,SUNITINIB,1,Completed,KDR,4
breast carcinoma,SUNITINIB,1,Completed,KIT,4
breast carcinoma,SUNITINIB,1,Completed,PDGFRA,4
breast carcinoma,CAPECITABINE,3,Terminated,TYMS,4
breast carcinoma,LEUPROLIDE,3,Completed,GNRHR,4
breast carcinoma,TIPIFARNIB,2,Completed,FNTB,4
breast carcinoma,TIPIFARNIB,2,Completed,FNTA,4
breast carcinoma,LETROZOLE,3,Unknown status,CYP19A1,4
breast carcinoma,TAMOXIFEN,4,Completed,ESR1,4
breast carcinoma,COPANLISIB,1,Recruiting,PIK3CD,4
breast carcinoma,CAPECITABINE,2,"Active, not recruiting",TYMS,4
breast carcinoma,COPANLISIB,1,Recruiting,PIK3CA,4
breast carcinoma,SUNITINIB,1,Completed,PDGFRB,4
breast carcinoma,TAMOXIFEN,1,Completed,ESR1,4
breast carcinoma,SARGRAMOSTIM,1,Completed,CSF2RA,4
breast carcinoma,LETROZOLE,2,Not yet recruiting,CYP19A1,4
breast carcinoma,GOSERELIN,3,Recruiting,GNRHR,4
breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB,4
breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB1,4
breast carcinoma,SUNITINIB,1,Completed,RET,4
breast carcinoma,GOSERELIN,2,"Active, not recruiting",GNRHR,4
breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB2A,4
breast carcinoma,SORAFENIB,1,Completed,BRAF,4
breast carcinoma,SORAFENIB,1,Completed,PDGFRB,4
breast carcinoma,SORAFENIB,2,Completed,PDGFRB,4
breast carcinoma,GEMCITABINE,4,n/a,RRM1,4
breast carcinoma,SORAFENIB,2,Completed,KDR,4
breast carcinoma,GEMCITABINE,4,n/a,POLD4,4
breast carcinoma,SORAFENIB,2,Completed,FLT4,4
breast carcinoma,SORAFENIB,2,Completed,FLT3,4
breast carcinoma,SORAFENIB,2,Completed,FLT1,4
breast carcinoma,SORAFENIB,2,Completed,BRAF,4
breast carcinoma,SORAFENIB,1,Completed,RET,4
breast carcinoma,CHOLECALCIFEROL,1,Completed,VDR,4
breast carcinoma,CETUXIMAB,2,Completed,EGFR,4
breast carcinoma,SORAFENIB,1,Completed,RAF1,4
breast carcinoma,SORAFENIB,2,Completed,KIT,4
breast carcinoma,GEMCITABINE,4,n/a,POLE,4
breast carcinoma,SORAFENIB,1,Completed,FLT3,4
breast carcinoma,GEMCITABINE,4,n/a,PRIM2,4
breast carcinoma,EXEMESTANE,1,Recruiting,CYP19A1,4
breast carcinoma,SORAFENIB,1,Completed,KIT,4
breast carcinoma,TRASTUZUMAB EMTANSINE,3,"Active, not recruiting",TUBB2A,4
breast carcinoma,GEMCITABINE,4,n/a,PRIM1,4
breast carcinoma,SORAFENIB,1,Completed,FLT1,4
breast carcinoma,SORAFENIB,1,Completed,FLT4,4
breast carcinoma,SORAFENIB,1,Completed,KDR,4
breast carcinoma,GEMCITABINE,4,n/a,POLD3,4
breast carcinoma,GEMCITABINE,4,n/a,POLE2,4
breast carcinoma,GEMCITABINE,4,n/a,POLE3,4
breast carcinoma,GEMCITABINE,1,Terminated,POLE2,3
breast carcinoma,VANDETANIB,2,Terminated,SRC,3
breast carcinoma,VANDETANIB,2,Terminated,TEK,3
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Completed,TUBB1,3
breast carcinoma,ERIBULIN,2,Recruiting,TUBB6,3
breast carcinoma,ERIBULIN,2,Recruiting,TUBB8,3
breast carcinoma,GEMCITABINE,1,Terminated,POLE3,3
breast carcinoma,GEMCITABINE,1,Terminated,PRIM1,3
breast carcinoma,ERIBULIN,1,Completed,TUBB,3
breast carcinoma,ERIBULIN,1,Completed,TUBB1,3
breast carcinoma,GEMCITABINE,1,Terminated,POLA1,3
breast carcinoma,GEMCITABINE,1,Terminated,POLE,3
breast carcinoma,VINFLUNINE,3,Completed,TUBB4B,3
breast carcinoma,GEMCITABINE,1,Terminated,POLA2,3
breast carcinoma,VINFLUNINE,3,Completed,TUBA3E,3
breast carcinoma,VINFLUNINE,3,Completed,TUBA4A,3
breast carcinoma,VINFLUNINE,3,Completed,TUBB,3
breast carcinoma,VINFLUNINE,3,Completed,TUBB1,3
breast carcinoma,VINFLUNINE,3,Completed,TUBB2A,3
breast carcinoma,VINFLUNINE,3,Completed,TUBB2B,3
breast carcinoma,VINFLUNINE,3,Completed,TUBB3,3
breast carcinoma,VINFLUNINE,3,Completed,TUBB4A,3
breast carcinoma,ERIBULIN,1,Completed,TUBB2B,3
breast carcinoma,VINFLUNINE,3,Completed,TUBB6,3
breast carcinoma,VINFLUNINE,3,Completed,TUBB8,3
breast carcinoma,GEMCITABINE,1,Terminated,POLD1,3
breast carcinoma,GEMCITABINE,1,Terminated,POLD2,3
breast carcinoma,ERIBULIN,1,Completed,TUBB2A,3
breast carcinoma,VINFLUNINE,3,Completed,TUBA1B,3
breast carcinoma,ERIBULIN,1,Completed,TUBB3,3
breast carcinoma,GEDATOLISIB,1,Recruiting,PIK3CD,3
breast carcinoma,GEMCITABINE,1,Terminated,RRM1,3
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Completed,TUBB,3
breast carcinoma,ERIBULIN,3,Completed,TUBB,3
breast carcinoma,GEMCITABINE,1,Terminated,PRIM2,3
breast carcinoma,ERIBULIN,2,Recruiting,TUBB,3
breast carcinoma,GEFITINIB,2,Terminated,EGFR,3
breast carcinoma,TRIPTORELIN,3,"Active, not recruiting",GNRHR,3
breast carcinoma,ERIBULIN,2,Recruiting,TUBB1,3
breast carcinoma,ERIBULIN,2,Recruiting,TUBB2A,3
breast carcinoma,GEDATOLISIB,1,Recruiting,PIK3R5,3
breast carcinoma,GEDATOLISIB,1,Recruiting,PIK3R3,3
breast carcinoma,GEDATOLISIB,1,Recruiting,PIK3R2,3
breast carcinoma,GEDATOLISIB,1,Recruiting,PIK3R1,3
breast carcinoma,GEDATOLISIB,1,Recruiting,PIK3CG,3
breast carcinoma,GEDATOLISIB,1,Recruiting,PIK3CB,3
breast carcinoma,GANETESPIB,2,Completed,HSP90AA1,3
breast carcinoma,GEDATOLISIB,1,Recruiting,PIK3CA,3
breast carcinoma,GEDATOLISIB,1,Recruiting,MTOR,3
breast carcinoma,ERIBULIN,2,Recruiting,TUBB2B,3
breast carcinoma,ERIBULIN,2,Recruiting,TUBB3,3
breast carcinoma,VINFLUNINE,3,Completed,TUBA1A,3
breast carcinoma,VINFLUNINE,3,Completed,TUBA1C,3
breast carcinoma,VINFLUNINE,3,Completed,TUBA3C,3
breast carcinoma,ERIBULIN,2,Recruiting,TUBB4A,3
breast carcinoma,ERIBULIN,2,Recruiting,TUBB4B,3
breast carcinoma,ERIBULIN,1,Completed,TUBB8,3
breast carcinoma,ERIBULIN,1,Completed,TUBB6,3
breast carcinoma,ERIBULIN,1,Completed,TUBB4B,3
breast carcinoma,ERIBULIN,1,Completed,TUBB4A,3
breast carcinoma,GANETESPIB,2,Completed,HSP90AB1,3
breast carcinoma,ENZALUTAMIDE,2,Recruiting,AR,3
breast carcinoma,VANDETANIB,2,Terminated,ERBB3,3
breast carcinoma,ERIBULIN,3,Completed,TUBB1,3
breast carcinoma,GEMCITABINE,3,"Active, not recruiting",PRIM2,3
breast carcinoma,EXEMESTANE,1,Completed,CYP19A1,3
breast carcinoma,EVEROLIMUS,3,Recruiting,FKBP1A,3
breast carcinoma,EVEROLIMUS,2,Unknown status,FKBP1A,3
breast carcinoma,EVEROLIMUS,2,Terminated,FKBP1A,3
breast carcinoma,ERIBULIN,3,Completed,TUBB8,3
breast carcinoma,ERIBULIN,3,Completed,TUBB6,3
breast carcinoma,GOSERELIN,2,Unknown status,GNRHR,3
breast carcinoma,EVEROLIMUS,1,Recruiting,FKBP1A,3
breast carcinoma,ERIBULIN,3,Completed,TUBB4B,3
breast carcinoma,EVEROLIMUS,1,"Active, not recruiting",FKBP1A,3
breast carcinoma,GEMCITABINE,3,"Active, not recruiting",RRM1,3
breast carcinoma,GEMCITABINE,3,"Active, not recruiting",PRIM1,3
breast carcinoma,FLUDARABINE PHOSPHATE,2,Completed,RRM1,3
breast carcinoma,GEMCITABINE,3,"Active, not recruiting",POLE3,3
breast carcinoma,GEMCITABINE,3,"Active, not recruiting",POLE2,3
breast carcinoma,GEMCITABINE,3,"Active, not recruiting",POLE,3
breast carcinoma,FLUOROURACIL,2,Terminated,TYMS,3
breast carcinoma,GEMCITABINE,3,"Active, not recruiting",POLD4,3
breast carcinoma,GEMCITABINE,3,"Active, not recruiting",POLD3,3
breast carcinoma,GEMCITABINE,3,"Active, not recruiting",POLD2,3
breast carcinoma,GEMCITABINE,3,"Active, not recruiting",POLD1,3
breast carcinoma,GEMCITABINE,3,"Active, not recruiting",POLA2,3
breast carcinoma,GEMCITABINE,3,"Active, not recruiting",POLA1,3
breast carcinoma,GOSERELIN,2,Withdrawn,GNRHR,3
breast carcinoma,GEMCITABINE,3,Unknown status,POLA1,3
breast carcinoma,FLUDARABINE PHOSPHATE,2,Completed,PRIM2,3
breast carcinoma,VANDETANIB,2,Terminated,RET,3
breast carcinoma,GEMCITABINE,3,Unknown status,POLD2,3
breast carcinoma,GEMCITABINE,3,Unknown status,RRM1,3
breast carcinoma,GEMCITABINE,3,Unknown status,PRIM2,3
breast carcinoma,FILGRASTIM,1,Terminated,CSF3R,3
breast carcinoma,GEMCITABINE,3,Unknown status,PRIM1,3
breast carcinoma,GEMCITABINE,3,Unknown status,POLE3,3
breast carcinoma,GEMCITABINE,3,Unknown status,POLE2,3
breast carcinoma,FILGRASTIM,2,Terminated,CSF3R,3
breast carcinoma,IMATINIB,2,Completed,KIT,3
breast carcinoma,GEMCITABINE,3,Unknown status,POLE,3
breast carcinoma,GEMCITABINE,3,Unknown status,POLD4,3
breast carcinoma,GEMCITABINE,3,Unknown status,POLD3,3
breast carcinoma,GEMCITABINE,3,Unknown status,POLD1,3
breast carcinoma,FLUDARABINE PHOSPHATE,2,Completed,PRIM1,3
breast carcinoma,GEMCITABINE,3,Unknown status,POLA2,3
breast carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLA1,3
breast carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLA2,3
breast carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLD1,3
breast carcinoma,EXEMESTANE,3,Terminated,CYP19A1,3
breast carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLD3,3
breast carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLD4,3
breast carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLE,3
breast carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLE2,3
breast carcinoma,IMATINIB,2,Completed,PDGFRB,3
breast carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLE3,3
breast carcinoma,GOSERELIN,3,"Active, not recruiting",GNRHR,3
breast carcinoma,ETOPOSIDE,2,Terminated,TOP2B,3
breast carcinoma,ETOPOSIDE,2,Terminated,TOP2A,3
breast carcinoma,VANDETANIB,2,Terminated,EPHB3,3
breast carcinoma,VANDETANIB,2,Terminated,EPHA3,3
breast carcinoma,ERIBULIN,3,Completed,TUBB2B,3
breast carcinoma,ERIBULIN,3,Completed,TUBB2A,3
breast carcinoma,VANDETANIB,2,Terminated,EPHA4,3
breast carcinoma,VANDETANIB,2,Terminated,EPHA5,3
breast carcinoma,VANDETANIB,2,Terminated,EPHA6,3
breast carcinoma,VANDETANIB,2,Terminated,EPHA7,3
breast carcinoma,VANDETANIB,2,Terminated,EPHA8,3
breast carcinoma,VANDETANIB,2,Terminated,EPHB1,3
breast carcinoma,VANDETANIB,2,Terminated,EPHB2,3
breast carcinoma,IXABEPILONE,2,Terminated,TUBB8,3
breast carcinoma,VANDETANIB,2,Terminated,EPHB4,3
breast carcinoma,GOSERELIN,3,Unknown status,GNRHR,3
breast carcinoma,VANDETANIB,2,Terminated,EPHB6,3
breast carcinoma,VANDETANIB,2,Terminated,ERBB2,3
breast carcinoma,IMATINIB,2,Completed,ABL1,3
breast carcinoma,VANDETANIB,2,Terminated,ERBB4,3
breast carcinoma,VANDETANIB,2,Terminated,FLT1,3
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Completed,ERBB2,3
breast carcinoma,VANDETANIB,2,Terminated,FLT4,3
breast carcinoma,VANDETANIB,2,Terminated,KDR,3
breast carcinoma,FULVESTRANT,3,Terminated,ESR1,3
breast carcinoma,VANDETANIB,2,Terminated,PTK6,3
breast carcinoma,FULVESTRANT,3,Terminated,ESR2,3
breast carcinoma,VANDETANIB,2,Terminated,EPHA2,3
breast carcinoma,ERTUMAXOMAB,2,Terminated,CD3E,3
breast carcinoma,ERTUMAXOMAB,2,Terminated,ERBB2,3
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Completed,TUBB2A,3
breast carcinoma,ERIBULIN,3,Completed,TUBB4A,3
breast carcinoma,ERIBULIN,3,Completed,TUBB3,3
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Completed,TUBB8,3
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Completed,TUBB6,3
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Completed,TUBB4B,3
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Completed,TUBB4A,3
breast carcinoma,VANDETANIB,2,Terminated,EGFR,3
breast carcinoma,VANDETANIB,2,Terminated,EPHA1,3
breast carcinoma,VANDETANIB,2,Terminated,EPHA10,3
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Completed,TUBB3,3
breast carcinoma,FULVESTRANT,1,Not yet recruiting,ESR1,3
breast carcinoma,IXABEPILONE,2,Terminated,TUBB,3
breast carcinoma,IXABEPILONE,2,Terminated,TUBB1,3
breast carcinoma,IXABEPILONE,2,Terminated,TUBB2A,3
breast carcinoma,IXABEPILONE,2,Terminated,TUBB2B,3
breast carcinoma,IXABEPILONE,2,Terminated,TUBB3,3
breast carcinoma,IXABEPILONE,2,Terminated,TUBB4A,3
breast carcinoma,IXABEPILONE,2,Terminated,TUBB4B,3
breast carcinoma,IXABEPILONE,2,Terminated,TUBB6,3
breast carcinoma,FULVESTRANT,1,Not yet recruiting,ESR2,3
breast carcinoma,FULVESTRANT,1,Terminated,ESR1,3
breast carcinoma,FULVESTRANT,1,Terminated,ESR2,3
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Completed,TUBB2B,3
breast carcinoma,FLUDARABINE PHOSPHATE,2,Completed,POLD2,3
breast carcinoma,GEMCITABINE,1,Terminated,POLD3,3
breast carcinoma,PACLITAXEL,1,Withdrawn,TUBB4A,3
breast carcinoma,AZD-2014,1,"Active, not recruiting",MTOR,3
breast carcinoma,PACLITAXEL,1,Withdrawn,TUBB4B,3
breast carcinoma,DASATINIB,1,Completed,LCK,3
breast carcinoma,DASATINIB,1,Completed,KIT,3
breast carcinoma,DASATINIB,1,Completed,HCK,3
breast carcinoma,DASATINIB,1,Completed,FYN,3
breast carcinoma,DASATINIB,1,Completed,FRK,3
breast carcinoma,DASATINIB,1,Completed,FGR,3
breast carcinoma,DASATINIB,1,Completed,EPHA2,3
breast carcinoma,DASATINIB,1,Completed,BLK,3
breast carcinoma,DASATINIB,1,Completed,ABL1,3
breast carcinoma,PACLITAXEL,1,Withdrawn,TUBB3,3
breast carcinoma,PACLITAXEL,1,Withdrawn,TUBB2B,3
breast carcinoma,PACLITAXEL,1,Withdrawn,TUBB2A,3
breast carcinoma,PACLITAXEL,1,Withdrawn,TUBB1,3
breast carcinoma,PACLITAXEL,1,Withdrawn,TUBB,3
breast carcinoma,ABEMACICLIB,2,"Active, not recruiting",CDK4,3
breast carcinoma,ABEMACICLIB,2,"Active, not recruiting",CDK6,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",GPD2,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND1,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND2,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND3,3
breast carcinoma,ABEMACICLIB,2,Completed,CDK4,3
breast carcinoma,ABEMACICLIB,2,Completed,CDK6,3
breast carcinoma,ABEMACICLIB,3,"Active, not recruiting",CDK4,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4L,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND5,3
breast carcinoma,PACLITAXEL,1,Withdrawn,TUBB6,3
breast carcinoma,PACLITAXEL,1,Withdrawn,TUBB8,3
breast carcinoma,DASATINIB,1,Completed,LYN,3
Hereditary breast and ovarian cancer syndrome,VELIPARIB,1,Completed,PARP1,3
triple-negative breast cancer,PACLITAXEL,2,"Active, not recruiting",TUBB8,3
triple-negative breast cancer,PACLITAXEL,2,"Active, not recruiting",TUBB6,3
triple-negative breast cancer,PACLITAXEL,2,"Active, not recruiting",TUBB4B,3
triple-negative breast cancer,PACLITAXEL,2,"Active, not recruiting",TUBB4A,3
triple-negative breast cancer,PACLITAXEL,2,"Active, not recruiting",TUBB3,3
triple-negative breast cancer,PACLITAXEL,2,"Active, not recruiting",TUBB2B,3
breast carcinoma,SUNITINIB,2,Completed,FLT4,3
breast carcinoma,SUNITINIB,2,Completed,FLT3,3
breast carcinoma,SUNITINIB,2,Completed,FLT1,3
breast carcinoma,SUNITINIB,2,Completed,CSF1R,3
triple-negative breast cancer,PACLITAXEL,2,"Active, not recruiting",TUBB2A,3
triple-negative breast cancer,PACLITAXEL,2,"Active, not recruiting",TUBB1,3
Hereditary breast and ovarian cancer syndrome,VELIPARIB,1,Completed,PARP2,3
breast carcinoma,DASATINIB,1,Completed,PDGFRB,3
Hereditary breast and ovarian cancer syndrome,VELIPARIB,1,Completed,PARP3,3
breast carcinoma,RIBOCICLIB,1,Recruiting,CDK4,3
breast carcinoma,RIBOCICLIB,1,Recruiting,CDK6,3
breast carcinoma,NERATINIB,2,Completed,ERBB3,3
breast carcinoma,NERATINIB,2,Completed,ERBB4,3
breast carcinoma,RIBOCICLIB,2,Not yet recruiting,CDK4,3
breast carcinoma,RIBOCICLIB,2,Not yet recruiting,CDK6,3
breast carcinoma,PERTUZUMAB,1,Terminated,ERBB2,3
breast carcinoma,SIMVASTATIN,2,Completed,HMGCR,3
breast carcinoma,DASATINIB,1,Completed,YES1,3
breast carcinoma,DASATINIB,1,Completed,SRMS,3
breast carcinoma,DASATINIB,1,Completed,SRC,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND6,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA1,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA10,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS7,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB6,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB7,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB8,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB9,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFC1,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFC2,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS1,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS2,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS3,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS4,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS5,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS6,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS8,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB4,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV1,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV2,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV3,3
breast carcinoma,CHOLECALCIFEROL,2,Completed,VDR,3
breast carcinoma,CAPECITABINE,4,Completed,TYMS,3
breast carcinoma,CAPECITABINE,3,Unknown status,TYMS,3
breast carcinoma,CAPECITABINE,2,Withdrawn,TYMS,3
breast carcinoma,NIVOLUMAB,2,Not yet recruiting,PDCD1,3
breast carcinoma,PEGFILGRASTIM,1,Completed,CSF3R,3
breast carcinoma,PEGFILGRASTIM,3,"Active, not recruiting",CSF3R,3
breast carcinoma,ANASTROZOLE,2,Withdrawn,CYP19A1,3
breast carcinoma,PEGFILGRASTIM,2,Recruiting,CSF3R,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB5,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB3,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA11,3
male breast carcinoma,TAMOXIFEN,2,Completed,ESR1,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA12,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA13,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA2,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA3,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4L2,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA5,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA6,3
breast carcinoma,ABEMACICLIB,3,"Active, not recruiting",CDK6,3
male breast carcinoma,TRASTUZUMAB,2,Completed,ERBB2,3
breast carcinoma,ALDESLEUKIN,1,Completed,IL2RA,3
breast carcinoma,ALDESLEUKIN,1,Completed,IL2RB,3
breast carcinoma,ALPELISIB,1,Completed,PIK3CA,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB2,3
breast carcinoma,PEMBROLIZUMAB,0,Recruiting,PDCD1,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA7,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA8,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA9,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAB1,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF1,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF2,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF3,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF4,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB1,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB10,3
breast carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB11,3
breast carcinoma,AVELUMAB,2,Recruiting,CD274,3
triple-negative breast cancer,PACLITAXEL,2,"Active, not recruiting",TUBB,3
breast carcinoma,SUNITINIB,2,Completed,KDR,3
breast carcinoma,BICALUTAMIDE,2,Recruiting,AR,3
breast carcinoma,DOCETAXEL,4,Recruiting,TUBB,3
breast carcinoma,LAPATINIB,2,Withdrawn,ERBB2,3
breast carcinoma,LAPATINIB,3,Completed,EGFR,3
breast carcinoma,LAPATINIB,3,Completed,ERBB2,3
breast carcinoma,LAPATINIB,3,Recruiting,EGFR,3
breast carcinoma,LAPATINIB,3,Recruiting,ERBB2,3
breast carcinoma,LAPATINIB,3,Unknown status,EGFR,3
breast carcinoma,LAPATINIB,3,Unknown status,ERBB2,3
breast carcinoma,PANOBINOSTAT,1,Completed,HDAC3,3
breast carcinoma,PANOBINOSTAT,1,Completed,HDAC4,3
breast carcinoma,LETROZOLE,1,Terminated,CYP19A1,3
breast carcinoma,PANOBINOSTAT,1,Completed,HDAC5,3
breast carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB8,3
breast carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB6,3
breast carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB4B,3
breast carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB4A,3
breast carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB3,3
breast carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB2B,3
breast carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB1,3
breast carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB,3
breast carcinoma,LETROZOLE,2,Withdrawn,CYP19A1,3
breast carcinoma,PANOBINOSTAT,1,Completed,HDAC6,3
breast carcinoma,PALBOCICLIB,1,"Active, not recruiting",CDK6,3
breast carcinoma,PALBOCICLIB,1,"Active, not recruiting",CDK4,3
breast carcinoma,PANOBINOSTAT,1,Completed,HDAC7,3
breast carcinoma,PANOBINOSTAT,1,Completed,HDAC8,3
breast carcinoma,PANOBINOSTAT,1,Completed,HDAC9,3
breast carcinoma,DOCETAXEL,4,Recruiting,TUBB1,3
breast carcinoma,DOCETAXEL,4,Recruiting,TUBB2A,3
breast carcinoma,DOCETAXEL,4,Recruiting,TUBB2B,3
breast carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC1,3
breast carcinoma,MITOXANTRONE,3,Completed,TOP2A,3
breast carcinoma,BEVACIZUMAB,4,Completed,VEGFA,3
breast carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC9,3
breast carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC8,3
breast carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC7,3
breast carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC6,3
breast carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC5,3
breast carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC4,3
breast carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC3,3
breast carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC2,3
breast carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC11,3
breast carcinoma,ENTINOSTAT,1,"Active, not recruiting",HDAC10,3
breast carcinoma,PANOBINOSTAT,1,Completed,HDAC1,3
breast carcinoma,DOCETAXEL,4,Recruiting,TUBB3,3
breast carcinoma,TRASTUZUMAB,4,Completed,ERBB2,3
breast carcinoma,DOXORUBICIN,2,Not yet recruiting,TOP2A,3
breast carcinoma,DOXORUBICIN,1,Unknown status,TOP2A,3
breast carcinoma,PANOBINOSTAT,1,Completed,HDAC10,3
breast carcinoma,TRASTUZUMAB,1,Withdrawn,ERBB2,3
breast carcinoma,PANOBINOSTAT,1,Completed,HDAC11,3
breast carcinoma,PANOBINOSTAT,1,Completed,HDAC2,3
breast carcinoma,LAPATINIB,2,Withdrawn,EGFR,3
breast carcinoma,DOCETAXEL,4,Recruiting,TUBB8,3
breast carcinoma,DOCETAXEL,4,Recruiting,TUBB6,3
breast carcinoma,DOCETAXEL,4,Recruiting,TUBB4B,3
breast carcinoma,DOCETAXEL,4,Recruiting,TUBB4A,3
breast carcinoma,LEUPROLIDE,2,Recruiting,GNRHR,3
breast carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB2A,3
breast carcinoma,SUNITINIB,2,Terminated,PDGFRB,3
breast carcinoma,ZOLEDRONIC ACID,4,Completed,FDPS,3
male breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB6,3
breast carcinoma,PACLITAXEL,4,Unknown status,TUBB3,3
breast carcinoma,PACLITAXEL,4,Unknown status,TUBB2B,3
breast carcinoma,PACLITAXEL,4,Unknown status,TUBB2A,3
breast carcinoma,PACLITAXEL,4,Unknown status,TUBB1,3
breast carcinoma,PACLITAXEL,4,Unknown status,TUBB,3
breast carcinoma,SUNITINIB,2,Completed,PDGFRB,3
breast carcinoma,DEXAMETHASONE,2,Completed,NR3C1,3
breast carcinoma,SUNITINIB,2,Terminated,RET,3
breast carcinoma,SUNITINIB,2,Terminated,PDGFRA,3
breast carcinoma,DENOSUMAB,2,"Active, not recruiting",TNFSF11,3
breast carcinoma,SUNITINIB,2,Terminated,KIT,3
breast carcinoma,SUNITINIB,2,Terminated,KDR,3
breast carcinoma,SUNITINIB,2,Completed,RET,3
breast carcinoma,SUNITINIB,2,Terminated,CSF1R,3
breast carcinoma,SUNITINIB,2,Terminated,FLT1,3
breast carcinoma,SUNITINIB,2,Terminated,FLT4,3
breast carcinoma,SUNITINIB,2,Terminated,FLT3,3
male breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB3,3
male breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB8,3
male breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4A,3
breast carcinoma,TAMOXIFEN,3,Terminated,ESR1,3
male breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4B,3
male breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2B,3
breast carcinoma,GEMCITABINE,1,Terminated,POLD4,3
male breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB1,3
breast carcinoma,METHOTREXATE,2,Terminated,DHFR,3
male breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2A,3
breast carcinoma,SUNITINIB,2,Completed,PDGFRA,3
breast carcinoma,MIFEPRISTONE,2,Recruiting,NR3C1,3
breast carcinoma,MIFEPRISTONE,2,Recruiting,PGR,3
breast carcinoma,PACLITAXEL,4,Unknown status,TUBB8,3
male breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,3
breast carcinoma,PACLITAXEL,4,Unknown status,TUBB6,3
breast carcinoma,PACLITAXEL,4,Unknown status,TUBB4B,3
breast carcinoma,ZOLEDRONIC ACID,3,"Active, not recruiting",FDPS,3
breast carcinoma,PACLITAXEL,4,Unknown status,TUBB4A,3
breast carcinoma,TAMOXIFEN,4,Recruiting,ESR1,3
breast carcinoma,SUNITINIB,2,Completed,KIT,3
breast carcinoma,PICTILISIB,1,Completed,PIK3CB,2
breast carcinoma,MK-2206,1,Terminated,AKT3,2
breast carcinoma,PICTILISIB,1,Completed,PIK3CA,2
breast carcinoma,OLANZAPINE,3,Recruiting,DRD2,2
breast carcinoma,PEGFILGRASTIM,2,Terminated,CSF3R,2
breast carcinoma,OLANZAPINE,3,Recruiting,DRD3,2
breast carcinoma,MK-2206,1,Terminated,AKT2,2
breast carcinoma,PEGFILGRASTIM,3,Unknown status,CSF3R,2
breast carcinoma,PEGFILGRASTIM,3,Recruiting,CSF3R,2
breast carcinoma,NIRAPARIB,1,"Active, not recruiting",PARP2,2
breast carcinoma,OCTREOTIDE,3,Completed,SSTR5,2
breast carcinoma,NIRAPARIB,1,Not yet recruiting,PARP1,2
breast carcinoma,NIRAPARIB,1,Not yet recruiting,PARP2,2
breast carcinoma,PEGFILGRASTIM,4,Completed,CSF3R,2
breast carcinoma,NIRAPARIB,2,Recruiting,PARP1,2
breast carcinoma,NIRAPARIB,2,Recruiting,PARP2,2
breast carcinoma,OCTREOTIDE,3,Completed,SSTR1,2
breast carcinoma,OCTREOTIDE,3,Completed,SSTR3,2
breast carcinoma,OCTREOTIDE,3,Completed,SSTR4,2
breast carcinoma,OCTREOTIDE,3,Completed,SSTR2,2
breast carcinoma,PICTILISIB,1,Completed,PIK3R3,2
breast carcinoma,PICTILISIB,2,Completed,PIK3CD,2
breast carcinoma,PEMBROLIZUMAB,1,"Active, not recruiting",PDCD1,2
breast carcinoma,PICTILISIB,1,Completed,PIK3R5,2
breast carcinoma,MM-121,2,Completed,ERBB3,2
breast carcinoma,PICTILISIB,1,Completed,PIK3R1,2
breast carcinoma,PICTILISIB,1,Completed,PIK3CG,2
breast carcinoma,PICTILISIB,1,Completed,PIK3CD,2
breast carcinoma,PEMETREXED,1,Completed,DHFR,2
breast carcinoma,MK-2206,2,Terminated,AKT3,2
breast carcinoma,PERTUZUMAB,2,Terminated,ERBB2,2
breast carcinoma,MK-2206,2,Terminated,AKT2,2
breast carcinoma,PEMETREXED,1,Completed,GART,2
breast carcinoma,PEMETREXED,1,Completed,TYMS,2
breast carcinoma,PEMBROLIZUMAB,3,"Active, not recruiting",PDCD1,2
breast carcinoma,NERATINIB,4,n/a,ERBB2,2
breast carcinoma,PICTILISIB,2,Completed,PIK3CB,2
breast carcinoma,NERATINIB,4,n/a,EGFR,2
breast carcinoma,NERATINIB,3,"Active, not recruiting",ERBB4,2
breast carcinoma,NERATINIB,3,"Active, not recruiting",ERBB3,2
breast carcinoma,NERATINIB,2,Not yet recruiting,ERBB2,2
breast carcinoma,NIRAPARIB,1,"Active, not recruiting",PARP1,2
breast carcinoma,NERATINIB,2,Not yet recruiting,EGFR,2
breast carcinoma,PICTILISIB,1,Completed,PIK3R2,2
breast carcinoma,MK-2206,2,Terminated,AKT1,2
breast carcinoma,NERATINIB,1,Recruiting,ERBB4,2
breast carcinoma,PICTILISIB,2,Completed,PIK3CA,2
breast carcinoma,NERATINIB,1,Recruiting,ERBB3,2
breast carcinoma,OLANZAPINE,3,Recruiting,HTR2A,2
breast carcinoma,OLANZAPINE,3,Recruiting,DRD4,2
breast carcinoma,IXABEPILONE,3,"Active, not recruiting",TUBB2B,2
breast carcinoma,OLANZAPINE,3,Recruiting,HTR2C,2
breast carcinoma,PACLITAXEL,4,Recruiting,TUBB6,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA4A,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA3E,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA3C,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA1C,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA1B,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA1A,2
breast carcinoma,PACLITAXEL,4,Recruiting,TUBB8,2
breast carcinoma,PACLITAXEL,4,Recruiting,TUBB4B,2
breast carcinoma,PACLITAXEL,4,Completed,TUBB4B,2
breast carcinoma,PACLITAXEL,4,Recruiting,TUBB4A,2
breast carcinoma,PACLITAXEL,4,Recruiting,TUBB3,2
breast carcinoma,PACLITAXEL,4,Recruiting,TUBB2B,2
breast carcinoma,PACLITAXEL,4,Recruiting,TUBB2A,2
breast carcinoma,PACLITAXEL,4,Recruiting,TUBB1,2
breast carcinoma,PACLITAXEL,4,Recruiting,TUBB,2
breast carcinoma,PACLITAXEL,4,Completed,TUBB8,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB1,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB2A,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB2B,2
breast carcinoma,PALBOCICLIB,4,n/a,CDK6,2
breast carcinoma,PALBOCICLIB,4,n/a,CDK4,2
breast carcinoma,PALBOCICLIB,4,Recruiting,CCND1,2
breast carcinoma,PALBOCICLIB,4,"Active, not recruiting",CCND1,2
breast carcinoma,PALBOCICLIB,3,Recruiting,CCND1,2
breast carcinoma,PALBOCICLIB,3,Not yet recruiting,CCND1,2
breast carcinoma,PALBOCICLIB,2,Withdrawn,CCND1,2
breast carcinoma,PALBOCICLIB,2,Completed,CCND1,2
breast carcinoma,PALBOCICLIB,1,Unknown status,CCND1,2
breast carcinoma,PALBOCICLIB,1,Not yet recruiting,CCND1,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB8,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB6,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB4B,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB4A,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB3,2
breast carcinoma,PACLITAXEL,4,Completed,TUBB6,2
breast carcinoma,PACLITAXEL,4,Completed,TUBB4A,2
breast carcinoma,PEGFILGRASTIM,2,"Active, not recruiting",CSF3R,2
breast carcinoma,OLAPARIB,3,"Active, not recruiting",PARP3,2
breast carcinoma,PACLITAXEL,0,Not yet recruiting,TUBB2B,2
breast carcinoma,PACLITAXEL,0,Not yet recruiting,TUBB2A,2
breast carcinoma,PACLITAXEL,0,Not yet recruiting,TUBB1,2
breast carcinoma,PACLITAXEL,0,Not yet recruiting,TUBB,2
breast carcinoma,OLAPARIB,3,Recruiting,PARP3,2
breast carcinoma,OLAPARIB,3,Recruiting,PARP2,2
breast carcinoma,OLAPARIB,3,Recruiting,PARP1,2
breast carcinoma,OLAPARIB,3,"Active, not recruiting",PARP2,2
breast carcinoma,PACLITAXEL,4,Completed,TUBB3,2
breast carcinoma,OLAPARIB,3,"Active, not recruiting",PARP1,2
breast carcinoma,OLAPARIB,1,Recruiting,PARP3,2
breast carcinoma,OLAPARIB,1,Recruiting,PARP2,2
breast carcinoma,OLAPARIB,1,Recruiting,PARP1,2
breast carcinoma,OLAPARIB,1,Completed,PARP3,2
breast carcinoma,OLAPARIB,1,Completed,PARP2,2
breast carcinoma,OLAPARIB,1,Completed,PARP1,2
breast carcinoma,PACLITAXEL,0,Not yet recruiting,TUBB3,2
breast carcinoma,PACLITAXEL,0,Not yet recruiting,TUBB4A,2
breast carcinoma,PACLITAXEL,0,Not yet recruiting,TUBB4B,2
breast carcinoma,PACLITAXEL,0,Not yet recruiting,TUBB6,2
breast carcinoma,PACLITAXEL,4,Completed,TUBB2B,2
breast carcinoma,PACLITAXEL,4,Completed,TUBB2A,2
breast carcinoma,PACLITAXEL,4,Completed,TUBB1,2
breast carcinoma,PACLITAXEL,4,Completed,TUBB,2
breast carcinoma,PACLITAXEL,2,Suspended,TUBB8,2
breast carcinoma,PACLITAXEL,2,Suspended,TUBB6,2
breast carcinoma,PACLITAXEL,2,Suspended,TUBB4B,2
breast carcinoma,PACLITAXEL,2,Suspended,TUBB4A,2
breast carcinoma,PACLITAXEL,2,Suspended,TUBB3,2
breast carcinoma,PACLITAXEL,2,Suspended,TUBB2B,2
breast carcinoma,PACLITAXEL,2,Suspended,TUBB2A,2
breast carcinoma,PACLITAXEL,2,Suspended,TUBB1,2
breast carcinoma,PACLITAXEL,2,Suspended,TUBB,2
breast carcinoma,MK-2206,1,Completed,AKT3,2
breast carcinoma,PACLITAXEL,0,Not yet recruiting,TUBB8,2
breast carcinoma,MK-2206,1,Terminated,AKT1,2
breast carcinoma,METFORMIN,2,Terminated,NDUFAF4,2
breast carcinoma,MK-2206,1,Completed,AKT2,2
breast carcinoma,IXABEPILONE,1,Terminated,TUBB,2
breast carcinoma,SUNITINIB,1,Terminated,FLT1,2
breast carcinoma,SUNITINIB,1,Terminated,FLT3,2
breast carcinoma,IRINOTECAN,2,"Active, not recruiting",TOP1,2
breast carcinoma,SUNITINIB,1,Terminated,FLT4,2
breast carcinoma,IRINOTECAN,2,Recruiting,TOP1,2
breast carcinoma,SUNITINIB,1,Terminated,KDR,2
breast carcinoma,SUNITINIB,1,Terminated,KIT,2
breast carcinoma,SUNITINIB,1,Terminated,PDGFRA,2
breast carcinoma,SUNITINIB,1,Terminated,PDGFRB,2
breast carcinoma,SUNITINIB,1,Terminated,RET,2
breast carcinoma,IXABEPILONE,1,Terminated,TUBB1,2
breast carcinoma,IXABEPILONE,2,"Active, not recruiting",TUBB3,2
breast carcinoma,IXABEPILONE,1,Terminated,TUBB2A,2
breast carcinoma,IXABEPILONE,1,Terminated,TUBB2B,2
breast carcinoma,IXABEPILONE,1,Terminated,TUBB3,2
breast carcinoma,IXABEPILONE,1,Terminated,TUBB4A,2
breast carcinoma,IXABEPILONE,1,Terminated,TUBB4B,2
breast carcinoma,IXABEPILONE,1,Terminated,TUBB6,2
breast carcinoma,IXABEPILONE,1,Terminated,TUBB8,2
breast carcinoma,IXABEPILONE,2,"Active, not recruiting",TUBB,2
breast carcinoma,IXABEPILONE,2,"Active, not recruiting",TUBB1,2
breast carcinoma,IXABEPILONE,2,"Active, not recruiting",TUBB2A,2
breast carcinoma,SUNITINIB,1,Terminated,CSF1R,2
breast carcinoma,SORAFENIB,2,Unknown status,RET,2
breast carcinoma,SORAFENIB,2,Unknown status,RAF1,2
breast carcinoma,SORAFENIB,2,Unknown status,PDGFRB,2
breast carcinoma,IPATASERTIB,1,Recruiting,AKT3,2
breast carcinoma,RUCAPARIB,2,"Active, not recruiting",PARP1,2
breast carcinoma,RUCAPARIB,2,"Active, not recruiting",PARP2,2
breast carcinoma,RUCAPARIB,2,"Active, not recruiting",PARP3,2
breast carcinoma,RUXOLITINIB,2,Terminated,JAK1,2
breast carcinoma,RUXOLITINIB,2,Terminated,JAK2,2
breast carcinoma,SAPANISERTIB,1,Recruiting,MTOR,2
breast carcinoma,SARGRAMOSTIM,1,Unknown status,CSF2RA,2
breast carcinoma,SARGRAMOSTIM,3,Completed,CSF2RA,2
breast carcinoma,IPATASERTIB,2,Recruiting,AKT1,2
breast carcinoma,IPATASERTIB,2,Recruiting,AKT2,2
breast carcinoma,IPATASERTIB,2,Recruiting,AKT3,2
breast carcinoma,IPILIMUMAB,2,Not yet recruiting,CTLA4,2
breast carcinoma,IPILIMUMAB,2,Recruiting,CTLA4,2
breast carcinoma,SIMVASTATIN,2,Recruiting,HMGCR,2
breast carcinoma,SORAFENIB,2,Unknown status,BRAF,2
breast carcinoma,SORAFENIB,2,Unknown status,FLT1,2
breast carcinoma,SORAFENIB,2,Unknown status,FLT3,2
breast carcinoma,SORAFENIB,2,Unknown status,FLT4,2
breast carcinoma,SORAFENIB,2,Unknown status,KDR,2
breast carcinoma,SORAFENIB,2,Unknown status,KIT,2
breast carcinoma,IXABEPILONE,2,"Active, not recruiting",TUBB2B,2
breast carcinoma,IXABEPILONE,2,"Active, not recruiting",TUBB4A,2
breast carcinoma,IPATASERTIB,1,Recruiting,AKT1,2
breast carcinoma,LAPATINIB,1,Unknown status,ERBB2,2
breast carcinoma,LEUPROLIDE,2,"Active, not recruiting",GNRHR,2
breast carcinoma,TOREMIFENE,2,Recruiting,ESR2,2
breast carcinoma,LETROZOLE,4,Unknown status,CYP19A1,2
breast carcinoma,LETROZOLE,4,Terminated,CYP19A1,2
breast carcinoma,TOREMIFENE,3,Recruiting,ESR1,2
breast carcinoma,TOREMIFENE,3,Recruiting,ESR2,2
breast carcinoma,LETROZOLE,1,Unknown status,CYP19A1,2
breast carcinoma,LETROZOLE,0,Recruiting,CYP19A1,2
breast carcinoma,TOREMIFENE,4,n/a,ESR1,2
breast carcinoma,TOREMIFENE,4,n/a,ESR2,2
breast carcinoma,LAPATINIB,1,Unknown status,EGFR,2
breast carcinoma,IXABEPILONE,2,"Active, not recruiting",TUBB4B,2
breast carcinoma,TRASTUZUMAB,1,Not yet recruiting,ERBB2,2
breast carcinoma,TRASTUZUMAB,2,Not yet recruiting,ERBB2,2
breast carcinoma,TRASTUZUMAB,3,Not yet recruiting,ERBB2,2
breast carcinoma,IXABEPILONE,3,"Active, not recruiting",TUBB8,2
breast carcinoma,IXABEPILONE,3,"Active, not recruiting",TUBB6,2
breast carcinoma,IXABEPILONE,3,"Active, not recruiting",TUBB4B,2
breast carcinoma,IXABEPILONE,3,"Active, not recruiting",TUBB4A,2
breast carcinoma,IXABEPILONE,3,"Active, not recruiting",TUBB3,2
breast carcinoma,IXABEPILONE,3,"Active, not recruiting",TUBB,2
breast carcinoma,IXABEPILONE,3,"Active, not recruiting",TUBB1,2
breast carcinoma,TOREMIFENE,2,Recruiting,ESR1,2
breast carcinoma,TEMSIROLIMUS,1,Completed,FKBP1A,2
breast carcinoma,TASELISIB,1,Recruiting,PIK3R5,2
breast carcinoma,TASELISIB,1,Recruiting,PIK3R3,2
breast carcinoma,SURAMIN,1,Completed,FGF1,2
breast carcinoma,TALAZOPARIB,2,Recruiting,PARP1,2
breast carcinoma,TALAZOPARIB,2,Recruiting,PARP2,2
breast carcinoma,TAMOXIFEN,1,"Active, not recruiting",ESR1,2
breast carcinoma,TAMOXIFEN,1,Recruiting,ESR1,2
breast carcinoma,TANESPIMYCIN,1,Completed,HSP90AA1,2
breast carcinoma,TANESPIMYCIN,1,Completed,HSP90AB1,2
breast carcinoma,LUCITANIB,2,Completed,KDR,2
breast carcinoma,IXABEPILONE,2,"Active, not recruiting",TUBB6,2
breast carcinoma,IXABEPILONE,2,"Active, not recruiting",TUBB8,2
breast carcinoma,LUCITANIB,2,Completed,FLT1,2
breast carcinoma,LUCITANIB,2,Completed,FGFR2,2
breast carcinoma,LUCITANIB,2,Completed,FGFR1,2
breast carcinoma,LOVASTATIN,2,Terminated,HMGCR,2
breast carcinoma,LOPERAMIDE,2,Recruiting,OPRM1,2
breast carcinoma,TASELISIB,1,Recruiting,PIK3CA,2
breast carcinoma,TASELISIB,1,Recruiting,PIK3CB,2
breast carcinoma,TASELISIB,1,Recruiting,PIK3CD,2
breast carcinoma,TASELISIB,1,Recruiting,PIK3CG,2
breast carcinoma,TASELISIB,1,Recruiting,PIK3R1,2
breast carcinoma,TASELISIB,1,Recruiting,PIK3R2,2
breast carcinoma,IPATASERTIB,1,Recruiting,AKT2,2
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,ERBB2,2
breast carcinoma,MK-2206,1,Completed,AKT1,2
breast carcinoma,METFORMIN,2,Terminated,NDUFV3,2
breast carcinoma,PYROTINIB,3,Recruiting,ERBB2,2
breast carcinoma,RALOXIFENE,2,Completed,ESR2,2
breast carcinoma,GLEMBATUMUMAB VEDOTIN,2,Completed,GPNMB,2
breast carcinoma,GOSERELIN,1,"Active, not recruiting",GNRHR,2
breast carcinoma,RAMUCIRUMAB,2,Completed,KDR,2
breast carcinoma,RIBOCICLIB,1,Completed,CDK4,2
breast carcinoma,RIBOCICLIB,1,Completed,CDK6,2
breast carcinoma,RIBOCICLIB,2,"Active, not recruiting",CDK4,2
breast carcinoma,RIBOCICLIB,2,"Active, not recruiting",CDK6,2
breast carcinoma,RIDAFOROLIMUS,2,Completed,MTOR,2
breast carcinoma,METFORMIN,2,Terminated,NDUFV2,2
breast carcinoma,GOSERELIN,3,Terminated,GNRHR,2
breast carcinoma,METFORMIN,2,Terminated,NDUFV1,2
breast carcinoma,METFORMIN,2,Terminated,NDUFS8,2
breast carcinoma,METFORMIN,2,Terminated,NDUFS7,2
breast carcinoma,METFORMIN,2,Terminated,NDUFS6,2
breast carcinoma,METFORMIN,2,Terminated,NDUFS5,2
breast carcinoma,METFORMIN,2,Terminated,NDUFS4,2
breast carcinoma,METFORMIN,2,Terminated,NDUFS3,2
breast carcinoma,METFORMIN,2,Terminated,NDUFS2,2
breast carcinoma,METFORMIN,2,Terminated,NDUFS1,2
breast carcinoma,METFORMIN,2,Terminated,NDUFC2,2
breast carcinoma,PYROTINIB,3,Recruiting,EGFR,2
breast carcinoma,PYROTINIB,1,Recruiting,ERBB2,2
breast carcinoma,PYROTINIB,1,Recruiting,EGFR,2
breast carcinoma,PYROTINIB,1,Completed,ERBB2,2
breast carcinoma,MITOXANTRONE,2,Unknown status,TOP2A,2
breast carcinoma,PICTILISIB,2,Completed,PIK3CG,2
breast carcinoma,MITOXANTRONE,2,Completed,TOP2A,2
breast carcinoma,PICTILISIB,2,Completed,PIK3R1,2
breast carcinoma,PICTILISIB,2,Completed,PIK3R2,2
breast carcinoma,PICTILISIB,2,Completed,PIK3R3,2
breast carcinoma,PICTILISIB,2,Completed,PIK3R5,2
breast carcinoma,PILARALISIB,1,Completed,PIK3CA,2
breast carcinoma,PILARALISIB,1,Completed,PIK3CB,2
breast carcinoma,PILARALISIB,1,Completed,PIK3CD,2
breast carcinoma,PILARALISIB,1,Completed,PIK3CG,2
breast carcinoma,PILARALISIB,1,Completed,PIK3R1,2
breast carcinoma,PILARALISIB,1,Completed,PIK3R2,2
breast carcinoma,PILARALISIB,1,Completed,PIK3R3,2
breast carcinoma,PILARALISIB,1,Completed,PIK3R5,2
breast carcinoma,METHOTREXATE,3,Unknown status,DHFR,2
breast carcinoma,METHOTREXATE,3,"Active, not recruiting",DHFR,2
breast carcinoma,METHOTREXATE,2,Withdrawn,DHFR,2
breast carcinoma,METHOTREXATE,2,Recruiting,DHFR,2
breast carcinoma,METHOTREXATE,1,Completed,DHFR,2
breast carcinoma,PYROTINIB,1,Completed,EGFR,2
breast carcinoma,METFORMIN,2,Terminated,NDUFC1,2
breast carcinoma,METFORMIN,2,Terminated,NDUFB9,2
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB,2
breast carcinoma,METFORMIN,2,Terminated,MT-ND3,2
breast carcinoma,METFORMIN,2,Terminated,NDUFA2,2
breast carcinoma,METFORMIN,2,Terminated,NDUFA13,2
breast carcinoma,METFORMIN,2,Terminated,NDUFA12,2
breast carcinoma,METFORMIN,2,Terminated,NDUFA11,2
breast carcinoma,METFORMIN,2,Terminated,NDUFA10,2
breast carcinoma,METFORMIN,2,Terminated,NDUFA1,2
breast carcinoma,METFORMIN,2,Terminated,MT-ND6,2
breast carcinoma,METFORMIN,2,Terminated,MT-ND5,2
breast carcinoma,METFORMIN,2,Terminated,MT-ND4L,2
breast carcinoma,METFORMIN,2,Terminated,MT-ND4,2
breast carcinoma,METFORMIN,2,Terminated,MT-ND2,2
breast carcinoma,METFORMIN,2,Terminated,NDUFB8,2
breast carcinoma,METFORMIN,2,Terminated,MT-ND1,2
breast carcinoma,METFORMIN,2,Terminated,GPD2,2
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB8,2
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB6,2
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB4B,2
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB4A,2
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB3,2
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB2B,2
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB2A,2
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB1,2
breast carcinoma,METFORMIN,2,Terminated,NDUFA3,2
breast carcinoma,METFORMIN,2,Terminated,NDUFA4,2
breast carcinoma,METFORMIN,2,Terminated,NDUFA4L2,2
breast carcinoma,METFORMIN,2,Terminated,NDUFA5,2
breast carcinoma,METFORMIN,2,Terminated,NDUFB7,2
breast carcinoma,HEMAY-022,1,Recruiting,ERBB2,2
breast carcinoma,METFORMIN,2,Terminated,NDUFB6,2
breast carcinoma,METFORMIN,2,Terminated,NDUFB5,2
breast carcinoma,METFORMIN,2,Terminated,NDUFB4,2
breast carcinoma,HYDROXYCHLOROQUINE,1,Terminated,TLR7,2
breast carcinoma,HYDROXYCHLOROQUINE,1,Terminated,TLR9,2
breast carcinoma,METFORMIN,2,Terminated,NDUFB3,2
breast carcinoma,METFORMIN,2,Terminated,NDUFB2,2
breast carcinoma,METFORMIN,2,Terminated,NDUFB11,2
breast carcinoma,METFORMIN,2,Terminated,NDUFB10,2
breast carcinoma,METFORMIN,2,Terminated,NDUFB1,2
breast carcinoma,IXABEPILONE,3,"Active, not recruiting",TUBB2A,2
breast carcinoma,METFORMIN,2,Terminated,NDUFAF3,2
breast carcinoma,METFORMIN,2,Terminated,NDUFAF2,2
breast carcinoma,METFORMIN,2,Terminated,NDUFAF1,2
breast carcinoma,METFORMIN,2,Terminated,NDUFAB1,2
breast carcinoma,METFORMIN,2,Terminated,NDUFA9,2
breast carcinoma,METFORMIN,2,Terminated,NDUFA8,2
breast carcinoma,METFORMIN,2,Terminated,NDUFA7,2
breast carcinoma,METFORMIN,2,Terminated,NDUFA6,2
breast carcinoma,LUCITANIB,2,Completed,FLT4,2
breast carcinoma,GEMCITABINE,1,Recruiting,POLE,2
breast carcinoma,GEMCITABINE,1,Recruiting,RRM1,2
breast carcinoma,DOXORUBICIN,4,Recruiting,TOP2A,2
breast carcinoma,VINORELBINE,4,Recruiting,TUBB1,2
breast carcinoma,VINORELBINE,4,Recruiting,TUBB,2
triple-negative breast cancer,APATINIB,2,Recruiting,KDR,2
breast carcinoma,VINORELBINE,3,Unknown status,TUBB8,2
breast carcinoma,VINORELBINE,3,Unknown status,TUBB6,2
breast carcinoma,VINORELBINE,3,Unknown status,TUBB4B,2
breast carcinoma,VINORELBINE,3,Unknown status,TUBB4A,2
breast carcinoma,VINORELBINE,3,Unknown status,TUBB3,2
breast carcinoma,VINORELBINE,3,Unknown status,TUBB2B,2
breast carcinoma,VINORELBINE,3,Unknown status,TUBB2A,2
breast carcinoma,VINORELBINE,3,Unknown status,TUBB1,2
breast carcinoma,VINORELBINE,3,Unknown status,TUBB,2
breast carcinoma,DOXORUBICIN,1,"Active, not recruiting",TOP2A,2
breast carcinoma,DOXORUBICIN,2,Suspended,TOP2A,2
breast carcinoma,DOXORUBICIN,4,Unknown status,TOP2A,2
breast carcinoma,VINORELBINE,4,Recruiting,TUBB2B,2
breast carcinoma,DURVALUMAB,2,Not yet recruiting,CD274,2
triple-negative breast cancer,DOCETAXEL,2,Recruiting,TUBB,2
triple-negative breast cancer,DOCETAXEL,2,Recruiting,TUBB1,2
triple-negative breast cancer,DOCETAXEL,2,Recruiting,TUBB2A,2
triple-negative breast cancer,DOCETAXEL,2,Recruiting,TUBB2B,2
breast carcinoma,ENOBOSARM,2,Completed,AR,2
breast carcinoma,VINORELBINE,2,Not yet recruiting,TUBB8,2
breast carcinoma,VINORELBINE,2,Not yet recruiting,TUBB6,2
breast carcinoma,VINORELBINE,2,Not yet recruiting,TUBB4B,2
breast carcinoma,VINORELBINE,2,Not yet recruiting,TUBB4A,2
breast carcinoma,VINORELBINE,2,Not yet recruiting,TUBB3,2
breast carcinoma,VINORELBINE,2,Not yet recruiting,TUBB2B,2
breast carcinoma,VINORELBINE,2,Not yet recruiting,TUBB2A,2
breast carcinoma,VINORELBINE,2,Not yet recruiting,TUBB1,2
breast carcinoma,VINORELBINE,4,Recruiting,TUBB2A,2
breast carcinoma,VINORELBINE,4,Recruiting,TUBB3,2
breast carcinoma,ENTINOSTAT,1,Recruiting,HDAC1,2
breast carcinoma,ABEMACICLIB,1,Recruiting,CDK6,2
breast carcinoma,VORINOSTAT,2,Completed,HDAC1,2
breast carcinoma,VORINOSTAT,1,Unknown status,HDAC6,2
breast carcinoma,VORINOSTAT,1,Unknown status,HDAC3,2
breast carcinoma,VORINOSTAT,1,Unknown status,HDAC2,2
breast carcinoma,VORINOSTAT,1,Unknown status,HDAC1,2
breast carcinoma,DOCETAXEL,3,Not yet recruiting,TUBB,2
breast carcinoma,DOCETAXEL,3,Not yet recruiting,TUBB1,2
breast carcinoma,DOCETAXEL,3,Not yet recruiting,TUBB2A,2
breast carcinoma,DOCETAXEL,3,Not yet recruiting,TUBB2B,2
breast carcinoma,DOCETAXEL,3,Not yet recruiting,TUBB3,2
breast carcinoma,DOCETAXEL,3,Not yet recruiting,TUBB4A,2
breast carcinoma,ABEMACICLIB,2,Recruiting,CDK6,2
breast carcinoma,DOCETAXEL,3,Not yet recruiting,TUBB4B,2
breast carcinoma,ABEMACICLIB,2,Recruiting,CDK4,2
breast carcinoma,ABEMACICLIB,1,Recruiting,CDK4,2
breast carcinoma,VINORELBINE,4,Recruiting,TUBB4A,2
breast carcinoma,DOCETAXEL,3,Not yet recruiting,TUBB6,2
breast carcinoma,DOCETAXEL,3,Not yet recruiting,TUBB8,2
male breast carcinoma,VORINOSTAT,1,Completed,HDAC1,2
male breast carcinoma,VORINOSTAT,1,Completed,HDAC2,2
male breast carcinoma,VORINOSTAT,1,Completed,HDAC3,2
male breast carcinoma,VORINOSTAT,1,Completed,HDAC6,2
breast adenocarcinoma,TAMOXIFEN,3,"Active, not recruiting",ESR1,2
breast carcinoma,VORINOSTAT,1,Completed,HDAC6,2
breast carcinoma,VORINOSTAT,1,Completed,HDAC3,2
breast carcinoma,VORINOSTAT,1,Completed,HDAC2,2
breast carcinoma,VORINOSTAT,1,Completed,HDAC1,2
breast carcinoma,VINORELBINE,4,Recruiting,TUBB8,2
breast carcinoma,VINORELBINE,4,Recruiting,TUBB6,2
breast carcinoma,VINORELBINE,4,Recruiting,TUBB4B,2
breast carcinoma,VINORELBINE,2,Not yet recruiting,TUBB,2
breast carcinoma,ENTINOSTAT,1,Recruiting,HDAC10,2
breast carcinoma,VORINOSTAT,2,Completed,HDAC2,2
breast adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB6,2
triple-negative breast cancer,DOXORUBICIN,2,"Active, not recruiting",TOP2A,2
breast carcinoma,EPOETIN ALFA,3,Completed,EPOR,2
breast carcinoma,ERGOCALCIFEROL,2,Completed,VDR,2
breast carcinoma,ERGOCALCIFEROL,2,Recruiting,VDR,2
breast carcinoma,ERIBULIN,1,Recruiting,TUBB,2
breast carcinoma,ERIBULIN,1,Recruiting,TUBB1,2
breast carcinoma,ERIBULIN,1,Recruiting,TUBB2A,2
breast carcinoma,ERIBULIN,1,Recruiting,TUBB2B,2
breast carcinoma,ERIBULIN,1,Recruiting,TUBB3,2
breast carcinoma,ERIBULIN,1,Recruiting,TUBB4A,2
breast carcinoma,ERIBULIN,1,Recruiting,TUBB4B,2
breast carcinoma,ERIBULIN,1,Recruiting,TUBB6,2
breast carcinoma,ERIBULIN,1,Recruiting,TUBB8,2
breast adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB8,2
breast adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB4B,2
triple-negative breast cancer,DOCETAXEL,2,Recruiting,TUBB8,2
breast adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB4A,2
breast adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB3,2
breast adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB2B,2
breast adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB2A,2
breast adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB1,2
breast adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB,2
breast adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB8,2
breast adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB6,2
breast adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB4B,2
breast adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB4A,2
breast adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB3,2
breast adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB2B,2
breast adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB2A,2
breast adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB1,2
breast carcinoma,ENZASTAURIN,2,Completed,PRKCB,2
triple-negative breast cancer,DOCETAXEL,2,Recruiting,TUBB6,2
breast carcinoma,ENTINOSTAT,1,Recruiting,HDAC11,2
breast carcinoma,VINORELBINE,1,Unknown status,TUBB2A,2
breast carcinoma,ENTINOSTAT,1,Recruiting,HDAC2,2
breast carcinoma,ENTINOSTAT,1,Recruiting,HDAC3,2
breast carcinoma,ENTINOSTAT,1,Recruiting,HDAC4,2
breast carcinoma,ENTINOSTAT,1,Recruiting,HDAC5,2
breast carcinoma,ENTINOSTAT,1,Recruiting,HDAC6,2
breast carcinoma,ENTINOSTAT,1,Recruiting,HDAC7,2
breast carcinoma,ENTINOSTAT,1,Recruiting,HDAC8,2
breast carcinoma,ENTINOSTAT,1,Recruiting,HDAC9,2
breast carcinoma,VINORELBINE,1,Unknown status,TUBB8,2
breast carcinoma,VINORELBINE,1,Unknown status,TUBB6,2
breast carcinoma,VINORELBINE,1,Unknown status,TUBB4B,2
breast carcinoma,VINORELBINE,1,Unknown status,TUBB4A,2
breast carcinoma,VINORELBINE,1,Unknown status,TUBB3,2
breast carcinoma,VINORELBINE,1,Unknown status,TUBB2B,2
breast carcinoma,ENTINOSTAT,2,Completed,HDAC1,2
triple-negative breast cancer,DOCETAXEL,2,Recruiting,TUBB4B,2
breast carcinoma,ENTINOSTAT,2,Completed,HDAC10,2
breast carcinoma,ENTINOSTAT,2,Completed,HDAC11,2
breast carcinoma,ENTINOSTAT,2,Completed,HDAC2,2
breast carcinoma,ENTINOSTAT,2,Completed,HDAC3,2
breast carcinoma,ENTINOSTAT,2,Completed,HDAC4,2
breast carcinoma,ENTINOSTAT,2,Completed,HDAC5,2
breast carcinoma,ENTINOSTAT,2,Completed,HDAC6,2
breast carcinoma,ENTINOSTAT,2,Completed,HDAC7,2
breast carcinoma,ENTINOSTAT,2,Completed,HDAC8,2
breast carcinoma,ENTINOSTAT,2,Completed,HDAC9,2
breast carcinoma,VINORELBINE,1,Unknown status,TUBB1,2
breast carcinoma,VINORELBINE,1,Unknown status,TUBB,2
triple-negative breast cancer,DOCETAXEL,2,Recruiting,TUBB3,2
triple-negative breast cancer,DOCETAXEL,2,Recruiting,TUBB4A,2
breast carcinoma,ACETAMINOPHEN,2,Recruiting,FAAH,2
breast carcinoma,VORINOSTAT,2,Completed,HDAC3,2
breast adenocarcinoma,EXEMESTANE,3,"Active, not recruiting",CYP19A1,2
inflammatory breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB6,2
inflammatory breast carcinoma,PACLITAXEL,2,Recruiting,TUBB4A,2
inflammatory breast carcinoma,PACLITAXEL,2,Recruiting,TUBB3,2
inflammatory breast carcinoma,PACLITAXEL,2,Recruiting,TUBB2B,2
inflammatory breast carcinoma,PACLITAXEL,2,Recruiting,TUBB2A,2
inflammatory breast carcinoma,PACLITAXEL,2,Recruiting,TUBB1,2
inflammatory breast carcinoma,PACLITAXEL,2,Recruiting,TUBB,2
breast carcinoma,GEMCITABINE,1,Recruiting,PRIM2,2
breast carcinoma,DALOTUZUMAB,1,Completed,IGF1R,2
breast carcinoma,DARBEPOETIN ALFA,2,Completed,EPOR,2
breast carcinoma,BRILANESTRANT,2,"Active, not recruiting",ESR1,2
breast carcinoma,BOSUTINIB,2,Terminated,SRC,2
breast carcinoma,BOSUTINIB,2,Terminated,LYN,2
breast carcinoma,BOSUTINIB,2,Terminated,HCK,2
inflammatory breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB8,2
breast carcinoma,BOSUTINIB,2,Terminated,ABL1,2
inflammatory breast carcinoma,PACLITAXEL,2,Recruiting,TUBB6,2
inflammatory breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4B,2
inflammatory breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4A,2
inflammatory breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB3,2
inflammatory breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2B,2
inflammatory breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2A,2
breast carcinoma,BORTEZOMIB,2,Completed,PSMB5,2
male breast carcinoma,LAPATINIB,2,Completed,EGFR,2
male breast carcinoma,LAPATINIB,2,Completed,ERBB2,2
inflammatory breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB1,2
inflammatory breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,2
breast carcinoma,BEVACIZUMAB,4,Withdrawn,VEGFA,2
breast carcinoma,BEVACIZUMAB,1,Recruiting,VEGFA,2
breast carcinoma,BEVACIZUMAB,0,Unknown status,VEGFA,2
breast carcinoma,AZD-6738,2,Recruiting,ATR,2
inflammatory breast carcinoma,PACLITAXEL,2,Recruiting,TUBB4B,2
inflammatory breast carcinoma,PACLITAXEL,2,Recruiting,TUBB8,2
breast carcinoma,AZD-5363,2,Recruiting,AKT2,2
breast carcinoma,COPANLISIB,1,Not yet recruiting,PIK3CA,2
male breast carcinoma,BEVACIZUMAB,2,Completed,VEGFA,2
male breast carcinoma,ALDESLEUKIN,2,Completed,IL2RB,2
breast carcinoma,CARVEDILOL,2,"Active, not recruiting",ADRA1A,2
breast carcinoma,CARVEDILOL,2,"Active, not recruiting",ADRA1B,2
breast carcinoma,CARVEDILOL,2,"Active, not recruiting",ADRA1D,2
breast carcinoma,CARVEDILOL,2,"Active, not recruiting",ADRB1,2
breast carcinoma,CARVEDILOL,2,"Active, not recruiting",ADRB2,2
breast carcinoma,CARVEDILOL,2,"Active, not recruiting",ADRB3,2
male breast carcinoma,ALDESLEUKIN,2,Completed,IL2RA,2
male breast carcinoma,CILENGITIDE,1,Completed,ITGAV,2
breast carcinoma,COBIMETINIB,1,Recruiting,MAP2K1,2
breast carcinoma,COBIMETINIB,1,Recruiting,MAP2K2,2
male breast carcinoma,DOXORUBICIN,1,Completed,TOP2A,2
male breast carcinoma,DOXORUBICIN,2,"Active, not recruiting",TOP2A,2
breast carcinoma,COPANLISIB,1,Not yet recruiting,PIK3CD,2
breast carcinoma,CYCLOSPORINE,2,Completed,PPIA,2
breast carcinoma,COPANLISIB,1,Recruiting,PIK3CB,2
breast carcinoma,COPANLISIB,1,Recruiting,PIK3CG,2
breast carcinoma,COPANLISIB,1,Recruiting,PIK3R1,2
breast carcinoma,COPANLISIB,1,Recruiting,PIK3R2,2
breast carcinoma,COPANLISIB,1,Recruiting,PIK3R3,2
breast carcinoma,COPANLISIB,1,Recruiting,PIK3R5,2
breast carcinoma,COPANLISIB,2,Withdrawn,PIK3CA,2
breast carcinoma,COPANLISIB,2,Withdrawn,PIK3CD,2
breast carcinoma,BUPIVACAINE,3,Unknown status,SCN4A,2
breast carcinoma,BUPIVACAINE,2,Not yet recruiting,SCN4A,2
breast carcinoma,CROFELEMER,2,Recruiting,ANO1,2
breast carcinoma,CROFELEMER,2,Recruiting,CFTR,2
inflammatory breast carcinoma,PEMBROLIZUMAB,2,Recruiting,PDCD1,2
breast carcinoma,CYCLOSPORINE,1,Unknown status,PPIA,2
breast carcinoma,AZD-5363,2,Recruiting,AKT3,2
breast carcinoma,AZD-5363,2,Recruiting,AKT1,2
breast carcinoma,VORINOSTAT,2,Completed,HDAC6,2
breast carcinoma,ALVOCIDIB,1,Completed,CDK4,2
breast carcinoma,DEXAMETHASONE,2,Unknown status,NR3C1,2
breast carcinoma,DEXMEDETOMIDINE,3,Unknown status,ADRA2A,2
breast carcinoma,ANASTROZOLE,3,Terminated,CYP19A1,2
breast carcinoma,DEXMEDETOMIDINE,3,Unknown status,ADRA2B,2
breast carcinoma,DEXMEDETOMIDINE,3,Unknown status,ADRA2C,2
breast carcinoma,ANASTROZOLE,2,Not yet recruiting,CYP19A1,2
breast carcinoma,ZOLEDRONIC ACID,3,Unknown status,FDPS,2
breast carcinoma,ZOLEDRONIC ACID,2,Terminated,FDPS,2
breast carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB,2
breast carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB1,2
breast carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB2A,2
breast carcinoma,ALVOCIDIB,1,Completed,CDK9,2
breast carcinoma,ALVOCIDIB,1,Completed,CDK7,2
breast carcinoma,ALVOCIDIB,1,Completed,CDK6,2
breast carcinoma,ALVOCIDIB,1,Completed,CDK2,2
inflammatory breast carcinoma,DOXORUBICIN,2,Recruiting,TOP2A,2
breast carcinoma,ALVOCIDIB,1,Completed,CDK1,2
breast carcinoma,ALPELISIB,2,Recruiting,PIK3CA,2
breast carcinoma,ALDESLEUKIN,2,Terminated,IL2RB,2
breast carcinoma,ALDESLEUKIN,2,Terminated,IL2RA,2
breast carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB3,2
breast carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB4A,2
breast carcinoma,ALDESLEUKIN,1,Unknown status,IL2RB,2
breast carcinoma,ALDESLEUKIN,1,Unknown status,IL2RA,2
breast carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB4B,2
breast carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB6,2
breast carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB8,2
breast carcinoma,ACETAMINOPHEN,2,Recruiting,TRPV1,2
breast carcinoma,ACETAMINOPHEN,2,Recruiting,PTGS2,2
breast carcinoma,ACETAMINOPHEN,2,Recruiting,PTGS1,2
breast carcinoma,DEXAMETHASONE,2,Terminated,NR3C1,2
breast carcinoma,ARZOXIFENE,2,Completed,ESR1,2
breast carcinoma,AZD-1775,2,Recruiting,WEE1,2
breast carcinoma,ATEZOLIZUMAB,2,"Active, not recruiting",CD274,2
breast carcinoma,AVELUMAB,2,Not yet recruiting,CD274,2
breast carcinoma,ATORVASTATIN,2,Recruiting,HMGCR,2
male breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,2
breast carcinoma,DASATINIB,2,Terminated,ABL1,2
breast carcinoma,DASATINIB,2,Terminated,BLK,2
breast carcinoma,DASATINIB,2,Terminated,EPHA2,2
breast carcinoma,DASATINIB,2,Terminated,FGR,2
breast carcinoma,DASATINIB,2,Terminated,FRK,2
breast carcinoma,DASATINIB,2,Terminated,FYN,2
breast carcinoma,DASATINIB,2,Terminated,HCK,2
breast carcinoma,DASATINIB,2,Terminated,KIT,2
breast carcinoma,DASATINIB,2,Terminated,LCK,2
breast carcinoma,DASATINIB,2,Terminated,LYN,2
breast carcinoma,ATEZOLIZUMAB,2,Not yet recruiting,CD274,2
breast carcinoma,ATEZOLIZUMAB,1,"Active, not recruiting",CD274,2
breast carcinoma,ARZOXIFENE,2,Completed,ESR2,2
male breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB1,2
male breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB2A,2
male breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB2B,2
breast carcinoma,ASPIRIN,2,Not yet recruiting,PTGS2,2
breast carcinoma,ASPIRIN,2,Not yet recruiting,PTGS1,2
male breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB3,2
male breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB4A,2
male breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB4B,2
male breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB6,2
male breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB8,2
breast carcinoma,DASATINIB,2,Terminated,PDGFRB,2
breast carcinoma,DASATINIB,2,Terminated,SRC,2
breast carcinoma,DASATINIB,2,Terminated,SRMS,2
breast carcinoma,DASATINIB,2,Terminated,YES1,2
breast adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB,2
breast carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB2B,2
triple-negative breast cancer,PACLITAXEL,3,Recruiting,TUBB1,2
triple-negative breast cancer,PACLITAXEL,3,Recruiting,TUBB,2
breast carcinoma,ESTRADIOL,2,Terminated,ESR1,2
breast carcinoma,ESTRADIOL,2,Recruiting,ESR1,2
breast carcinoma,ESTRADIOL,2,"Active, not recruiting",ESR1,2
breast carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLA1,2
breast carcinoma,TRIPTORELIN,2,Terminated,GNRHR,2
breast carcinoma,TREMELIMUMAB,2,Recruiting,CTLA4,2
breast carcinoma,FULVESTRANT,2,Withdrawn,ESR1,2
breast carcinoma,FULVESTRANT,2,Withdrawn,ESR2,2
breast carcinoma,FULVESTRANT,3,Recruiting,ESR1,2
breast carcinoma,FLUOROURACIL,1,Recruiting,TYMS,2
breast carcinoma,FILGRASTIM,2,Unknown status,CSF3R,2
breast carcinoma,VELIPARIB,1,Completed,PARP1,2
breast carcinoma,VELIPARIB,1,Completed,PARP2,2
breast carcinoma,VELIPARIB,1,Completed,PARP3,2
triple-negative breast cancer,PACLITAXEL,3,Recruiting,TUBB2A,2
breast carcinoma,FLUOROURACIL,2,Recruiting,TYMS,2
breast carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,RRM1,2
triple-negative breast cancer,PACLITAXEL,3,Recruiting,TUBB2B,2
triple-negative breast cancer,PACLITAXEL,3,Recruiting,TUBB3,2
breast carcinoma,FLUOROURACIL,3,Terminated,TYMS,2
breast carcinoma,TUCATINIB,1,"Active, not recruiting",ERBB2,2
breast carcinoma,TUCATINIB,2,Recruiting,ERBB2,2
breast carcinoma,VELIPARIB,3,"Active, not recruiting",PARP2,2
breast carcinoma,EVEROLIMUS,1,Unknown status,FKBP1A,2
triple-negative breast cancer,PACLITAXEL,2,Completed,TUBB,2
Hereditary breast and ovarian cancer syndrome,PALBOCICLIB,1,Not yet recruiting,CCND1,2
breast carcinoma,EVEROLIMUS,4,Completed,FKBP1A,2
breast carcinoma,EVEROLIMUS,2,Withdrawn,FKBP1A,2
triple-negative breast cancer,PACLITAXEL,2,Completed,TUBB1,2
triple-negative breast cancer,PACLITAXEL,2,Completed,TUBB2A,2
triple-negative breast cancer,PACLITAXEL,2,Completed,TUBB2B,2
triple-negative breast cancer,PACLITAXEL,2,Completed,TUBB3,2
triple-negative breast cancer,PACLITAXEL,2,Completed,TUBB4A,2
Hereditary breast and ovarian cancer syndrome,VELIPARIB,2,"Active, not recruiting",PARP1,2
breast carcinoma,EXEMESTANE,2,Unknown status,CYP19A1,2
Hereditary breast and ovarian cancer syndrome,VELIPARIB,2,"Active, not recruiting",PARP2,2
breast carcinoma,ETOPOSIDE,2,Unknown status,TOP2B,2
breast carcinoma,ETOPOSIDE,2,Unknown status,TOP2A,2
Hereditary breast and ovarian cancer syndrome,VELIPARIB,2,"Active, not recruiting",PARP3,2
breast carcinoma,EXEMESTANE,1,Not yet recruiting,CYP19A1,2
breast carcinoma,EXEMESTANE,1,Terminated,CYP19A1,2
triple-negative breast cancer,PACLITAXEL,2,Completed,TUBB4B,2
triple-negative breast cancer,PACLITAXEL,2,Completed,TUBB6,2
triple-negative breast cancer,PACLITAXEL,2,Completed,TUBB8,2
breast carcinoma,VELIPARIB,3,"Active, not recruiting",PARP1,2
breast carcinoma,EVEROLIMUS,3,"Active, not recruiting",FKBP1A,2
breast carcinoma,VELIPARIB,3,"Active, not recruiting",PARP3,2
breast carcinoma,GEMCITABINE,1,Recruiting,POLD1,2
breast carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLD4,2
breast carcinoma,GEMCITABINE,1,Recruiting,POLE3,2
breast carcinoma,GEMCITABINE,1,Recruiting,POLE2,2
breast carcinoma,ERIBULIN,2,Not yet recruiting,TUBB6,2
breast carcinoma,GEMCITABINE,1,Recruiting,POLD4,2
breast carcinoma,GEMCITABINE,1,Recruiting,POLD3,2
breast carcinoma,ERIBULIN,2,Not yet recruiting,TUBB4B,2
breast carcinoma,GEMCITABINE,1,Recruiting,POLD2,2
breast carcinoma,GEMCITABINE,1,Recruiting,POLA2,2
breast carcinoma,ERIBULIN,2,Not yet recruiting,TUBB4A,2
triple-negative breast cancer,PACLITAXEL,3,Recruiting,TUBB4A,2
breast carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLE3,2
breast carcinoma,ERIBULIN,2,Not yet recruiting,TUBB2A,2
breast carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLE,2
breast carcinoma,ERIBULIN,2,Not yet recruiting,TUBB,2
breast carcinoma,ERIBULIN,2,Not yet recruiting,TUBB1,2
breast carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLE2,2
breast carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLD2,2
breast carcinoma,FULVESTRANT,3,Recruiting,ESR2,2
breast carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLD3,2
breast carcinoma,ERIBULIN,2,Not yet recruiting,TUBB8,2
breast carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLA2,2
triple-negative breast cancer,PACLITAXEL,3,Recruiting,TUBB4B,2
triple-negative breast cancer,PACLITAXEL,3,Recruiting,TUBB6,2
Hereditary breast and ovarian cancer syndrome,NIRAPARIB,3,"Active, not recruiting",PARP2,2
Hereditary breast and ovarian cancer syndrome,NIRAPARIB,3,"Active, not recruiting",PARP1,2
triple-negative breast cancer,PACLITAXEL,3,Recruiting,TUBB8,2
Hereditary breast and ovarian cancer syndrome,NIRAPARIB,1,Recruiting,PARP2,2
Hereditary breast and ovarian cancer syndrome,NIRAPARIB,1,Recruiting,PARP1,2
breast carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,PRIM2,2
breast carcinoma,ERIBULIN,2,Not yet recruiting,TUBB2B,2
breast carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,POLD1,2
breast carcinoma,FLUDARABINE PHOSPHATE,2,Terminated,PRIM1,2
breast carcinoma,ERIBULIN,2,Not yet recruiting,TUBB3,2
breast carcinoma,GEMCITABINE,1,Recruiting,POLA1,2
breast carcinoma,GEMCITABINE,1,Recruiting,PRIM1,2
breast carcinoma,POZIOTINIB,2,Recruiting,EGFR,1
breast carcinoma,POZIOTINIB,2,Unknown status,ERBB2,1
breast carcinoma,POZIOTINIB,2,Unknown status,EGFR,1
breast carcinoma,POZIOTINIB,2,Recruiting,ERBB4,1
breast carcinoma,POZIOTINIB,2,"Active, not recruiting",ERBB4,1
breast carcinoma,POZIOTINIB,2,Recruiting,ERBB3,1
breast carcinoma,POZIOTINIB,2,Recruiting,ERBB2,1
breast carcinoma,PROPRANOLOL,2,"Active, not recruiting",ADRB1,1
breast carcinoma,POZIOTINIB,2,"Active, not recruiting",ERBB3,1
breast carcinoma,PROPOFOL,4,Completed,GABRQ,1
breast carcinoma,POZIOTINIB,2,Unknown status,ERBB4,1
breast carcinoma,POZIOTINIB,2,"Active, not recruiting",ERBB2,1
breast carcinoma,POZIOTINIB,2,"Active, not recruiting",EGFR,1
breast carcinoma,PROPRANOLOL,2,"Active, not recruiting",ADRB2,1
breast carcinoma,PROPRANOLOL,2,Terminated,ADRB1,1
breast carcinoma,PROPRANOLOL,2,Terminated,ADRB2,1
breast carcinoma,PYROTINIB,1,"Active, not recruiting",EGFR,1
breast carcinoma,PYROTINIB,1,"Active, not recruiting",ERBB2,1
breast carcinoma,POZIOTINIB,1,"Active, not recruiting",ERBB4,1
breast carcinoma,POZIOTINIB,2,Unknown status,ERBB3,1
male breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB4B,1
breast carcinoma,PRALATREXATE,2,Completed,DHFR,1
breast carcinoma,PROPOFOL,4,Completed,GABRB2,1
breast carcinoma,PROPOFOL,4,Completed,GABRA3,1
breast carcinoma,PROPOFOL,4,Completed,GABRA4,1
breast carcinoma,PROPOFOL,4,Completed,GABRA5,1
breast carcinoma,PROPOFOL,4,Completed,GABRA6,1
triple-negative breast cancer,SACITUZUMAB GOVITECAN,2,Unknown status,TACSTD2,1
breast carcinoma,POZIOTINIB,1,"Active, not recruiting",ERBB3,1
breast carcinoma,PROPOFOL,4,Completed,GABRB3,1
breast carcinoma,PROPOFOL,4,Completed,GABRA1,1
breast carcinoma,PROPOFOL,4,Completed,GABRD,1
breast carcinoma,PROPOFOL,4,Completed,GABRE,1
breast carcinoma,PROPOFOL,4,Completed,GABRG1,1
breast carcinoma,PROPOFOL,4,Completed,GABRG2,1
breast carcinoma,PROPOFOL,4,Completed,GABRG3,1
breast carcinoma,PROPOFOL,4,Completed,GABRP,1
breast carcinoma,PROPOFOL,4,Completed,GABRA2,1
breast carcinoma,PROGESTERONE,3,"Active, not recruiting",PGR,1
breast carcinoma,PRAVASTATIN,1,Completed,HMGCR,1
male breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB6,1
male breast carcinoma,IXABEPILONE,2,Completed,TUBB2A,1
breast carcinoma,PREDNISOLONE,2,Completed,NR3C1,1
breast carcinoma,PREDNISOLONE,2,Unknown status,NR3C1,1
male breast carcinoma,IXABEPILONE,2,Completed,TUBB1,1
male breast carcinoma,IXABEPILONE,2,Completed,TUBB,1
male breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB8,1
male breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB4A,1
breast carcinoma,PROGESTERONE,2,Completed,PGR,1
triple-negative breast cancer,ROMIDEPSIN,1,Recruiting,HDAC9,1
breast carcinoma,PREDNISONE,2,Completed,NR3C1,1
breast carcinoma,PREDNISONE,2,Withdrawn,NR3C1,1
male breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB3,1
breast carcinoma,PREGABALIN,3,Not yet recruiting,CACNA2D1,1
breast carcinoma,PROCHLORPERAZINE,3,Recruiting,DRD2,1
breast carcinoma,PROPOFOL,4,Completed,GABRB1,1
male breast carcinoma,LAPATINIB,1,Completed,EGFR,1
breast carcinoma,POZIOTINIB,1,"Active, not recruiting",ERBB2,1
breast carcinoma,POZIOTINIB,1,"Active, not recruiting",EGFR,1
breast carcinoma,PF-04691502,2,Terminated,PIK3R2,1
breast carcinoma,PF-04691502,2,Terminated,PIK3R3,1
breast carcinoma,PF-04691502,2,Terminated,PIK3R5,1
breast carcinoma,PHENELZINE,1,Recruiting,MAOA,1
breast carcinoma,PHENELZINE,1,Recruiting,MAOB,1
male breast carcinoma,PACLITAXEL,2,Completed,TUBB1,1
male breast carcinoma,PACLITAXEL,2,Completed,TUBB,1
male breast carcinoma,PACLITAXEL,1,Terminated,TUBB8,1
male breast carcinoma,PACLITAXEL,1,Terminated,TUBB6,1
male breast carcinoma,PACLITAXEL,1,Terminated,TUBB4B,1
male breast carcinoma,PACLITAXEL,1,Terminated,TUBB4A,1
male breast carcinoma,PACLITAXEL,1,Terminated,TUBB3,1
male breast carcinoma,PACLITAXEL,1,Terminated,TUBB2B,1
breast carcinoma,PICTILISIB,1,Unknown status,PIK3CA,1
breast carcinoma,PICTILISIB,1,Unknown status,PIK3CB,1
breast carcinoma,PICTILISIB,1,Unknown status,PIK3CD,1
breast carcinoma,PICTILISIB,1,Unknown status,PIK3CG,1
breast carcinoma,PICTILISIB,1,Unknown status,PIK3R1,1
triple-negative breast cancer,PYROTINIB,1,Recruiting,ERBB2,1
breast carcinoma,PF-04691502,2,Terminated,PIK3R1,1
breast carcinoma,PF-04691502,2,Terminated,PIK3CG,1
breast carcinoma,PF-04691502,2,Terminated,PIK3CD,1
triple-negative breast cancer,PYROTINIB,1,Recruiting,EGFR,1
male breast carcinoma,PACLITAXEL,2,Recruiting,TUBB2A,1
male breast carcinoma,PACLITAXEL,2,Recruiting,TUBB1,1
male breast carcinoma,PACLITAXEL,2,Recruiting,TUBB,1
male breast carcinoma,PACLITAXEL,2,Completed,TUBB8,1
male breast carcinoma,PACLITAXEL,2,Completed,TUBB6,1
triple-negative breast cancer,PEMBROLIZUMAB,2,Recruiting,PDCD1,1
male breast carcinoma,PACLITAXEL,2,Completed,TUBB4B,1
male breast carcinoma,PACLITAXEL,2,Completed,TUBB4A,1
breast carcinoma,PERTUZUMAB,2,Withdrawn,ERBB2,1
breast carcinoma,PF-04691502,2,Terminated,PIK3CB,1
male breast carcinoma,PACLITAXEL,2,Completed,TUBB3,1
male breast carcinoma,PACLITAXEL,2,Completed,TUBB2B,1
breast carcinoma,PERTUZUMAB,3,Not yet recruiting,ERBB2,1
male breast carcinoma,PACLITAXEL,2,Completed,TUBB2A,1
breast carcinoma,PERTUZUMAB,4,Completed,ERBB2,1
breast carcinoma,PERTUZUMAB,4,n/a,ERBB2,1
breast carcinoma,PF-04691502,2,Terminated,MTOR,1
breast carcinoma,PF-04691502,2,Terminated,PIK3CA,1
breast carcinoma,PICTILISIB,1,Unknown status,PIK3R2,1
breast carcinoma,PICTILISIB,1,Unknown status,PIK3R3,1
breast carcinoma,PICTILISIB,1,Unknown status,PIK3R5,1
breast carcinoma,PIMASERTIB,1,Completed,MAP2K2,1
male breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB2A,1
male breast carcinoma,LAPATINIB,1,"Active, not recruiting",ERBB2,1
male breast carcinoma,LAPATINIB,1,"Active, not recruiting",EGFR,1
male breast carcinoma,IXABEPILONE,2,Completed,TUBB8,1
male breast carcinoma,IXABEPILONE,2,Completed,TUBB6,1
male breast carcinoma,IXABEPILONE,2,Completed,TUBB4B,1
male breast carcinoma,IXABEPILONE,2,Completed,TUBB4A,1
breast carcinoma,PIMASERTIB,1,Completed,MAP2K1,1
breast carcinoma,PLX-3397,1,"Active, not recruiting",CSF1R,1
triple-negative breast cancer,ROMIDEPSIN,1,Recruiting,HDAC8,1
breast carcinoma,PLX-3397,1,"Active, not recruiting",FLT3,1
breast carcinoma,PLX-3397,1,"Active, not recruiting",KIT,1
breast carcinoma,PLX-3397,2,Recruiting,CSF1R,1
breast carcinoma,PLX-3397,2,Recruiting,FLT3,1
breast carcinoma,PLX-3397,2,Recruiting,KIT,1
breast carcinoma,POL6326,1,Completed,CXCR4,1
male breast carcinoma,IXABEPILONE,2,Completed,TUBB3,1
male breast carcinoma,IXABEPILONE,2,Completed,TUBB2B,1
male breast carcinoma,LAPATINIB,1,Completed,ERBB2,1
triple-negative breast cancer,ROMIDEPSIN,1,Recruiting,HDAC7,1
triple-negative breast cancer,ROMIDEPSIN,1,Recruiting,HDAC1,1
male breast carcinoma,MK-2206,1,Completed,AKT3,1
triple-negative breast cancer,ROMIDEPSIN,1,Recruiting,HDAC10,1
triple-negative breast cancer,ROMIDEPSIN,1,Recruiting,HDAC11,1
male breast carcinoma,PACLITAXEL,1,Terminated,TUBB2A,1
male breast carcinoma,PACLITAXEL,1,Terminated,TUBB1,1
male breast carcinoma,PACLITAXEL,1,Terminated,TUBB,1
triple-negative breast cancer,ROMIDEPSIN,1,Recruiting,HDAC2,1
triple-negative breast cancer,ROMIDEPSIN,1,Recruiting,HDAC3,1
triple-negative breast cancer,ROMIDEPSIN,1,Recruiting,HDAC4,1
male breast carcinoma,MK-2206,1,Completed,AKT2,1
male breast carcinoma,LAPATINIB,2,Terminated,EGFR,1
male breast carcinoma,MK-2206,1,Completed,AKT1,1
male breast carcinoma,MIFEPRISTONE,1,Completed,PGR,1
triple-negative breast cancer,ROMIDEPSIN,1,Recruiting,HDAC5,1
male breast carcinoma,MIFEPRISTONE,1,Completed,NR3C1,1
triple-negative breast cancer,ROMIDEPSIN,1,Recruiting,HDAC6,1
male breast carcinoma,LAPATINIB,3,"Active, not recruiting",ERBB2,1
male breast carcinoma,LAPATINIB,3,"Active, not recruiting",EGFR,1
male breast carcinoma,LAPATINIB,2,Terminated,ERBB2,1
male breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB2B,1
breast carcinoma,REPARIXIN,2,"Active, not recruiting",CXCR1,1
male breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB1,1
male breast carcinoma,ENTINOSTAT,2,Completed,HDAC3,1
breast carcinoma,PANOBINOSTAT,0,Withdrawn,HDAC7,1
male breast carcinoma,ENTINOSTAT,2,Completed,HDAC9,1
male breast carcinoma,ENTINOSTAT,2,Completed,HDAC8,1
male breast carcinoma,ENTINOSTAT,2,Completed,HDAC7,1
male breast carcinoma,ENTINOSTAT,2,Completed,HDAC6,1
breast carcinoma,PANOBINOSTAT,0,Withdrawn,HDAC6,1
male breast carcinoma,ENTINOSTAT,2,Completed,HDAC5,1
male breast carcinoma,ENTINOSTAT,2,Completed,HDAC4,1
triple-negative breast cancer,VELIPARIB,2,"Active, not recruiting",PARP1,1
male breast carcinoma,DOXORUBICIN,3,"Active, not recruiting",TOP2A,1
breast carcinoma,PANOBINOSTAT,0,Withdrawn,HDAC5,1
breast carcinoma,PANOBINOSTAT,0,Withdrawn,HDAC4,1
triple-negative breast cancer,VELIPARIB,2,"Active, not recruiting",PARP2,1
breast carcinoma,PANOBINOSTAT,0,Withdrawn,HDAC3,1
breast carcinoma,PANOBINOSTAT,0,Withdrawn,HDAC2,1
male breast carcinoma,ENTINOSTAT,2,Completed,HDAC2,1
male breast carcinoma,ENTINOSTAT,2,Completed,HDAC11,1
male breast carcinoma,ENTINOSTAT,2,Completed,HDAC10,1
triple-negative breast cancer,UCN-01,1,Completed,PRKD3,1
male breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB,1
male breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB1,1
male breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB2A,1
male breast carcinoma,GEFITINIB,2,Completed,EGFR,1
male breast carcinoma,GANETESPIB,1,Completed,HSP90AB1,1
male breast carcinoma,GANETESPIB,1,Completed,HSP90AA1,1
male breast carcinoma,FILGRASTIM,2,Completed,CSF3R,1
male breast carcinoma,FILGRASTIM,2,"Active, not recruiting",CSF3R,1
breast carcinoma,PANOBINOSTAT,0,Withdrawn,HDAC9,1
male breast carcinoma,FILGRASTIM,1,Terminated,CSF3R,1
male breast carcinoma,EXEMESTANE,3,Completed,CYP19A1,1
male breast carcinoma,EXEMESTANE,1,Terminated,CYP19A1,1
male breast carcinoma,EVEROLIMUS,1,"Active, not recruiting",FKBP1A,1
breast carcinoma,PANOBINOSTAT,0,Withdrawn,HDAC8,1
male breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB8,1
male breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB6,1
male breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB4B,1
male breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB4A,1
male breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB3,1
male breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB2B,1
male breast carcinoma,ENTINOSTAT,2,Completed,HDAC1,1
triple-negative breast cancer,VELIPARIB,2,"Active, not recruiting",PARP3,1
breast carcinoma,RILUZOLE,1,Withdrawn,SCN5A,1
male breast carcinoma,CEDIRANIB,2,Completed,FLT4,1
male breast carcinoma,DENILEUKIN DIFTITOX,1,Completed,EEF2,1
male breast carcinoma,CIXUTUMUMAB,1,Completed,IGF1R,1
male breast carcinoma,CILENGITIDE,1,Completed,ITGB5,1
male breast carcinoma,CILENGITIDE,1,Completed,ITGB3,1
male breast carcinoma,CEDIRANIB,2,Completed,PDGFRB,1
male breast carcinoma,CEDIRANIB,2,Completed,PDGFRA,1
male breast carcinoma,CEDIRANIB,2,Completed,KIT,1
male breast carcinoma,CEDIRANIB,2,Completed,KDR,1
male breast carcinoma,CEDIRANIB,2,Completed,FLT1,1
male breast carcinoma,DOXORUBICIN,2,Completed,TOP2A,1
breast carcinoma,PANITUMUMAB,2,Terminated,EGFR,1
male breast carcinoma,CAPECITABINE,2,Completed,TYMS,1
male breast carcinoma,CAPECITABINE,1,"Active, not recruiting",TYMS,1
male breast carcinoma,BEVACIZUMAB,3,"Active, not recruiting",VEGFA,1
male breast carcinoma,BEVACIZUMAB,2,"Active, not recruiting",VEGFA,1
male breast carcinoma,BEVACIZUMAB,1,Completed,VEGFA,1
male breast carcinoma,BECATECARIN,2,Completed,TOP2B,1
male breast carcinoma,BECATECARIN,2,Completed,TOP2A,1
male breast carcinoma,DENILEUKIN DIFTITOX,1,Completed,IL2RA,1
male breast carcinoma,DENILEUKIN DIFTITOX,1,Completed,IL2RB,1
male breast carcinoma,DINACICLIB,1,Completed,CDK1,1
male breast carcinoma,DINACICLIB,1,Completed,CDK2,1
triple-negative breast cancer,VELIPARIB,2,Completed,PARP1,1
triple-negative breast cancer,VELIPARIB,2,Completed,PARP2,1
male breast carcinoma,DOXORUBICIN,1,Terminated,TOP2A,1
breast carcinoma,PANOBINOSTAT,0,Withdrawn,HDAC11,1
male breast carcinoma,DOCETAXEL,1,Terminated,TUBB8,1
breast carcinoma,PANOBINOSTAT,0,Withdrawn,HDAC10,1
breast carcinoma,PANOBINOSTAT,0,Withdrawn,HDAC1,1
male breast carcinoma,DOCETAXEL,1,Terminated,TUBB6,1
male breast carcinoma,DOCETAXEL,1,Terminated,TUBB4B,1
male breast carcinoma,DOCETAXEL,1,Terminated,TUBB4A,1
male breast carcinoma,DOCETAXEL,1,Terminated,TUBB3,1
male breast carcinoma,DOCETAXEL,1,Terminated,TUBB2B,1
male breast carcinoma,DOCETAXEL,1,Terminated,TUBB2A,1
male breast carcinoma,DOCETAXEL,1,Terminated,TUBB1,1
male breast carcinoma,DOCETAXEL,1,Terminated,TUBB,1
male breast carcinoma,DINACICLIB,1,Completed,CDK9,1
male breast carcinoma,DINACICLIB,1,Completed,CDK5,1
breast carcinoma,RILUZOLE,1,Withdrawn,SCN7A,1
breast carcinoma,RILUZOLE,1,Withdrawn,SCN4A,1
triple-negative breast cancer,SELUMETINIB,1,"Active, not recruiting",MAP2K1,1
breast carcinoma,RETASPIMYCIN,2,Terminated,HSP90AA1,1
breast carcinoma,REPARIXIN,1,Completed,CXCR1,1
breast carcinoma,REPARIXIN,1,Completed,CXCR2,1
male breast carcinoma,PACLITAXEL,2,Recruiting,TUBB3,1
breast carcinoma,REPARIXIN,2,"Active, not recruiting",CXCR2,1
breast carcinoma,REPARIXIN,2,Terminated,CXCR1,1
breast carcinoma,REPARIXIN,2,Terminated,CXCR2,1
breast carcinoma,RETASPIMYCIN,1,Withdrawn,HSP90AA1,1
breast carcinoma,RETASPIMYCIN,1,Withdrawn,HSP90AB1,1
breast carcinoma,RETASPIMYCIN,2,Terminated,HSP90AB1,1
male breast carcinoma,IMATINIB,2,Completed,PDGFRB,1
breast carcinoma,RG-7666,2,Recruiting,PIK3CA,1
breast carcinoma,RG-7666,2,Recruiting,PIK3CB,1
breast carcinoma,RG-7666,2,Recruiting,PIK3CD,1
breast carcinoma,RG-7666,2,Recruiting,PIK3CG,1
breast carcinoma,RG-7666,2,Recruiting,PIK3R1,1
breast carcinoma,RG-7666,2,Recruiting,PIK3R2,1
breast carcinoma,RG-7666,2,Recruiting,PIK3R3,1
breast carcinoma,RG-7666,2,Recruiting,PIK3R5,1
breast carcinoma,RANITIDINE,2,Completed,HRH2,1
breast carcinoma,RAMUCIRUMAB,3,"Active, not recruiting",KDR,1
male breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB,1
breast carcinoma,RAMUCIRUMAB,1,Recruiting,KDR,1
breast carcinoma,PYROTINIB,2,Not yet recruiting,EGFR,1
breast carcinoma,PYROTINIB,2,Not yet recruiting,ERBB2,1
breast carcinoma,PYROTINIB,2,Recruiting,EGFR,1
breast carcinoma,PYROTINIB,2,Recruiting,ERBB2,1
breast carcinoma,PYROTINIB,3,"Active, not recruiting",EGFR,1
breast carcinoma,PYROTINIB,3,"Active, not recruiting",ERBB2,1
breast carcinoma,PYROTINIB,3,Not yet recruiting,EGFR,1
triple-negative breast cancer,SELUMETINIB,1,"Active, not recruiting",MAP2K2,1
triple-negative breast cancer,TALAZOPARIB,2,Recruiting,PARP1,1
breast carcinoma,PYROTINIB,3,Not yet recruiting,ERBB2,1
triple-negative breast cancer,TALAZOPARIB,2,Recruiting,PARP2,1
triple-negative breast cancer,UCN-01,1,Completed,CDK2,1
breast carcinoma,RAD1901,1,"Active, not recruiting",ESR1,1
breast carcinoma,RALIMETINIB,2,Terminated,MAPK14,1
triple-negative breast cancer,UCN-01,1,Completed,CDK4,1
breast carcinoma,RALOXIFENE,3,Completed,ESR2,1
breast carcinoma,RAMUCIRUMAB,1,Completed,KDR,1
breast carcinoma,RIBAVIRIN,1,Terminated,IMPDH1,1
triple-negative breast cancer,UCN-01,1,Completed,CDK6,1
breast carcinoma,RILUZOLE,1,Withdrawn,SCN3A,1
triple-negative breast cancer,UCN-01,1,Completed,PRKCI,1
triple-negative breast cancer,UCN-01,1,Completed,PRKCA,1
breast carcinoma,RIBOCICLIB,4,n/a,CDK4,1
breast carcinoma,RIBOCICLIB,4,n/a,CDK6,1
triple-negative breast cancer,UCN-01,1,Completed,PRKCB,1
triple-negative breast cancer,UCN-01,1,Completed,PRKCD,1
triple-negative breast cancer,UCN-01,1,Completed,PRKCE,1
triple-negative breast cancer,UCN-01,1,Completed,PRKCG,1
triple-negative breast cancer,UCN-01,1,Completed,PRKCH,1
triple-negative breast cancer,UCN-01,1,Completed,PRKCQ,1
male breast carcinoma,IMATINIB,2,Completed,KIT,1
triple-negative breast cancer,UCN-01,1,Completed,PRKCZ,1
triple-negative breast cancer,UCN-01,1,Completed,PRKD1,1
breast carcinoma,RIDAFOROLIMUS,1,Completed,MTOR,1
male breast carcinoma,GEMCITABINE,2,Terminated,POLA1,1
breast carcinoma,RILUZOLE,1,Withdrawn,SCN10A,1
breast carcinoma,RILUZOLE,1,Withdrawn,SCN11A,1
breast carcinoma,RILUZOLE,1,Withdrawn,SCN1A,1
breast carcinoma,RILUZOLE,1,Withdrawn,SCN2A,1
breast carcinoma,RIBOCICLIB,3,Withdrawn,CDK6,1
breast carcinoma,RIBOCICLIB,3,Withdrawn,CDK4,1
male breast carcinoma,GEMCITABINE,2,Terminated,POLA2,1
male breast carcinoma,GEMCITABINE,2,Terminated,POLD1,1
male breast carcinoma,IMATINIB,2,Completed,ABL1,1
male breast carcinoma,GOSERELIN,1,Terminated,GNRHR,1
male breast carcinoma,GEMCITABINE,2,Terminated,RRM1,1
breast carcinoma,RIBOCICLIB,1,Unknown status,CDK4,1
breast carcinoma,RIBOCICLIB,1,Unknown status,CDK6,1
male breast carcinoma,GEMCITABINE,2,Terminated,PRIM2,1
male breast carcinoma,GEMCITABINE,2,Terminated,PRIM1,1
male breast carcinoma,GEMCITABINE,2,Terminated,POLE3,1
male breast carcinoma,GEMCITABINE,2,Terminated,POLE2,1
male breast carcinoma,GEMCITABINE,2,Terminated,POLE,1
male breast carcinoma,GEMCITABINE,2,Terminated,POLD4,1
breast carcinoma,RIBOCICLIB,2,Terminated,CDK4,1
triple-negative breast cancer,UCN-01,1,Completed,CHEK1,1
breast carcinoma,RIBOCICLIB,2,Terminated,CDK6,1
male breast carcinoma,GEMCITABINE,2,Terminated,POLD3,1
male breast carcinoma,GEMCITABINE,2,Terminated,POLD2,1
triple-negative breast cancer,UCN-01,1,Completed,PDPK1,1
male breast carcinoma,PACLITAXEL,2,Recruiting,TUBB2B,1
triple-negative breast cancer,ENTINOSTAT,2,Terminated,HDAC9,1
breast carcinoma,PANOBINOSTAT,1,Terminated,HDAC1,1
triple-negative breast cancer,CAPECITABINE,2,Recruiting,TYMS,1
triple-negative breast cancer,BEVACIZUMAB,2,Completed,VEGFA,1
triple-negative breast cancer,AZD-2014,1,"Active, not recruiting",MTOR,1
triple-negative breast cancer,AZD-1775,1,"Active, not recruiting",WEE1,1
triple-negative breast cancer,ATEZOLIZUMAB,3,Recruiting,CD274,1
triple-negative breast cancer,ATEZOLIZUMAB,3,"Active, not recruiting",CD274,1
triple-negative breast cancer,APATINIB,1,Recruiting,KDR,1
triple-negative breast cancer,APATINIB,1,Not yet recruiting,KDR,1
triple-negative breast cancer,ANASTROZOLE,2,Terminated,CYP19A1,1
male breast carcinoma,VORINOSTAT,2,Terminated,HDAC6,1
triple-negative breast cancer,PACLITAXEL,1,Recruiting,TUBB4B,1
triple-negative breast cancer,PACLITAXEL,1,Recruiting,TUBB6,1
triple-negative breast cancer,PACLITAXEL,1,Recruiting,TUBB8,1
male breast carcinoma,VORINOSTAT,2,Terminated,HDAC3,1
male breast carcinoma,VORINOSTAT,2,Terminated,HDAC2,1
male breast carcinoma,VORINOSTAT,2,Terminated,HDAC1,1
triple-negative breast cancer,PACLITAXEL,2,Recruiting,TUBB,1
triple-negative breast cancer,PACLITAXEL,2,Recruiting,TUBB1,1
triple-negative breast cancer,CAPECITABINE,1,Recruiting,TYMS,1
triple-negative breast cancer,PACLITAXEL,1,Recruiting,TUBB4A,1
male breast carcinoma,VORINOSTAT,1,"Active, not recruiting",HDAC3,1
triple-negative breast cancer,PACLITAXEL,1,Recruiting,TUBB3,1
breast carcinoma,PAZOPANIB,1,Completed,KIT,1
breast carcinoma,PAZOPANIB,1,Completed,LCK,1
breast carcinoma,PAZOPANIB,1,"Active, not recruiting",FGFR1,1
breast carcinoma,PAZOPANIB,1,Completed,PDGFRA,1
breast carcinoma,PAZOPANIB,1,"Active, not recruiting",CSF1R,1
breast carcinoma,PATRITUMAB,2,Recruiting,ERBB3,1
breast carcinoma,PASIREOTIDE,2,Completed,SSTR5,1
breast carcinoma,PAZOPANIB,1,Completed,PDGFRB,1
breast carcinoma,PAZOPANIB,2,"Active, not recruiting",CSF1R,1
breast carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR1,1
triple-negative breast cancer,DOCETAXEL,2,"Active, not recruiting",TUBB4A,1
triple-negative breast cancer,DOCETAXEL,2,"Active, not recruiting",TUBB3,1
triple-negative breast cancer,DOCETAXEL,2,"Active, not recruiting",TUBB2B,1
triple-negative breast cancer,DOCETAXEL,2,"Active, not recruiting",TUBB2A,1
triple-negative breast cancer,DOCETAXEL,2,"Active, not recruiting",TUBB1,1
triple-negative breast cancer,DOCETAXEL,2,"Active, not recruiting",TUBB,1
breast carcinoma,PASIREOTIDE,2,Completed,SSTR3,1
male breast carcinoma,VORINOSTAT,1,"Active, not recruiting",HDAC6,1
triple-negative breast cancer,PACLITAXEL,2,Recruiting,TUBB2A,1
breast carcinoma,PAZOPANIB,1,Completed,ITK,1
breast carcinoma,PANOBINOSTAT,2,Terminated,HDAC4,1
triple-negative breast cancer,PACLITAXEL,3,"Active, not recruiting",TUBB1,1
triple-negative breast cancer,PACLITAXEL,3,"Active, not recruiting",TUBB2A,1
triple-negative breast cancer,PACLITAXEL,3,"Active, not recruiting",TUBB2B,1
triple-negative breast cancer,PACLITAXEL,3,"Active, not recruiting",TUBB3,1
male breast carcinoma,VINORELBINE,2,Completed,TUBB3,1
male breast carcinoma,VINORELBINE,2,Completed,TUBB2B,1
male breast carcinoma,VINORELBINE,2,Completed,TUBB2A,1
male breast carcinoma,VINORELBINE,2,Completed,TUBB1,1
triple-negative breast cancer,PACLITAXEL,3,"Active, not recruiting",TUBB4A,1
triple-negative breast cancer,PACLITAXEL,3,"Active, not recruiting",TUBB4B,1
male breast carcinoma,VINORELBINE,2,Completed,TUBB,1
male breast carcinoma,VELIPARIB,1,Completed,PARP3,1
triple-negative breast cancer,PACLITAXEL,3,"Active, not recruiting",TUBB6,1
male breast carcinoma,VELIPARIB,1,Completed,PARP2,1
male breast carcinoma,VELIPARIB,1,Completed,PARP1,1
male breast carcinoma,TRASTUZUMAB,3,"Active, not recruiting",ERBB2,1
male breast carcinoma,TRASTUZUMAB,1,Terminated,ERBB2,1
triple-negative breast cancer,PACLITAXEL,3,"Active, not recruiting",TUBB,1
breast carcinoma,PANOBINOSTAT,2,Terminated,HDAC5,1
triple-negative breast cancer,PACLITAXEL,2,Recruiting,TUBB2B,1
breast carcinoma,PANOBINOSTAT,2,Terminated,HDAC6,1
triple-negative breast cancer,PACLITAXEL,2,Recruiting,TUBB3,1
triple-negative breast cancer,PACLITAXEL,2,Recruiting,TUBB4A,1
triple-negative breast cancer,PACLITAXEL,2,Recruiting,TUBB4B,1
triple-negative breast cancer,PACLITAXEL,2,Recruiting,TUBB6,1
triple-negative breast cancer,PACLITAXEL,2,Recruiting,TUBB8,1
male breast carcinoma,VORINOSTAT,1,"Active, not recruiting",HDAC2,1
breast carcinoma,PASIREOTIDE,2,Completed,SSTR2,1
breast carcinoma,PASIREOTIDE,2,Completed,SSTR1,1
breast carcinoma,PARICALCITOL,1,Completed,VDR,1
male breast carcinoma,VORINOSTAT,1,"Active, not recruiting",HDAC1,1
male breast carcinoma,VINORELBINE,2,Completed,TUBB8,1
male breast carcinoma,VINORELBINE,2,Completed,TUBB6,1
male breast carcinoma,VINORELBINE,2,Completed,TUBB4B,1
male breast carcinoma,VINORELBINE,2,Completed,TUBB4A,1
breast carcinoma,PANOBINOSTAT,2,Terminated,HDAC9,1
breast carcinoma,PANOBINOSTAT,2,Terminated,HDAC8,1
breast carcinoma,PANOBINOSTAT,2,Terminated,HDAC7,1
breast carcinoma,PAZOPANIB,1,Completed,KDR,1
breast carcinoma,PAZOPANIB,1,Completed,FLT4,1
male breast carcinoma,PACLITAXEL,2,Recruiting,TUBB4A,1
triple-negative breast cancer,ENTINOSTAT,2,Terminated,HDAC11,1
triple-negative breast cancer,ENTINOSTAT,2,Terminated,HDAC1,1
triple-negative breast cancer,GEMCITABINE,2,"Active, not recruiting",POLA2,1
triple-negative breast cancer,GEMCITABINE,2,"Active, not recruiting",POLD1,1
triple-negative breast cancer,GEMCITABINE,2,"Active, not recruiting",POLD2,1
triple-negative breast cancer,GEMCITABINE,2,"Active, not recruiting",POLD3,1
triple-negative breast cancer,GEMCITABINE,2,"Active, not recruiting",POLD4,1
triple-negative breast cancer,GEMCITABINE,2,"Active, not recruiting",POLE,1
triple-negative breast cancer,GEMCITABINE,2,"Active, not recruiting",POLE2,1
triple-negative breast cancer,GEMCITABINE,2,"Active, not recruiting",POLE3,1
triple-negative breast cancer,GEMCITABINE,2,"Active, not recruiting",PRIM1,1
triple-negative breast cancer,DURVALUMAB,1,Recruiting,CD274,1
triple-negative breast cancer,DOXORUBICIN,3,"Active, not recruiting",TOP2A,1
triple-negative breast cancer,DOXORUBICIN,2,Recruiting,TOP2A,1
triple-negative breast cancer,GEMCITABINE,2,"Active, not recruiting",PRIM2,1
triple-negative breast cancer,GEMCITABINE,2,"Active, not recruiting",RRM1,1
triple-negative breast cancer,GEMCITABINE,2,Completed,POLA1,1
triple-negative breast cancer,GEMCITABINE,2,Completed,POLA2,1
triple-negative breast cancer,ENTINOSTAT,2,Terminated,HDAC10,1
triple-negative breast cancer,ENTINOSTAT,2,Terminated,HDAC2,1
breast carcinoma,PAZOPANIB,1,Completed,FGFR3,1
triple-negative breast cancer,GEMCITABINE,2,"Active, not recruiting",POLA1,1
triple-negative breast cancer,ENTINOSTAT,2,Terminated,HDAC7,1
triple-negative breast cancer,ERIBULIN,2,"Active, not recruiting",TUBB,1
triple-negative breast cancer,ENTINOSTAT,2,Terminated,HDAC6,1
triple-negative breast cancer,ENTINOSTAT,2,Terminated,HDAC5,1
triple-negative breast cancer,ENTINOSTAT,2,Terminated,HDAC4,1
triple-negative breast cancer,ENTINOSTAT,2,Terminated,HDAC3,1
triple-negative breast cancer,ERIBULIN,2,"Active, not recruiting",TUBB1,1
triple-negative breast cancer,ERIBULIN,2,"Active, not recruiting",TUBB2A,1
triple-negative breast cancer,ERIBULIN,2,"Active, not recruiting",TUBB2B,1
triple-negative breast cancer,ERIBULIN,2,"Active, not recruiting",TUBB3,1
triple-negative breast cancer,ERIBULIN,2,"Active, not recruiting",TUBB4A,1
triple-negative breast cancer,ERIBULIN,2,"Active, not recruiting",TUBB4B,1
triple-negative breast cancer,ERIBULIN,2,"Active, not recruiting",TUBB6,1
triple-negative breast cancer,ERIBULIN,2,"Active, not recruiting",TUBB8,1
triple-negative breast cancer,ERLOTINIB,2,Completed,EGFR,1
triple-negative breast cancer,EVEROLIMUS,1,Recruiting,FKBP1A,1
triple-negative breast cancer,FILGRASTIM,3,"Active, not recruiting",CSF3R,1
breast carcinoma,PAZOPANIB,1,Completed,FLT1,1
breast carcinoma,PAZOPANIB,1,Completed,FGFR1,1
breast carcinoma,PAZOPANIB,1,"Active, not recruiting",FGFR3,1
triple-negative breast cancer,GEMCITABINE,3,Recruiting,POLD3,1
triple-negative breast cancer,GEMCITABINE,3,Recruiting,POLE,1
triple-negative breast cancer,GEMCITABINE,3,Recruiting,POLE2,1
triple-negative breast cancer,GEMCITABINE,3,Recruiting,POLE3,1
triple-negative breast cancer,GEMCITABINE,3,Recruiting,PRIM1,1
triple-negative breast cancer,GEMCITABINE,3,Recruiting,PRIM2,1
triple-negative breast cancer,GEMCITABINE,3,Recruiting,RRM1,1
triple-negative breast cancer,NIVOLUMAB,1,Recruiting,PDCD1,1
triple-negative breast cancer,PACLITAXEL,1,Recruiting,TUBB,1
triple-negative breast cancer,PACLITAXEL,1,Recruiting,TUBB1,1
triple-negative breast cancer,PACLITAXEL,1,Recruiting,TUBB2A,1
triple-negative breast cancer,PACLITAXEL,1,Recruiting,TUBB2B,1
breast carcinoma,PAZOPANIB,1,"Active, not recruiting",ITK,1
breast carcinoma,PAZOPANIB,1,"Active, not recruiting",FLT4,1
breast carcinoma,PAZOPANIB,1,"Active, not recruiting",FLT1,1
triple-negative breast cancer,DOCETAXEL,2,"Active, not recruiting",TUBB8,1
triple-negative breast cancer,DOCETAXEL,2,"Active, not recruiting",TUBB6,1
triple-negative breast cancer,DOCETAXEL,2,"Active, not recruiting",TUBB4B,1
triple-negative breast cancer,GEMCITABINE,3,Recruiting,POLD4,1
triple-negative breast cancer,GEMCITABINE,3,Recruiting,POLD2,1
breast carcinoma,PAZOPANIB,1,Completed,CSF1R,1
triple-negative breast cancer,GEMCITABINE,3,Recruiting,POLD1,1
breast carcinoma,PAZOPANIB,1,"Active, not recruiting",PDGFRB,1
breast carcinoma,PAZOPANIB,1,"Active, not recruiting",PDGFRA,1
breast carcinoma,PAZOPANIB,1,"Active, not recruiting",LCK,1
breast carcinoma,PAZOPANIB,1,"Active, not recruiting",KIT,1
breast carcinoma,PAZOPANIB,1,"Active, not recruiting",KDR,1
triple-negative breast cancer,GEMCITABINE,2,Completed,POLD1,1
triple-negative breast cancer,GEMCITABINE,2,Completed,POLD2,1
triple-negative breast cancer,GEMCITABINE,2,Completed,POLD3,1
triple-negative breast cancer,GEMCITABINE,2,Completed,POLD4,1
triple-negative breast cancer,GEMCITABINE,2,Completed,POLE,1
triple-negative breast cancer,GEMCITABINE,2,Completed,POLE2,1
triple-negative breast cancer,GEMCITABINE,2,Completed,POLE3,1
triple-negative breast cancer,GEMCITABINE,2,Completed,PRIM1,1
triple-negative breast cancer,GEMCITABINE,2,Completed,PRIM2,1
triple-negative breast cancer,GEMCITABINE,2,Completed,RRM1,1
triple-negative breast cancer,GEMCITABINE,3,Recruiting,POLA1,1
triple-negative breast cancer,GEMCITABINE,3,Recruiting,POLA2,1
male breast carcinoma,TIPIFARNIB,1,Completed,FNTB,1
male breast carcinoma,TIPIFARNIB,1,Completed,FNTA,1
male breast carcinoma,TEMSIROLIMUS,1,Completed,FKBP1A,1
male breast carcinoma,PEGFILGRASTIM,2,Completed,CSF3R,1
male breast carcinoma,PAZOPANIB,2,Terminated,PDGFRB,1
male breast carcinoma,PAZOPANIB,2,Terminated,PDGFRA,1
breast carcinoma,PEGFILGRASTIM,3,Withdrawn,CSF3R,1
male breast carcinoma,PAZOPANIB,2,Terminated,LCK,1
male breast carcinoma,PAZOPANIB,2,Terminated,KIT,1
male breast carcinoma,PAZOPANIB,2,Terminated,KDR,1
male breast carcinoma,PAZOPANIB,2,Terminated,ITK,1
male breast carcinoma,PAZOPANIB,2,Terminated,FLT4,1
breast carcinoma,PEGFILGRASTIM,4,Recruiting,CSF3R,1
male breast carcinoma,PAZOPANIB,2,Terminated,FLT1,1
male breast carcinoma,PAZOPANIB,2,Terminated,FGFR3,1
breast carcinoma,PEGINTERFERON ALFA-2A,2,Terminated,IFNAR1,1
breast carcinoma,PEGINTERFERON ALFA-2A,2,Terminated,IFNAR2,1
male breast carcinoma,PAZOPANIB,2,Terminated,FGFR1,1
male breast carcinoma,PAZOPANIB,2,Terminated,CSF1R,1
breast carcinoma,PEMBROLIZUMAB,1,Not yet recruiting,PDCD1,1
male breast carcinoma,PAZOPANIB,1,Terminated,PDGFRB,1
male breast carcinoma,PEGFILGRASTIM,1,Terminated,CSF3R,1
male breast carcinoma,PEMBROLIZUMAB,2,Recruiting,PDCD1,1
male breast carcinoma,PAZOPANIB,1,Terminated,PDGFRA,1
male breast carcinoma,PEMETREXED,2,Completed,DHFR,1
breast carcinoma,PANOBINOSTAT,2,Completed,HDAC4,1
male breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC6,1
male breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC5,1
male breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC4,1
male breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC3,1
breast carcinoma,PANOBINOSTAT,2,Completed,HDAC3,1
male breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC2,1
male breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC11,1
male breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC10,1
breast carcinoma,PEGFILGRASTIM,2,Suspended,CSF3R,1
male breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC1,1
breast carcinoma,PANOBINOSTAT,2,Completed,HDAC2,1
male breast carcinoma,RINTATOLIMOD,1,"Active, not recruiting",TLR3,1
breast carcinoma,PEGFILGRASTIM,3,Completed,CSF3R,1
male breast carcinoma,PERTUZUMAB,1,Completed,ERBB2,1
male breast carcinoma,PEMETREXED,2,Completed,TYMS,1
male breast carcinoma,PEMETREXED,2,Completed,GART,1
breast carcinoma,PEMBROLIZUMAB,1,Suspended,PDCD1,1
male breast carcinoma,PAZOPANIB,1,Terminated,LCK,1
triple-negative breast cancer,PACLITAXEL,3,"Active, not recruiting",TUBB8,1
triple-negative breast cancer,ENTINOSTAT,2,Terminated,HDAC8,1
triple-negative breast cancer,PEGFILGRASTIM,2,Recruiting,CSF3R,1
triple-negative breast cancer,PEGFILGRASTIM,3,"Active, not recruiting",CSF3R,1
breast carcinoma,PANOBINOSTAT,2,Completed,HDAC1,1
breast carcinoma,PANOBINOSTAT,1,Terminated,HDAC9,1
breast carcinoma,PANOBINOSTAT,1,Terminated,HDAC8,1
breast carcinoma,PANOBINOSTAT,1,Terminated,HDAC7,1
breast carcinoma,PANOBINOSTAT,1,Terminated,HDAC6,1
breast carcinoma,PANOBINOSTAT,1,Terminated,HDAC5,1
breast carcinoma,PANOBINOSTAT,1,Terminated,HDAC4,1
breast carcinoma,PANOBINOSTAT,1,Terminated,HDAC3,1
breast carcinoma,PANOBINOSTAT,1,Terminated,HDAC2,1
breast carcinoma,PANOBINOSTAT,1,Terminated,HDAC11,1
breast carcinoma,PANOBINOSTAT,1,Terminated,HDAC10,1
breast carcinoma,PERTUZUMAB,2,Not yet recruiting,ERBB2,1
male breast carcinoma,PACLITAXEL,2,Recruiting,TUBB8,1
male breast carcinoma,PACLITAXEL,2,Recruiting,TUBB6,1
male breast carcinoma,PACLITAXEL,2,Recruiting,TUBB4B,1
male breast carcinoma,PAZOPANIB,1,Terminated,CSF1R,1
breast carcinoma,PEMETREXED,2,Recruiting,TYMS,1
male breast carcinoma,PAZOPANIB,1,Terminated,KIT,1
breast carcinoma,PEMETREXED,2,Recruiting,GART,1
breast carcinoma,PEMBROLIZUMAB,2,Suspended,PDCD1,1
male breast carcinoma,PAZOPANIB,1,Terminated,KDR,1
breast carcinoma,PEMBROLIZUMAB,3,Recruiting,PDCD1,1
male breast carcinoma,PAZOPANIB,1,Terminated,ITK,1
male breast carcinoma,PAZOPANIB,1,Terminated,FLT4,1
male breast carcinoma,PAZOPANIB,1,Terminated,FLT1,1
breast carcinoma,PEMETREXED,1,Recruiting,DHFR,1
breast carcinoma,PEMETREXED,1,Recruiting,GART,1
breast carcinoma,PEMETREXED,1,Recruiting,TYMS,1
breast carcinoma,PEMETREXED,2,"Active, not recruiting",DHFR,1
breast carcinoma,PEMETREXED,2,"Active, not recruiting",GART,1
breast carcinoma,PEMETREXED,2,"Active, not recruiting",TYMS,1
male breast carcinoma,PAZOPANIB,1,Terminated,FGFR3,1
breast carcinoma,PANOBINOSTAT,2,Completed,HDAC11,1
male breast carcinoma,PAZOPANIB,1,Terminated,FGFR1,1
breast carcinoma,PANOBINOSTAT,2,Completed,HDAC10,1
breast carcinoma,PEMETREXED,2,Recruiting,DHFR,1
male breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC7,1
breast carcinoma,PANOBINOSTAT,2,Completed,HDAC5,1
breast carcinoma,PANOBINOSTAT,2,Completed,HDAC6,1
male breast carcinoma,SORAFENIB,2,Completed,FLT1,1
male breast carcinoma,SARGRAMOSTIM,2,Completed,CSF2RA,1
male breast carcinoma,SARGRAMOSTIM,2,"Active, not recruiting",CSF2RA,1
male breast carcinoma,SARGRAMOSTIM,1,Completed,CSF2RA,1
male breast carcinoma,SARGRAMOSTIM,1,"Active, not recruiting",CSF2RA,1
male breast carcinoma,SARACATINIB,2,Completed,SRC,1
breast carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR3,1
breast carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT1,1
breast carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT4,1
breast carcinoma,PAZOPANIB,2,"Active, not recruiting",ITK,1
breast carcinoma,PAZOPANIB,2,"Active, not recruiting",KDR,1
breast carcinoma,PAZOPANIB,2,"Active, not recruiting",KIT,1
breast carcinoma,PAZOPANIB,2,"Active, not recruiting",LCK,1
breast carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRA,1
breast carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRB,1
breast carcinoma,PAZOPANIB,2,Completed,CSF1R,1
breast carcinoma,PAZOPANIB,2,Completed,FGFR1,1
breast carcinoma,PANOBINOSTAT,2,Terminated,HDAC2,1
male breast carcinoma,SORAFENIB,2,Completed,BRAF,1
male breast carcinoma,SORAFENIB,2,Completed,FLT3,1
breast carcinoma,PANOBINOSTAT,2,Completed,HDAC7,1
male breast carcinoma,AZACITIDINE,2,Completed,DNMT3A,1
breast carcinoma,PANOBINOSTAT,2,Terminated,HDAC3,1
male breast carcinoma,TAMOXIFEN,3,Completed,ESR1,1
male breast carcinoma,SUNITINIB,2,"Active, not recruiting",RET,1
male breast carcinoma,SUNITINIB,2,"Active, not recruiting",PDGFRB,1
male breast carcinoma,SUNITINIB,2,"Active, not recruiting",PDGFRA,1
male breast carcinoma,SUNITINIB,2,"Active, not recruiting",KIT,1
male breast carcinoma,SUNITINIB,2,"Active, not recruiting",KDR,1
male breast carcinoma,SUNITINIB,2,"Active, not recruiting",FLT4,1
male breast carcinoma,SUNITINIB,2,"Active, not recruiting",FLT3,1
male breast carcinoma,SUNITINIB,2,"Active, not recruiting",FLT1,1
male breast carcinoma,SUNITINIB,2,"Active, not recruiting",CSF1R,1
male breast carcinoma,SORAFENIB,2,Completed,RET,1
male breast carcinoma,SORAFENIB,2,Completed,RAF1,1
male breast carcinoma,SORAFENIB,2,Completed,PDGFRB,1
male breast carcinoma,SORAFENIB,2,Completed,KIT,1
male breast carcinoma,SORAFENIB,2,Completed,KDR,1
male breast carcinoma,SORAFENIB,2,Completed,FLT4,1
breast carcinoma,PANOBINOSTAT,2,Terminated,HDAC11,1
breast carcinoma,PANOBINOSTAT,2,Terminated,HDAC10,1
breast carcinoma,PAZOPANIB,2,Completed,FGFR3,1
breast carcinoma,PAZOPANIB,2,Completed,FLT1,1
male breast carcinoma,ROMIDEPSIN,2,Completed,HDAC3,1
male breast carcinoma,ROMIDEPSIN,2,Completed,HDAC2,1
breast carcinoma,PAZOPANIB,2,Withdrawn,ITK,1
breast carcinoma,PANOBINOSTAT,2,Completed,HDAC9,1
breast carcinoma,PAZOPANIB,2,Withdrawn,KDR,1
breast carcinoma,PAZOPANIB,2,Withdrawn,KIT,1
breast carcinoma,PAZOPANIB,2,Withdrawn,LCK,1
breast carcinoma,PAZOPANIB,2,Withdrawn,PDGFRA,1
breast carcinoma,PAZOPANIB,2,Withdrawn,PDGFRB,1
male breast carcinoma,ROMIDEPSIN,2,Completed,HDAC11,1
male breast carcinoma,ROMIDEPSIN,2,Completed,HDAC10,1
male breast carcinoma,ROMIDEPSIN,2,Completed,HDAC1,1
male breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC9,1
breast carcinoma,PEGFILGRASTIM,1,Recruiting,CSF3R,1
breast carcinoma,PEGFILGRASTIM,1,Terminated,CSF3R,1
breast carcinoma,PANOBINOSTAT,2,Completed,HDAC8,1
male breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC8,1
male breast carcinoma,ROMIDEPSIN,2,Completed,HDAC4,1
breast carcinoma,PAZOPANIB,2,Withdrawn,FLT4,1
breast carcinoma,PAZOPANIB,2,Withdrawn,FLT1,1
breast carcinoma,PAZOPANIB,2,Withdrawn,CSF1R,1
breast carcinoma,PAZOPANIB,2,Completed,FLT4,1
breast carcinoma,PAZOPANIB,2,Completed,ITK,1
breast carcinoma,PAZOPANIB,2,Completed,KDR,1
breast carcinoma,PAZOPANIB,2,Completed,KIT,1
breast carcinoma,PAZOPANIB,2,Completed,LCK,1
breast carcinoma,PAZOPANIB,2,Completed,PDGFRA,1
breast carcinoma,PAZOPANIB,2,Completed,PDGFRB,1
breast carcinoma,PAZOPANIB,2,Withdrawn,FGFR1,1
breast carcinoma,PAZOPANIB,2,Withdrawn,FGFR3,1
male breast carcinoma,SARACATINIB,2,Completed,ABL1,1
male breast carcinoma,ROMIDEPSIN,2,Completed,HDAC9,1
male breast carcinoma,ROMIDEPSIN,2,Completed,HDAC8,1
breast carcinoma,PANOBINOSTAT,2,Terminated,HDAC1,1
male breast carcinoma,ROMIDEPSIN,2,Completed,HDAC7,1
male breast carcinoma,ROMIDEPSIN,2,Completed,HDAC6,1
male breast carcinoma,ROMIDEPSIN,2,Completed,HDAC5,1
male breast carcinoma,BECATECARIN,2,Completed,TOP1,1
inflammatory breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB4B,1
male breast carcinoma,AZACITIDINE,2,Completed,DNMT1,1
breast carcinoma,TRAMETINIB,0,Completed,MAP2K2,1
breast carcinoma,VINORELBINE,3,Not yet recruiting,TUBB,1
breast carcinoma,TRASTUZUMAB,3,Withdrawn,ERBB2,1
breast carcinoma,TRASTUZUMAB,4,Recruiting,ERBB2,1
breast carcinoma,TRASTUZUMAB,4,Terminated,ERBB2,1
breast carcinoma,TRASTUZUMAB,4,n/a,ERBB2,1
breast carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB8,1
breast carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB6,1
breast carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB4B,1
breast carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB4A,1
breast carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB3,1
breast carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB2B,1
breast carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB2A,1
breast carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB1,1
breast carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB,1
breast carcinoma,VINORELBINE,0,Completed,TUBB8,1
breast carcinoma,VINORELBINE,0,Completed,TUBB6,1
breast carcinoma,VINORELBINE,0,Completed,TUBB4B,1
breast carcinoma,VINORELBINE,0,Completed,TUBB4A,1
breast carcinoma,VINORELBINE,0,Completed,TUBB3,1
breast carcinoma,VINORELBINE,0,Completed,TUBB2B,1
breast carcinoma,VINORELBINE,0,Completed,TUBB2A,1
breast carcinoma,VINORELBINE,3,Not yet recruiting,TUBB1,1
breast carcinoma,VINORELBINE,3,Not yet recruiting,TUBB2A,1
breast carcinoma,VINORELBINE,3,Not yet recruiting,TUBB2B,1
breast carcinoma,VINORELBINE,4,Completed,TUBB2B,1
breast carcinoma,VORINOSTAT,1,Not yet recruiting,HDAC2,1
breast carcinoma,VORINOSTAT,1,Not yet recruiting,HDAC1,1
breast carcinoma,VISMODEGIB,2,Recruiting,SMO,1
breast carcinoma,VISMODEGIB,1,Terminated,SMO,1
breast carcinoma,VINORELBINE,4,Completed,TUBB8,1
breast carcinoma,VINORELBINE,4,Completed,TUBB6,1
breast carcinoma,VINORELBINE,4,Completed,TUBB4B,1
breast carcinoma,VINORELBINE,4,Completed,TUBB4A,1
breast carcinoma,VINORELBINE,4,Completed,TUBB3,1
breast carcinoma,TRAMETINIB,2,"Active, not recruiting",MAP2K1,1
breast carcinoma,VINORELBINE,3,Not yet recruiting,TUBB3,1
breast carcinoma,TRAMETINIB,2,"Active, not recruiting",MAP2K2,1
breast carcinoma,TRASTUZUMAB,0,Completed,ERBB2,1
breast carcinoma,VINORELBINE,4,Completed,TUBB2A,1
breast carcinoma,VINORELBINE,4,Completed,TUBB1,1
breast carcinoma,VINORELBINE,4,Completed,TUBB,1
breast carcinoma,VINORELBINE,3,Not yet recruiting,TUBB8,1
breast carcinoma,VINORELBINE,3,Not yet recruiting,TUBB6,1
breast carcinoma,VINORELBINE,3,Not yet recruiting,TUBB4B,1
breast carcinoma,VINORELBINE,3,Not yet recruiting,TUBB4A,1
breast carcinoma,VINORELBINE,0,Completed,TUBB1,1
breast carcinoma,VINORELBINE,0,Completed,TUBB,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBB8,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Withdrawn,TUBB3,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Terminated,TUBB4A,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Terminated,TUBB4B,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Terminated,TUBB6,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Terminated,TUBB8,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Withdrawn,ERBB2,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Withdrawn,TUBB,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Withdrawn,TUBB1,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Withdrawn,TUBB2A,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Withdrawn,TUBB2B,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Withdrawn,TUBB4A,1
breast carcinoma,VINFLUNINE,2,Completed,TUBB3,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Withdrawn,TUBB4B,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Withdrawn,TUBB6,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Withdrawn,TUBB8,1
breast carcinoma,VINFLUNINE,2,Completed,TUBB2B,1
breast carcinoma,VINFLUNINE,2,Completed,TUBB2A,1
breast carcinoma,VINFLUNINE,2,Completed,TUBB1,1
breast carcinoma,VINFLUNINE,2,Completed,TUBB,1
breast carcinoma,VINFLUNINE,2,Completed,TUBA4A,1
breast carcinoma,VINFLUNINE,2,Completed,TUBA3E,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Terminated,TUBB3,1
breast carcinoma,VINFLUNINE,2,Completed,TUBB4A,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBB6,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBB2A,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Terminated,ERBB2,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Terminated,TUBB,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Terminated,TUBB1,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Terminated,TUBB2A,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Terminated,TUBB2B,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBB4B,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBB4A,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBB3,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBB2B,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBB1,1
breast carcinoma,VINFLUNINE,2,Completed,TUBB4B,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBB,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBA4A,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBA3E,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBA3C,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBA1C,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBA1B,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBA1A,1
breast carcinoma,VINFLUNINE,2,Completed,TUBB8,1
breast carcinoma,VINFLUNINE,2,Completed,TUBB6,1
breast carcinoma,VORINOSTAT,1,Not yet recruiting,HDAC3,1
breast carcinoma,TRAMETINIB,0,Completed,MAP2K1,1
breast carcinoma,VINFLUNINE,2,Completed,TUBA1C,1
breast carcinoma,TRAMADOL,2,Recruiting,OPRM1,1
breast carcinoma,TASELISIB,1,Unknown status,PIK3R3,1
breast carcinoma,TASELISIB,1,Unknown status,PIK3R5,1
breast carcinoma,TASELISIB,2,Completed,PIK3CA,1
breast carcinoma,TASELISIB,2,Completed,PIK3CB,1
breast carcinoma,TASELISIB,2,Completed,PIK3CD,1
breast carcinoma,TASELISIB,2,Completed,PIK3CG,1
breast carcinoma,TASELISIB,2,Completed,PIK3R1,1
breast carcinoma,TASELISIB,2,Completed,PIK3R2,1
breast carcinoma,TASELISIB,2,Completed,PIK3R3,1
breast carcinoma,TASELISIB,2,Completed,PIK3R5,1
breast carcinoma,TASELISIB,3,"Active, not recruiting",PIK3CA,1
breast carcinoma,TASELISIB,3,"Active, not recruiting",PIK3CB,1
breast carcinoma,TASELISIB,3,"Active, not recruiting",PIK3CD,1
breast carcinoma,TASELISIB,3,"Active, not recruiting",PIK3CG,1
breast carcinoma,TASELISIB,3,"Active, not recruiting",PIK3R1,1
breast carcinoma,TASELISIB,3,"Active, not recruiting",PIK3R2,1
breast carcinoma,TASELISIB,3,"Active, not recruiting",PIK3R3,1
breast carcinoma,TASELISIB,3,"Active, not recruiting",PIK3R5,1
breast carcinoma,TELAPRISTONE ACETATE,2,"Active, not recruiting",PGR,1
breast carcinoma,TEMSIROLIMUS,1,"Active, not recruiting",FKBP1A,1
breast carcinoma,TEMSIROLIMUS,1,Unknown status,FKBP1A,1
breast carcinoma,TASELISIB,1,Unknown status,PIK3R2,1
breast carcinoma,TASELISIB,1,Unknown status,PIK3R1,1
breast carcinoma,TASELISIB,1,Unknown status,PIK3CG,1
breast carcinoma,TASELISIB,1,"Active, not recruiting",PIK3R2,1
breast carcinoma,TASELISIB,1,"Active, not recruiting",PIK3CB,1
breast carcinoma,TASELISIB,1,"Active, not recruiting",PIK3CD,1
breast carcinoma,TASELISIB,1,"Active, not recruiting",PIK3CG,1
breast carcinoma,TASELISIB,1,"Active, not recruiting",PIK3R1,1
breast carcinoma,ZOLEDRONIC ACID,2,Recruiting,FDPS,1
breast carcinoma,ZIBOTENTAN,2,Withdrawn,EDNRA,1
breast carcinoma,ZAFIRLUKAST,2,Recruiting,CYSLTR1,1
breast carcinoma,VOXTALISIB,1,Completed,PIK3R5,1
breast carcinoma,VOXTALISIB,1,Completed,PIK3R3,1
breast carcinoma,TASELISIB,1,"Active, not recruiting",PIK3R3,1
breast carcinoma,TASELISIB,1,Unknown status,PIK3CD,1
breast carcinoma,VOXTALISIB,1,Completed,PIK3R2,1
breast carcinoma,TASELISIB,1,"Active, not recruiting",PIK3R5,1
breast carcinoma,VOXTALISIB,1,Completed,PIK3R1,1
breast carcinoma,VOXTALISIB,1,Completed,PIK3CG,1
breast carcinoma,VOXTALISIB,1,Completed,PIK3CD,1
breast carcinoma,VOXTALISIB,1,Completed,PIK3CB,1
breast carcinoma,VOXTALISIB,1,Completed,PIK3CA,1
breast carcinoma,TASELISIB,1,Unknown status,PIK3CA,1
breast carcinoma,TASELISIB,1,Unknown status,PIK3CB,1
breast carcinoma,TEMSIROLIMUS,2,"Active, not recruiting",FKBP1A,1
breast carcinoma,TEPROTUMUMAB,1,Completed,IGF1R,1
breast carcinoma,TEPROTUMUMAB,2,Completed,IGF1R,1
breast carcinoma,VORINOSTAT,1,Terminated,HDAC3,1
breast carcinoma,VOXTALISIB,1,Completed,MTOR,1
breast carcinoma,VORINOSTAT,2,Terminated,HDAC6,1
breast carcinoma,TOREMIFENE,3,Completed,ESR1,1
breast carcinoma,VORINOSTAT,2,Terminated,HDAC3,1
breast carcinoma,TOREMIFENE,3,Completed,ESR2,1
breast carcinoma,VORINOSTAT,2,Terminated,HDAC2,1
breast carcinoma,VORINOSTAT,2,Terminated,HDAC1,1
breast carcinoma,TOREMIFENE,3,Terminated,ESR1,1
breast carcinoma,VORINOSTAT,1,Terminated,HDAC6,1
breast carcinoma,VORINOSTAT,1,Terminated,HDAC2,1
breast carcinoma,TOCILIZUMAB,1,Recruiting,IL6R,1
breast carcinoma,VORINOSTAT,1,Terminated,HDAC1,1
breast carcinoma,VORINOSTAT,1,Not yet recruiting,HDAC6,1
breast carcinoma,TOREMIFENE,3,Terminated,ESR2,1
breast carcinoma,TOREMIFENE,4,"Active, not recruiting",ESR1,1
breast carcinoma,TOREMIFENE,4,"Active, not recruiting",ESR2,1
breast carcinoma,TOREMIFENE,4,Recruiting,ESR1,1
breast carcinoma,TOREMIFENE,4,Recruiting,ESR2,1
breast carcinoma,TOREMIFENE,4,Withdrawn,ESR1,1
breast carcinoma,TOREMIFENE,4,Withdrawn,ESR2,1
breast carcinoma,TOPOTECAN,2,Terminated,TOP1MT,1
breast carcinoma,TIVOZANIB,2,Terminated,KDR,1
breast carcinoma,TESEVATINIB,1,Terminated,EGFR,1
breast carcinoma,THALIDOMIDE,2,Unknown status,DDB1,1
breast carcinoma,TESEVATINIB,1,Terminated,EPHB4,1
breast carcinoma,TESEVATINIB,1,Terminated,ERBB2,1
breast carcinoma,TESTOSTERONE,0,Completed,AR,1
breast carcinoma,THALIDOMIDE,2,Terminated,CRBN,1
breast carcinoma,THALIDOMIDE,2,Terminated,CUL4A,1
breast carcinoma,THALIDOMIDE,2,Terminated,DDB1,1
breast carcinoma,THALIDOMIDE,2,Terminated,RBX1,1
breast carcinoma,THALIDOMIDE,2,Unknown status,CRBN,1
breast carcinoma,THALIDOMIDE,2,Unknown status,CUL4A,1
breast carcinoma,THALIDOMIDE,2,Unknown status,RBX1,1
breast carcinoma,TIVOZANIB,2,Terminated,FLT4,1
breast carcinoma,TIPIFARNIB,1,Completed,FNTA,1
breast carcinoma,TIPIFARNIB,1,Completed,FNTB,1
breast carcinoma,TIPIFARNIB,2,Withdrawn,FNTA,1
breast carcinoma,TIPIFARNIB,2,Withdrawn,FNTB,1
breast carcinoma,TIVANTINIB,2,Completed,MET,1
breast carcinoma,TIVOZANIB,1,Completed,FLT1,1
breast carcinoma,TIVOZANIB,1,Completed,FLT4,1
breast carcinoma,TIVOZANIB,1,Completed,KDR,1
breast carcinoma,TIVOZANIB,2,Terminated,FLT1,1
breast carcinoma,VINFLUNINE,2,Completed,TUBA3C,1
breast carcinoma,VINFLUNINE,2,Completed,TUBA1B,1
male breast carcinoma,ANASTROZOLE,2,Terminated,CYP19A1,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,"Active, not recruiting",ERBB2,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,"Active, not recruiting",TUBB2B,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,"Active, not recruiting",TUBB3,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,"Active, not recruiting",TUBB4A,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,"Active, not recruiting",TUBB4B,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,"Active, not recruiting",TUBB6,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,"Active, not recruiting",TUBB8,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,n/a,ERBB2,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,n/a,TUBB,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,n/a,TUBB1,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,n/a,TUBB2A,1
breast carcinoma,VANDETANIB,1,Completed,FLT1,1
breast carcinoma,VANDETANIB,1,Completed,ERBB4,1
breast carcinoma,VANDETANIB,1,Completed,ERBB3,1
breast carcinoma,VANDETANIB,1,Completed,ERBB2,1
breast carcinoma,VANDETANIB,1,Completed,EPHB6,1
breast carcinoma,VANDETANIB,1,Completed,EPHB4,1
breast carcinoma,VANDETANIB,1,Completed,EPHB3,1
breast carcinoma,VANDETANIB,1,Completed,EPHB2,1
breast carcinoma,VANDETANIB,1,Completed,EPHB1,1
breast carcinoma,VANDETANIB,1,Completed,EPHA8,1
breast carcinoma,VANDETANIB,1,Completed,EPHA7,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,"Active, not recruiting",TUBB2A,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,"Active, not recruiting",TUBB1,1
breast carcinoma,VANDETANIB,1,Completed,FLT4,1
breast carcinoma,VANDETANIB,2,Completed,EPHA5,1
breast carcinoma,VANDETANIB,2,Completed,ERBB2,1
breast carcinoma,VANDETANIB,2,Completed,EPHB6,1
breast carcinoma,VANDETANIB,2,Completed,EPHB4,1
breast carcinoma,VANDETANIB,2,Completed,EPHB3,1
breast carcinoma,VANDETANIB,2,Completed,EPHB2,1
breast carcinoma,VANDETANIB,2,Completed,EPHB1,1
breast carcinoma,VANDETANIB,2,Completed,EPHA8,1
breast carcinoma,VANDETANIB,2,Completed,EPHA7,1
breast carcinoma,VANDETANIB,2,Completed,EPHA6,1
breast carcinoma,VANDETANIB,2,Completed,EPHA4,1
breast carcinoma,VANDETANIB,1,Completed,KDR,1
breast carcinoma,VANDETANIB,2,Completed,EPHA3,1
breast carcinoma,VANDETANIB,2,Completed,EPHA2,1
breast carcinoma,VANDETANIB,2,Completed,EPHA10,1
breast carcinoma,VANDETANIB,2,Completed,EPHA1,1
breast carcinoma,VANDETANIB,2,Completed,EGFR,1
breast carcinoma,VANDETANIB,1,Completed,TEK,1
breast carcinoma,VANDETANIB,1,Completed,SRC,1
breast carcinoma,VANDETANIB,1,Completed,RET,1
breast carcinoma,VANDETANIB,1,Completed,PTK6,1
breast carcinoma,VANDETANIB,1,Completed,EPHA6,1
breast carcinoma,VANDETANIB,1,Completed,EPHA5,1
breast carcinoma,VANDETANIB,1,Completed,EPHA4,1
breast carcinoma,TREMELIMUMAB,1,Terminated,CTLA4,1
breast carcinoma,UCN-01,1,Completed,CDK6,1
breast carcinoma,UCN-01,1,Completed,CDK4,1
breast carcinoma,UCN-01,1,Completed,CDK2,1
breast carcinoma,TUCATINIB,1,Not yet recruiting,ERBB2,1
breast carcinoma,TRIPTORELIN,3,Terminated,GNRHR,1
breast carcinoma,TRIPTORELIN,3,Completed,GNRHR,1
breast carcinoma,TRIPTORELIN,2,Unknown status,GNRHR,1
breast carcinoma,TRIPTORELIN,2,Completed,GNRHR,1
breast carcinoma,TRIPTORELIN,2,"Active, not recruiting",GNRHR,1
breast carcinoma,TREMELIMUMAB,0,Recruiting,CTLA4,1
breast carcinoma,UCN-01,1,Completed,PDPK1,1
breast carcinoma,TREBANANIB,2,Completed,ANGPT2,1
breast carcinoma,TREBANANIB,2,Completed,ANGPT1,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,n/a,TUBB8,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,n/a,TUBB6,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,n/a,TUBB4B,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,n/a,TUBB4A,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,n/a,TUBB3,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,n/a,TUBB2B,1
breast carcinoma,PANITUMUMAB,2,Completed,EGFR,1
breast carcinoma,UCN-01,1,Completed,CHEK1,1
breast carcinoma,UCN-01,1,Completed,PRKCA,1
breast carcinoma,VANDETANIB,1,Completed,EPHA3,1
breast carcinoma,UPROSERTIB,2,"Active, not recruiting",AKT1,1
breast carcinoma,VANDETANIB,1,Completed,EPHA2,1
breast carcinoma,VANDETANIB,1,Completed,EPHA10,1
breast carcinoma,VANDETANIB,1,Completed,EPHA1,1
breast carcinoma,VANDETANIB,1,Completed,EGFR,1
breast carcinoma,VALPROIC ACID,2,"Active, not recruiting",ALDH5A1,1
breast carcinoma,UTOMILUMAB,2,Recruiting,TNFRSF9,1
breast carcinoma,UTOMILUMAB,1,Recruiting,TNFRSF9,1
breast carcinoma,UPROSERTIB,2,"Active, not recruiting",AKT3,1
breast carcinoma,UPROSERTIB,2,"Active, not recruiting",AKT2,1
breast carcinoma,ULIPRISTAL ACETATE,2,Unknown status,PGR,1
breast carcinoma,UCN-01,1,Completed,PRKCB,1
breast carcinoma,UCN-01,1,Completed,PRKD3,1
breast carcinoma,UCN-01,1,Completed,PRKD1,1
breast carcinoma,UCN-01,1,Completed,PRKCZ,1
breast carcinoma,UCN-01,1,Completed,PRKCQ,1
breast carcinoma,UCN-01,1,Completed,PRKCI,1
breast carcinoma,UCN-01,1,Completed,PRKCH,1
breast carcinoma,UCN-01,1,Completed,PRKCG,1
breast carcinoma,UCN-01,1,Completed,PRKCE,1
breast carcinoma,UCN-01,1,Completed,PRKCD,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,"Active, not recruiting",TUBB,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Terminated,TUBB8,1
breast carcinoma,VINFLUNINE,2,Completed,TUBA1A,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Terminated,TUBB6,1
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Withdrawn,TUBB8,1
breast carcinoma,VATALANIB,1,Terminated,KDR,1
breast carcinoma,VATALANIB,1,Terminated,FLT4,1
breast carcinoma,VATALANIB,1,Terminated,FLT1,1
breast carcinoma,VATALANIB,1,Terminated,CSF1R,1
breast carcinoma,VATALANIB,1,Completed,PDGFRB,1
breast carcinoma,VATALANIB,1,Completed,PDGFRA,1
breast carcinoma,VATALANIB,1,Completed,KIT,1
breast carcinoma,VATALANIB,1,Completed,KDR,1
breast carcinoma,VATALANIB,1,Completed,FLT4,1
breast carcinoma,VATALANIB,1,Completed,FLT1,1
breast carcinoma,VATALANIB,1,Completed,CSF1R,1
breast carcinoma,VANTICTUMAB,1,Completed,FZD8,1
breast carcinoma,VANTICTUMAB,1,Completed,FZD7,1
breast carcinoma,VANTICTUMAB,1,Completed,FZD5,1
breast carcinoma,VANTICTUMAB,1,Completed,FZD2,1
breast carcinoma,VANTICTUMAB,1,Completed,FZD1,1
breast carcinoma,VANDETANIB,2,Recruiting,TEK,1
breast carcinoma,VANDETANIB,2,Recruiting,SRC,1
breast carcinoma,VANDETANIB,2,Recruiting,RET,1
breast carcinoma,VANDETANIB,2,Recruiting,PTK6,1
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Withdrawn,TUBB6,1
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Withdrawn,TUBB4B,1
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Withdrawn,TUBB4A,1
breast carcinoma,VELIPARIB,1,"Active, not recruiting",PARP3,1
breast carcinoma,VENLAFAXINE,2,Completed,SLC6A4,1
breast carcinoma,VENLAFAXINE,2,Completed,SLC6A2,1
breast carcinoma,VENETOCLAX,2,Recruiting,BCL2,1
breast carcinoma,VELIPARIB,2,Recruiting,PARP3,1
breast carcinoma,VELIPARIB,2,Recruiting,PARP2,1
breast carcinoma,VELIPARIB,2,Recruiting,PARP1,1
breast carcinoma,VELIPARIB,2,"Active, not recruiting",PARP3,1
breast carcinoma,VELIPARIB,2,"Active, not recruiting",PARP2,1
breast carcinoma,VELIPARIB,2,"Active, not recruiting",PARP1,1
breast carcinoma,VELIPARIB,1,"Active, not recruiting",PARP2,1
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Withdrawn,TUBB3,1
breast carcinoma,VELIPARIB,1,"Active, not recruiting",PARP1,1
breast carcinoma,VATALANIB,1,Terminated,PDGFRB,1
breast carcinoma,VATALANIB,1,Terminated,PDGFRA,1
breast carcinoma,VATALANIB,1,Terminated,KIT,1
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Withdrawn,ERBB2,1
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Withdrawn,TUBB,1
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Withdrawn,TUBB1,1
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Withdrawn,TUBB2A,1
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Withdrawn,TUBB2B,1
breast carcinoma,VANDETANIB,2,Recruiting,KDR,1
breast carcinoma,VANDETANIB,2,Recruiting,FLT4,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Recruiting,ERBB2,1
breast carcinoma,VANDETANIB,2,Completed,FLT1,1
breast carcinoma,VANDETANIB,2,Recruiting,EPHA10,1
breast carcinoma,VANDETANIB,2,Recruiting,EPHA1,1
breast carcinoma,VANDETANIB,2,Recruiting,EGFR,1
breast carcinoma,VANDETANIB,2,Completed,TEK,1
breast carcinoma,VANDETANIB,2,Completed,SRC,1
breast carcinoma,VANDETANIB,2,Completed,RET,1
breast carcinoma,VANDETANIB,2,Completed,PTK6,1
breast carcinoma,VANDETANIB,2,Completed,KDR,1
breast carcinoma,VANDETANIB,2,Completed,FLT4,1
breast carcinoma,VANDETANIB,2,Completed,ERBB4,1
breast carcinoma,VANDETANIB,2,Recruiting,EPHA3,1
breast carcinoma,VANDETANIB,2,Completed,ERBB3,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Terminated,ERBB2,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Terminated,TUBB,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Terminated,TUBB1,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Terminated,TUBB2A,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Terminated,TUBB2B,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Terminated,TUBB3,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Terminated,TUBB4A,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Terminated,TUBB4B,1
breast carcinoma,VANDETANIB,2,Recruiting,EPHA2,1
breast carcinoma,VANDETANIB,2,Recruiting,EPHA4,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Recruiting,TUBB,1
breast carcinoma,VANDETANIB,2,Recruiting,EPHB2,1
breast carcinoma,VANDETANIB,2,Recruiting,FLT1,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Recruiting,TUBB1,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Recruiting,TUBB2A,1
breast carcinoma,VANDETANIB,2,Recruiting,ERBB4,1
breast carcinoma,VANDETANIB,2,Recruiting,ERBB3,1
breast carcinoma,VANDETANIB,2,Recruiting,ERBB2,1
breast carcinoma,VANDETANIB,2,Recruiting,EPHB6,1
breast carcinoma,VANDETANIB,2,Recruiting,EPHB4,1
breast carcinoma,VANDETANIB,2,Recruiting,EPHB3,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Recruiting,TUBB2B,1
breast carcinoma,VANDETANIB,2,Recruiting,EPHA5,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Recruiting,TUBB3,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Recruiting,TUBB4A,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Recruiting,TUBB4B,1
breast carcinoma,VANDETANIB,2,Recruiting,EPHB1,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Recruiting,TUBB6,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Recruiting,TUBB8,1
breast carcinoma,VANDETANIB,2,Recruiting,EPHA8,1
breast carcinoma,VANDETANIB,2,Recruiting,EPHA7,1
breast carcinoma,VANDETANIB,2,Recruiting,EPHA6,1
breast carcinoma,TASELISIB,1,"Active, not recruiting",PIK3CA,1
breast carcinoma,TANESPIMYCIN,2,Terminated,HSP90AB1,1
breast carcinoma,TANESPIMYCIN,2,Terminated,HSP90AA1,1
breast carcinoma,RISEDRONIC ACID,4,Completed,FDPS,1
breast carcinoma,RUCAPARIB,1,Recruiting,PARP2,1
breast carcinoma,RUCAPARIB,1,Recruiting,PARP3,1
inflammatory breast carcinoma,PACLITAXEL,2,Completed,TUBB2A,1
inflammatory breast carcinoma,PACLITAXEL,2,Completed,TUBB1,1
inflammatory breast carcinoma,PACLITAXEL,2,Completed,TUBB,1
breast carcinoma,RUXOLITINIB,1,"Active, not recruiting",JAK1,1
breast carcinoma,RUXOLITINIB,1,"Active, not recruiting",JAK2,1
breast carcinoma,RUXOLITINIB,1,Recruiting,JAK1,1
breast carcinoma,RUXOLITINIB,1,Recruiting,JAK2,1
breast carcinoma,RUXOLITINIB,1,Suspended,JAK1,1
breast carcinoma,RUXOLITINIB,1,Suspended,JAK2,1
breast carcinoma,RUXOLITINIB,2,"Active, not recruiting",JAK1,1
breast carcinoma,RUXOLITINIB,2,"Active, not recruiting",JAK2,1
breast carcinoma,SACITUZUMAB GOVITECAN,3,Recruiting,TACSTD2,1
breast carcinoma,SAGOPILONE,2,Completed,TUBA1A,1
breast carcinoma,SAGOPILONE,2,Completed,TUBA1B,1
breast carcinoma,SAGOPILONE,2,Completed,TUBA1C,1
breast carcinoma,SAGOPILONE,2,Completed,TUBA3C,1
breast carcinoma,SAGOPILONE,2,Completed,TUBA3E,1
breast carcinoma,SAGOPILONE,2,Completed,TUBA4A,1
breast carcinoma,SAGOPILONE,2,Completed,TUBB,1
breast carcinoma,RUCAPARIB,1,Recruiting,PARP1,1
breast carcinoma,ROSUVASTATIN,2,"Active, not recruiting",HMGCR,1
breast carcinoma,ROSUVASTATIN,1,Withdrawn,HMGCR,1
breast carcinoma,ROPIVACAINE,3,Terminated,SCN10A,1
breast carcinoma,ROPIVACAINE,3,Completed,SCN11A,1
breast carcinoma,ROPIVACAINE,3,Completed,SCN1A,1
breast carcinoma,ROPIVACAINE,3,Completed,SCN2A,1
breast carcinoma,ROPIVACAINE,3,Completed,SCN3A,1
breast carcinoma,ROPIVACAINE,3,Completed,SCN4A,1
breast carcinoma,ROPIVACAINE,3,Completed,SCN5A,1
breast carcinoma,ROPIVACAINE,3,Completed,SCN7A,1
breast carcinoma,ROPIVACAINE,3,Completed,SCN8A,1
breast carcinoma,ROPIVACAINE,3,Completed,SCN9A,1
breast carcinoma,ROPIVACAINE,3,Terminated,SCN11A,1
breast carcinoma,ROSUVASTATIN,1,Terminated,HMGCR,1
breast carcinoma,ROPIVACAINE,3,Terminated,SCN1A,1
breast carcinoma,ROPIVACAINE,3,Terminated,SCN2A,1
breast carcinoma,ROPIVACAINE,3,Terminated,SCN3A,1
breast carcinoma,ROPIVACAINE,3,Terminated,SCN4A,1
breast carcinoma,ROPIVACAINE,3,Terminated,SCN5A,1
breast carcinoma,ROPIVACAINE,3,Terminated,SCN7A,1
breast carcinoma,ROPIVACAINE,3,Terminated,SCN8A,1
breast carcinoma,ROPIVACAINE,3,Terminated,SCN9A,1
breast carcinoma,ROSIGLITAZONE,1,Completed,PPARG,1
breast carcinoma,SAGOPILONE,2,Completed,TUBB1,1
breast carcinoma,SAGOPILONE,2,Completed,TUBB2A,1
breast carcinoma,SAGOPILONE,2,Completed,TUBB2B,1
breast carcinoma,SEMAXANIB,1,Completed,KDR,1
breast carcinoma,SELUMETINIB,2,Completed,MAP2K2,1
breast carcinoma,SELUMETINIB,2,Recruiting,MAP2K1,1
breast carcinoma,SELUMETINIB,2,Recruiting,MAP2K2,1
breast carcinoma,SELUMETINIB,2,Terminated,MAP2K1,1
breast carcinoma,SELUMETINIB,2,Terminated,MAP2K2,1
breast carcinoma,SELUMETINIB,2,Unknown status,MAP2K1,1
breast carcinoma,SELUMETINIB,2,Unknown status,MAP2K2,1
breast carcinoma,SEMAXANIB,1,Completed,FLT1,1
breast carcinoma,SEMAXANIB,1,Completed,FLT4,1
breast carcinoma,SEMAXANIB,1,Completed,KIT,1
breast carcinoma,SELUMETINIB,1,"Active, not recruiting",MAP2K2,1
breast carcinoma,SERIBANTUMAB,2,Recruiting,ERBB3,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRA1,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRA2,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRA3,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRA4,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRA5,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRA6,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRB1,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRB2,1
breast carcinoma,SELUMETINIB,2,Completed,MAP2K1,1
breast carcinoma,SELUMETINIB,1,"Active, not recruiting",MAP2K1,1
breast carcinoma,SAGOPILONE,2,Completed,TUBB3,1
breast carcinoma,SARGRAMOSTIM,0,Completed,CSF2RA,1
breast carcinoma,SAGOPILONE,2,Completed,TUBB4A,1
breast carcinoma,SAGOPILONE,2,Completed,TUBB4B,1
breast carcinoma,SAGOPILONE,2,Completed,TUBB6,1
breast carcinoma,SAGOPILONE,2,Completed,TUBB8,1
breast carcinoma,SAPANISERTIB,2,"Active, not recruiting",MTOR,1
breast carcinoma,SAPANISERTIB,2,Completed,MTOR,1
breast carcinoma,SAPANISERTIB,2,Recruiting,MTOR,1
breast carcinoma,SARACATINIB,1,Completed,ABL1,1
breast carcinoma,SARACATINIB,1,Completed,SRC,1
breast carcinoma,SARGRAMOSTIM,1,Suspended,CSF2RA,1
breast carcinoma,SELINEXOR,2,"Active, not recruiting",XPO1,1
breast carcinoma,SARGRAMOSTIM,1,Withdrawn,CSF2RA,1
breast carcinoma,SARGRAMOSTIM,2,"Active, not recruiting",CSF2RA,1
breast carcinoma,SARGRAMOSTIM,2,Recruiting,CSF2RA,1
breast carcinoma,SARGRAMOSTIM,2,Unknown status,CSF2RA,1
breast carcinoma,SELICICLIB,1,Withdrawn,CDK1,1
breast carcinoma,SELICICLIB,1,Withdrawn,CDK2,1
breast carcinoma,SELICICLIB,1,Withdrawn,CDK5,1
breast carcinoma,SELICICLIB,1,Withdrawn,CDK7,1
breast carcinoma,SELICICLIB,1,Withdrawn,CDK9,1
breast carcinoma,ROPIVACAINE,3,Completed,SCN10A,1
breast carcinoma,RINTATOLIMOD,0,Recruiting,TLR3,1
breast carcinoma,ZOLEDRONIC ACID,2,Unknown status,FDPS,1
breast carcinoma,RILUZOLE,1,Withdrawn,SCN9A,1
invasive ductal carcinoma,ATEZOLIZUMAB,3,"Active, not recruiting",CD274,1
invasive ductal carcinoma,ANASTROZOLE,3,Recruiting,CYP19A1,1
invasive ductal carcinoma,ALPELISIB,1,"Active, not recruiting",PIK3CA,1
inflammatory breast carcinoma,TRASTUZUMAB,3,Terminated,ERBB2,1
inflammatory breast carcinoma,TRASTUZUMAB,2,"Active, not recruiting",ERBB2,1
inflammatory breast carcinoma,TRASTUZUMAB,1,Unknown status,ERBB2,1
inflammatory breast carcinoma,TRASTUZUMAB,1,Completed,ERBB2,1
inflammatory breast carcinoma,TIPIFARNIB,2,Completed,FNTB,1
inflammatory breast carcinoma,TIPIFARNIB,2,Completed,FNTA,1
inflammatory breast carcinoma,TAMOXIFEN,3,Terminated,ESR1,1
inflammatory breast carcinoma,TAMOXIFEN,2,Completed,ESR1,1
inflammatory breast carcinoma,SUNITINIB,2,"Active, not recruiting",RET,1
inflammatory breast carcinoma,SUNITINIB,2,"Active, not recruiting",PDGFRB,1
inflammatory breast carcinoma,SUNITINIB,2,"Active, not recruiting",PDGFRA,1
inflammatory breast carcinoma,SUNITINIB,2,"Active, not recruiting",KIT,1
inflammatory breast carcinoma,SUNITINIB,2,"Active, not recruiting",KDR,1
inflammatory breast carcinoma,SUNITINIB,2,"Active, not recruiting",FLT4,1
inflammatory breast carcinoma,SUNITINIB,2,"Active, not recruiting",FLT3,1
inflammatory breast carcinoma,SUNITINIB,2,"Active, not recruiting",FLT1,1
inflammatory breast carcinoma,SUNITINIB,2,"Active, not recruiting",CSF1R,1
inflammatory breast carcinoma,SARGRAMOSTIM,2,Completed,CSF2RA,1
invasive ductal carcinoma,ERGOCALCIFEROL,1,Terminated,VDR,1
invasive ductal carcinoma,FULVESTRANT,3,Recruiting,ESR1,1
invasive ductal carcinoma,FULVESTRANT,3,Recruiting,ESR2,1
invasive lobular carcinoma,FULVESTRANT,3,Recruiting,ESR1,1
male breast carcinoma,ALVOCIDIB,1,Terminated,CDK9,1
male breast carcinoma,ALVOCIDIB,1,Terminated,CDK7,1
male breast carcinoma,ALVOCIDIB,1,Terminated,CDK6,1
male breast carcinoma,ALVOCIDIB,1,Terminated,CDK4,1
male breast carcinoma,ALVOCIDIB,1,Terminated,CDK2,1
breast carcinoma,RILUZOLE,1,Withdrawn,SCN8A,1
male breast carcinoma,ALVOCIDIB,1,Terminated,CDK1,1
lobular breast carcinoma,LETROZOLE,1,Completed,CYP19A1,1
invasive lobular carcinoma,FULVESTRANT,3,Recruiting,ESR2,1
invasive lobular carcinoma,ANASTROZOLE,3,Recruiting,CYP19A1,1
invasive ductal carcinoma,LETROZOLE,1,"Active, not recruiting",CYP19A1,1
invasive ductal carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB8,1
invasive ductal carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB6,1
invasive ductal carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB4B,1
invasive ductal carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB4A,1
invasive ductal carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB3,1
invasive ductal carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB2B,1
invasive ductal carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB2A,1
invasive ductal carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB1,1
invasive ductal carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
inflammatory breast carcinoma,RUXOLITINIB,2,Recruiting,JAK2,1
inflammatory breast carcinoma,RUXOLITINIB,2,Recruiting,JAK1,1
inflammatory breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC9,1
inflammatory breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB3,1
inflammatory breast carcinoma,PACLITAXEL,3,Recruiting,TUBB4A,1
inflammatory breast carcinoma,PACLITAXEL,3,Recruiting,TUBB3,1
inflammatory breast carcinoma,PACLITAXEL,3,Recruiting,TUBB2B,1
inflammatory breast carcinoma,PACLITAXEL,3,Recruiting,TUBB2A,1
inflammatory breast carcinoma,PACLITAXEL,3,Recruiting,TUBB1,1
inflammatory breast carcinoma,PACLITAXEL,3,Recruiting,TUBB,1
inflammatory breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB8,1
inflammatory breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB6,1
inflammatory breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB4A,1
inflammatory breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB2B,1
inflammatory breast carcinoma,PACLITAXEL,3,Recruiting,TUBB6,1
inflammatory breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB2A,1
inflammatory breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB1,1
inflammatory breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,1
inflammatory breast carcinoma,PACLITAXEL,2,Completed,TUBB8,1
inflammatory breast carcinoma,PACLITAXEL,2,Completed,TUBB6,1
inflammatory breast carcinoma,PACLITAXEL,2,Completed,TUBB4B,1
inflammatory breast carcinoma,PACLITAXEL,2,Completed,TUBB4A,1
inflammatory breast carcinoma,PACLITAXEL,2,Completed,TUBB3,1
inflammatory breast carcinoma,PACLITAXEL,2,Completed,TUBB2B,1
inflammatory breast carcinoma,PACLITAXEL,3,Recruiting,TUBB4B,1
inflammatory breast carcinoma,PACLITAXEL,3,Recruiting,TUBB8,1
inflammatory breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC8,1
inflammatory breast carcinoma,R428,2,Recruiting,AXL,1
inflammatory breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC7,1
inflammatory breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC6,1
inflammatory breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC5,1
inflammatory breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC4,1
inflammatory breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC3,1
inflammatory breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC2,1
inflammatory breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC11,1
inflammatory breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC10,1
inflammatory breast carcinoma,ROMIDEPSIN,1,Terminated,HDAC1,1
inflammatory breast carcinoma,PERTUZUMAB,2,"Active, not recruiting",ERBB2,1
inflammatory breast carcinoma,PACLITAXEL,3,Terminated,TUBB,1
inflammatory breast carcinoma,PEMBROLIZUMAB,2,Not yet recruiting,PDCD1,1
inflammatory breast carcinoma,PACLITAXEL,3,Terminated,TUBB8,1
inflammatory breast carcinoma,PACLITAXEL,3,Terminated,TUBB6,1
inflammatory breast carcinoma,PACLITAXEL,3,Terminated,TUBB4B,1
inflammatory breast carcinoma,PACLITAXEL,3,Terminated,TUBB4A,1
inflammatory breast carcinoma,PACLITAXEL,3,Terminated,TUBB3,1
inflammatory breast carcinoma,PACLITAXEL,3,Terminated,TUBB2B,1
inflammatory breast carcinoma,PACLITAXEL,3,Terminated,TUBB2A,1
inflammatory breast carcinoma,PACLITAXEL,3,Terminated,TUBB1,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRB3,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRD,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRE,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRG1,1
inflammatory breast carcinoma,DOXORUBICIN,2,Completed,TOP2A,1
inflammatory breast carcinoma,DOXORUBICIN,2,"Active, not recruiting",TOP2A,1
inflammatory breast carcinoma,DOCETAXEL,3,Completed,TUBB8,1
inflammatory breast carcinoma,DOCETAXEL,3,Completed,TUBB6,1
inflammatory breast carcinoma,DOCETAXEL,3,Completed,TUBB4B,1
inflammatory breast carcinoma,DOCETAXEL,3,Completed,TUBB4A,1
inflammatory breast carcinoma,DOCETAXEL,3,Completed,TUBB3,1
breast carcinoma,SUNITINIB,1,Unknown status,CSF1R,1
breast carcinoma,SUNITINIB,1,Unknown status,FLT1,1
breast carcinoma,SUNITINIB,1,Unknown status,FLT3,1
breast carcinoma,SUNITINIB,1,Unknown status,FLT4,1
breast carcinoma,SUNITINIB,1,Unknown status,KDR,1
breast carcinoma,SUNITINIB,1,Unknown status,KIT,1
breast carcinoma,SUNITINIB,1,Unknown status,PDGFRA,1
breast carcinoma,SUNITINIB,1,Unknown status,PDGFRB,1
breast carcinoma,SUNITINIB,1,Unknown status,RET,1
inflammatory breast carcinoma,DOCETAXEL,3,Completed,TUBB2B,1
inflammatory breast carcinoma,DOCETAXEL,3,Completed,TUBB2A,1
inflammatory breast carcinoma,DOCETAXEL,3,Completed,TUBB1,1
inflammatory breast carcinoma,DOCETAXEL,3,Completed,TUBB,1
inflammatory breast carcinoma,DOCETAXEL,1,Unknown status,TUBB8,1
inflammatory breast carcinoma,DOXORUBICIN,3,Terminated,TOP2A,1
inflammatory breast carcinoma,ERIBULIN,2,Recruiting,TUBB,1
inflammatory breast carcinoma,ERIBULIN,2,Recruiting,TUBB1,1
breast carcinoma,SORAFENIB,3,Completed,KIT,1
inflammatory breast carcinoma,ERIBULIN,2,Recruiting,TUBB8,1
inflammatory breast carcinoma,ERIBULIN,2,Recruiting,TUBB6,1
inflammatory breast carcinoma,ERIBULIN,2,Recruiting,TUBB4B,1
inflammatory breast carcinoma,ERIBULIN,2,Recruiting,TUBB4A,1
breast carcinoma,SORAFENIB,3,Completed,BRAF,1
breast carcinoma,SORAFENIB,3,Completed,FLT1,1
breast carcinoma,SORAFENIB,3,Completed,FLT3,1
breast carcinoma,SORAFENIB,3,Completed,FLT4,1
breast carcinoma,SORAFENIB,3,Completed,KDR,1
breast carcinoma,SORAFENIB,3,Completed,PDGFRB,1
inflammatory breast carcinoma,ERIBULIN,2,Recruiting,TUBB2A,1
breast carcinoma,SORAFENIB,3,Completed,RAF1,1
breast carcinoma,SORAFENIB,3,Completed,RET,1
breast carcinoma,SR16234,2,Completed,ESR1,1
breast carcinoma,SULINDAC,1,Completed,PTGS1,1
breast carcinoma,SULINDAC,1,Completed,PTGS2,1
breast carcinoma,SULINDAC,2,Completed,PTGS1,1
breast carcinoma,SULINDAC,2,Completed,PTGS2,1
inflammatory breast carcinoma,ERIBULIN,2,Recruiting,TUBB3,1
inflammatory breast carcinoma,ERIBULIN,2,Recruiting,TUBB2B,1
inflammatory breast carcinoma,DOCETAXEL,1,Unknown status,TUBB6,1
inflammatory breast carcinoma,DOCETAXEL,1,Unknown status,TUBB4B,1
inflammatory breast carcinoma,DOCETAXEL,1,Unknown status,TUBB4A,1
breast carcinoma,TAMOXIFEN,2,Withdrawn,ESR1,1
ductal carcinoma in situ,PASIREOTIDE,1,Terminated,SSTR2,1
ductal carcinoma in situ,PASIREOTIDE,1,Terminated,SSTR1,1
breast carcinoma,TAMOXIFEN,1,Not yet recruiting,ESR1,1
breast carcinoma,TAMOXIFEN,1,Terminated,ESR1,1
breast carcinoma,TAMOXIFEN,1,Unknown status,ESR1,1
breast carcinoma,TAMOXIFEN,2,Not yet recruiting,ESR1,1
ductal carcinoma in situ,OXYTOCIN,2,Suspended,OXTR,1
ductal carcinoma in situ,MIFEPRISTONE,0,Terminated,PGR,1
ductal carcinoma in situ,MIFEPRISTONE,0,Terminated,NR3C1,1
ductal carcinoma in situ,LETROZOLE,2,Completed,CYP19A1,1
breast carcinoma,TALAZOPARIB,2,"Active, not recruiting",PARP2,1
ductal carcinoma in situ,FULVESTRANT,2,Recruiting,ESR2,1
ductal carcinoma in situ,FULVESTRANT,2,Recruiting,ESR1,1
breast carcinoma,ZOPTARELIN DOXORUBICIN,2,Terminated,GNRHR,1
breast carcinoma,ZOLEDRONIC ACID,4,Terminated,FDPS,1
breast carcinoma,TAMOXIFEN,3,Withdrawn,ESR1,1
breast carcinoma,TAMOXIFEN,4,"Active, not recruiting",ESR1,1
breast carcinoma,ZOLEDRONIC ACID,4,Recruiting,FDPS,1
breast carcinoma,TAMOXIFEN,4,Withdrawn,ESR1,1
breast carcinoma,ZOLEDRONIC ACID,3,Terminated,FDPS,1
ductal carcinoma in situ,PASIREOTIDE,1,Terminated,SSTR3,1
breast carcinoma,TALAZOPARIB,2,"Active, not recruiting",PARP1,1
inflammatory breast carcinoma,DOCETAXEL,1,Unknown status,TUBB3,1
inflammatory breast carcinoma,DOCETAXEL,1,Unknown status,TUBB2B,1
breast carcinoma,SUNITINIB,2,Recruiting,CSF1R,1
breast carcinoma,SUNITINIB,2,Recruiting,FLT1,1
breast carcinoma,SUNITINIB,2,Recruiting,FLT3,1
breast carcinoma,SUNITINIB,2,Recruiting,FLT4,1
breast carcinoma,SUNITINIB,2,Recruiting,KDR,1
breast carcinoma,SUNITINIB,2,Recruiting,KIT,1
breast carcinoma,SUNITINIB,2,Recruiting,PDGFRA,1
breast carcinoma,SUNITINIB,2,Recruiting,PDGFRB,1
breast carcinoma,SUNITINIB,2,Recruiting,RET,1
inflammatory breast carcinoma,DOCETAXEL,1,Unknown status,TUBB2A,1
breast carcinoma,TALAZOPARIB,1,Recruiting,PARP2,1
inflammatory breast carcinoma,DOCETAXEL,1,Unknown status,TUBB1,1
inflammatory breast carcinoma,DOCETAXEL,1,Unknown status,TUBB,1
inflammatory breast carcinoma,BEVACIZUMAB,1,Unknown status,VEGFA,1
inflammatory breast carcinoma,ALDESLEUKIN,2,Completed,IL2RB,1
inflammatory breast carcinoma,ALDESLEUKIN,2,Completed,IL2RA,1
ductal carcinoma in situ,ZOLEDRONIC ACID,2,Completed,FDPS,1
ductal carcinoma in situ,PASIREOTIDE,1,Terminated,SSTR5,1
breast carcinoma,T-DM1,1,Recruiting,ERBB2,1
breast carcinoma,TALAZOPARIB,1,Recruiting,PARP1,1
inflammatory breast carcinoma,FILGRASTIM,2,"Active, not recruiting",CSF3R,1
inflammatory breast carcinoma,FILGRASTIM,2,Completed,CSF3R,1
inflammatory breast carcinoma,FLUOROURACIL,1,Unknown status,TYMS,1
breast carcinoma,SIMVASTATIN,2,Not yet recruiting,HMGCR,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRP,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRQ,1
breast carcinoma,SEVOFLURANE,4,Completed,GLRA1,1
breast carcinoma,SEVOFLURANE,4,Completed,KCNK10,1
breast carcinoma,SEVOFLURANE,4,Completed,KCNK18,1
breast carcinoma,SEVOFLURANE,4,Completed,KCNK2,1
breast carcinoma,SEVOFLURANE,4,Completed,KCNK3,1
breast carcinoma,SEVOFLURANE,4,Completed,KCNK9,1
breast carcinoma,SIMVASTATIN,2,"Active, not recruiting",HMGCR,1
breast carcinoma,SIMVASTATIN,2,Unknown status,HMGCR,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRG2,1
breast carcinoma,SIROLIMUS,2,Completed,FKBP1A,1
breast carcinoma,SIROLIMUS,2,Recruiting,FKBP1A,1
breast carcinoma,SONIDEGIB,1,Completed,SMO,1
breast carcinoma,SORAFENIB,1,"Active, not recruiting",BRAF,1
breast carcinoma,SORAFENIB,1,"Active, not recruiting",FLT1,1
breast carcinoma,SORAFENIB,1,"Active, not recruiting",FLT3,1
breast carcinoma,SORAFENIB,1,"Active, not recruiting",FLT4,1
breast carcinoma,SORAFENIB,1,"Active, not recruiting",KDR,1
breast carcinoma,SORAFENIB,1,"Active, not recruiting",KIT,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRG3,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRG1,1
breast carcinoma,SORAFENIB,1,"Active, not recruiting",RAF1,1
breast carcinoma,SEVOFLURANE,2,Recruiting,KCNK9,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRG2,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRG3,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRP,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GABRQ,1
breast carcinoma,SEVOFLURANE,2,Recruiting,GLRA1,1
breast carcinoma,SEVOFLURANE,2,Recruiting,KCNK10,1
breast carcinoma,SEVOFLURANE,2,Recruiting,KCNK18,1
breast carcinoma,SEVOFLURANE,2,Recruiting,KCNK2,1
breast carcinoma,SEVOFLURANE,2,Recruiting,KCNK3,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRA1,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRE,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRA2,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRA3,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRA4,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRA5,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRA6,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRB1,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRB2,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRB3,1
breast carcinoma,SEVOFLURANE,4,Completed,GABRD,1
breast carcinoma,SORAFENIB,1,"Active, not recruiting",PDGFRB,1
breast carcinoma,SORAFENIB,1,"Active, not recruiting",RET,1
inflammatory breast carcinoma,FLUOROURACIL,3,Recruiting,TYMS,1
inflammatory breast carcinoma,LETROZOLE,2,Recruiting,CYP19A1,1
breast carcinoma,SORAFENIB,2,"Active, not recruiting",RAF1,1
breast carcinoma,SORAFENIB,2,"Active, not recruiting",RET,1
inflammatory breast carcinoma,OLAPARIB,2,Recruiting,PARP3,1
inflammatory breast carcinoma,OLAPARIB,2,Recruiting,PARP2,1
inflammatory breast carcinoma,OLAPARIB,2,Recruiting,PARP1,1
inflammatory breast carcinoma,OLAPARIB,1,Recruiting,PARP3,1
inflammatory breast carcinoma,OLAPARIB,1,Recruiting,PARP2,1
inflammatory breast carcinoma,OLAPARIB,1,Recruiting,PARP1,1
inflammatory breast carcinoma,NIVOLUMAB,2,"Active, not recruiting",PDCD1,1
inflammatory breast carcinoma,IPILIMUMAB,2,"Active, not recruiting",CTLA4,1
breast carcinoma,SORAFENIB,2,"Active, not recruiting",KIT,1
breast carcinoma,SORAFENIB,2,Recruiting,BRAF,1
breast carcinoma,SORAFENIB,2,Recruiting,FLT1,1
breast carcinoma,SORAFENIB,2,Recruiting,FLT3,1
breast carcinoma,SORAFENIB,2,Recruiting,FLT4,1
breast carcinoma,SORAFENIB,2,Recruiting,KDR,1
breast carcinoma,SORAFENIB,2,Recruiting,KIT,1
breast carcinoma,SORAFENIB,2,Recruiting,PDGFRB,1
breast carcinoma,SORAFENIB,2,Recruiting,RAF1,1
breast carcinoma,SORAFENIB,2,Recruiting,RET,1
breast carcinoma,SORAFENIB,2,"Active, not recruiting",PDGFRB,1
breast carcinoma,SORAFENIB,2,"Active, not recruiting",KDR,1
inflammatory breast carcinoma,PACLITAXEL,1,Terminated,TUBB8,1
breast carcinoma,SORAFENIB,1,Unknown status,FLT1,1
inflammatory breast carcinoma,PACLITAXEL,1,Terminated,TUBB6,1
inflammatory breast carcinoma,PACLITAXEL,1,Terminated,TUBB4B,1
inflammatory breast carcinoma,PACLITAXEL,1,Terminated,TUBB4A,1
inflammatory breast carcinoma,PACLITAXEL,1,Terminated,TUBB3,1
inflammatory breast carcinoma,PACLITAXEL,1,Terminated,TUBB2B,1
inflammatory breast carcinoma,PACLITAXEL,1,Terminated,TUBB2A,1
inflammatory breast carcinoma,PACLITAXEL,1,Terminated,TUBB1,1
inflammatory breast carcinoma,PACLITAXEL,1,Terminated,TUBB,1
breast carcinoma,SORAFENIB,1,Unknown status,BRAF,1
breast carcinoma,SORAFENIB,1,Unknown status,FLT3,1
breast carcinoma,SORAFENIB,2,"Active, not recruiting",FLT4,1
breast carcinoma,SORAFENIB,1,Unknown status,FLT4,1
breast carcinoma,SORAFENIB,1,Unknown status,KDR,1
breast carcinoma,SORAFENIB,1,Unknown status,KIT,1
breast carcinoma,SORAFENIB,1,Unknown status,PDGFRB,1
breast carcinoma,SORAFENIB,1,Unknown status,RAF1,1
breast carcinoma,SORAFENIB,1,Unknown status,RET,1
breast carcinoma,SORAFENIB,2,"Active, not recruiting",BRAF,1
breast carcinoma,SORAFENIB,2,"Active, not recruiting",FLT1,1
breast carcinoma,SORAFENIB,2,"Active, not recruiting",FLT3,1
breast carcinoma,PANITUMUMAB,2,Recruiting,EGFR,1
Hereditary breast and ovarian cancer syndrome,ARZOXIFENE,2,Completed,ESR1,1
breast carcinoma,PANITUMUMAB,2,"Active, not recruiting",EGFR,1
breast carcinoma,DOCETAXEL,1,Recruiting,TUBB,1
breast carcinoma,DINACICLIB,1,Recruiting,CDK5,1
breast carcinoma,DINACICLIB,1,Recruiting,CDK9,1
breast carcinoma,DIPHENHYDRAMINE,2,Completed,HRH1,1
breast carcinoma,DISULFIRAM,2,Recruiting,ALDH2,1
breast carcinoma,DOCETAXEL,0,Completed,TUBB,1
breast carcinoma,DOCETAXEL,0,Completed,TUBB1,1
breast carcinoma,DOCETAXEL,0,Completed,TUBB2A,1
breast carcinoma,DOCETAXEL,0,Completed,TUBB2B,1
breast carcinoma,DOCETAXEL,0,Completed,TUBB3,1
breast carcinoma,DOCETAXEL,0,Completed,TUBB4A,1
breast carcinoma,DOCETAXEL,0,Completed,TUBB4B,1
breast carcinoma,DOCETAXEL,0,Completed,TUBB6,1
breast carcinoma,DOCETAXEL,0,Completed,TUBB8,1
breast carcinoma,DOCETAXEL,1,Recruiting,TUBB1,1
breast carcinoma,DINACICLIB,1,Recruiting,CDK1,1
breast carcinoma,DOCETAXEL,1,Recruiting,TUBB2A,1
breast carcinoma,DOCETAXEL,1,Recruiting,TUBB2B,1
breast carcinoma,DOCETAXEL,1,Recruiting,TUBB3,1
breast carcinoma,DOCETAXEL,1,Recruiting,TUBB4A,1
breast carcinoma,DOCETAXEL,1,Recruiting,TUBB4B,1
breast carcinoma,DOCETAXEL,1,Recruiting,TUBB6,1
breast carcinoma,DOCETAXEL,1,Recruiting,TUBB8,1
breast carcinoma,DOCETAXEL,1,Withdrawn,TUBB,1
breast carcinoma,DOCETAXEL,1,Withdrawn,TUBB1,1
breast carcinoma,DOCETAXEL,1,Withdrawn,TUBB2A,1
breast carcinoma,DOCETAXEL,1,Withdrawn,TUBB2B,1
breast carcinoma,DOCETAXEL,1,Withdrawn,TUBB3,1
breast carcinoma,DOCETAXEL,1,Withdrawn,TUBB4A,1
breast carcinoma,DINACICLIB,1,Recruiting,CDK2,1
breast carcinoma,DIGOXIN,2,Terminated,ATP1A4,1
breast carcinoma,DECITABINE,1,"Active, not recruiting",DNMT3A,1
breast carcinoma,DEXAMETHASONE,2,"Active, not recruiting",NR3C1,1
breast carcinoma,DECITABINE,1,Terminated,DNMT3A,1
breast carcinoma,DEGARELIX,2,"Active, not recruiting",GNRHR,1
breast carcinoma,DENOSUMAB,0,Recruiting,TNFSF11,1
breast carcinoma,DENOSUMAB,1,Recruiting,TNFSF11,1
breast carcinoma,DENOSUMAB,2,Recruiting,TNFSF11,1
breast carcinoma,DENOSUMAB,2,Terminated,TNFSF11,1
breast carcinoma,DENOSUMAB,3,"Active, not recruiting",TNFSF11,1
breast carcinoma,DENOSUMAB,3,Recruiting,TNFSF11,1
breast carcinoma,DENOSUMAB,3,Terminated,TNFSF11,1
breast carcinoma,DESMOPRESSIN,2,Completed,AVPR1A,1
breast carcinoma,DESMOPRESSIN,2,Completed,AVPR1B,1
breast carcinoma,DESMOPRESSIN,2,Completed,AVPR2,1
breast carcinoma,DEXAMETHASONE,1,Terminated,NR3C1,1
breast carcinoma,DEXAMETHASONE,2,Withdrawn,NR3C1,1
breast carcinoma,DIGOXIN,2,Terminated,ATP1A3,1
breast carcinoma,DEXAMETHASONE,3,"Active, not recruiting",NR3C1,1
breast carcinoma,DEXAMETHASONE,3,Recruiting,NR3C1,1
breast carcinoma,DEXMEDETOMIDINE,4,Recruiting,ADRA2A,1
breast carcinoma,DEXMEDETOMIDINE,4,Recruiting,ADRA2B,1
breast carcinoma,DEXMEDETOMIDINE,4,Recruiting,ADRA2C,1
breast carcinoma,DICLOFENAC,0,"Active, not recruiting",PTGS1,1
breast carcinoma,DICLOFENAC,0,"Active, not recruiting",PTGS2,1
breast carcinoma,DIGOXIN,2,"Active, not recruiting",ATP1A1,1
breast carcinoma,DIGOXIN,2,"Active, not recruiting",ATP1A2,1
breast carcinoma,DIGOXIN,2,"Active, not recruiting",ATP1A3,1
breast carcinoma,DIGOXIN,2,"Active, not recruiting",ATP1A4,1
breast carcinoma,DIGOXIN,2,Terminated,ATP1A1,1
breast carcinoma,DIGOXIN,2,Terminated,ATP1A2,1
breast carcinoma,DOCETAXEL,1,Withdrawn,TUBB4B,1
breast carcinoma,DOCETAXEL,1,Withdrawn,TUBB6,1
breast carcinoma,DOCETAXEL,1,Withdrawn,TUBB8,1
breast carcinoma,DOVITINIB,2,Completed,FLT4,1
breast carcinoma,DOVITINIB,1,Terminated,PDGFRA,1
breast carcinoma,DOVITINIB,1,Terminated,PDGFRB,1
breast carcinoma,DOVITINIB,2,"Active, not recruiting",FGFR3,1
breast carcinoma,DOVITINIB,2,"Active, not recruiting",FLT1,1
breast carcinoma,DOVITINIB,2,"Active, not recruiting",FLT3,1
breast carcinoma,DOVITINIB,2,"Active, not recruiting",FLT4,1
breast carcinoma,DOVITINIB,2,"Active, not recruiting",KDR,1
breast carcinoma,DOVITINIB,2,"Active, not recruiting",KIT,1
breast carcinoma,DOVITINIB,2,"Active, not recruiting",PDGFRA,1
breast carcinoma,DOVITINIB,2,"Active, not recruiting",PDGFRB,1
breast carcinoma,DOVITINIB,2,Completed,FGFR3,1
breast carcinoma,DOVITINIB,2,Completed,FLT1,1
breast carcinoma,DOVITINIB,2,Completed,FLT3,1
breast carcinoma,DOVITINIB,2,Completed,KDR,1
breast carcinoma,DOCETAXEL,3,Withdrawn,TUBB,1
breast carcinoma,DOVITINIB,2,Completed,KIT,1
breast carcinoma,DOVITINIB,2,Completed,PDGFRA,1
breast carcinoma,DOVITINIB,2,Completed,PDGFRB,1
breast carcinoma,DOVITINIB,2,Terminated,FGFR3,1
breast carcinoma,DOVITINIB,2,Terminated,FLT1,1
breast carcinoma,DOVITINIB,2,Terminated,FLT3,1
breast carcinoma,DOVITINIB,2,Terminated,FLT4,1
breast carcinoma,DOVITINIB,2,Terminated,KDR,1
breast carcinoma,DOVITINIB,2,Terminated,KIT,1
breast carcinoma,DOVITINIB,2,Terminated,PDGFRA,1
breast carcinoma,DOVITINIB,2,Terminated,PDGFRB,1
breast carcinoma,DOXEPIN,2,Recruiting,SLC6A2,1
breast carcinoma,DOXORUBICIN,1,Recruiting,TOP2A,1
breast carcinoma,DOVITINIB,1,Terminated,KIT,1
breast carcinoma,DOVITINIB,1,Terminated,KDR,1
breast carcinoma,DOVITINIB,1,Terminated,FLT4,1
breast carcinoma,DOVITINIB,1,Terminated,FLT3,1
breast carcinoma,DOCETAXEL,3,Withdrawn,TUBB1,1
breast carcinoma,DOCETAXEL,3,Withdrawn,TUBB2A,1
breast carcinoma,DOCETAXEL,3,Withdrawn,TUBB2B,1
breast carcinoma,DOCETAXEL,3,Withdrawn,TUBB3,1
breast carcinoma,DOCETAXEL,3,Withdrawn,TUBB4A,1
breast carcinoma,DOCETAXEL,3,Withdrawn,TUBB4B,1
breast carcinoma,DOCETAXEL,3,Withdrawn,TUBB6,1
breast carcinoma,DOCETAXEL,3,Withdrawn,TUBB8,1
breast carcinoma,DOCETAXEL,4,Withdrawn,TUBB,1
breast carcinoma,DOCETAXEL,4,Withdrawn,TUBB1,1
breast carcinoma,DOCETAXEL,4,Withdrawn,TUBB2A,1
breast carcinoma,DOCETAXEL,4,Withdrawn,TUBB2B,1
breast carcinoma,DOCETAXEL,4,Withdrawn,TUBB3,1
breast carcinoma,DOCETAXEL,4,Withdrawn,TUBB4A,1
breast carcinoma,DOCETAXEL,4,Withdrawn,TUBB4B,1
breast carcinoma,DOCETAXEL,4,Withdrawn,TUBB6,1
breast carcinoma,DOCETAXEL,4,Withdrawn,TUBB8,1
breast carcinoma,DOVITINIB,1,Completed,FGFR3,1
breast carcinoma,DOVITINIB,1,Completed,FLT1,1
breast carcinoma,DOVITINIB,1,Completed,FLT3,1
breast carcinoma,DOVITINIB,1,Completed,FLT4,1
breast carcinoma,DOVITINIB,1,Completed,KDR,1
breast carcinoma,DOVITINIB,1,Completed,KIT,1
breast carcinoma,DOVITINIB,1,Completed,PDGFRA,1
breast carcinoma,DOVITINIB,1,Completed,PDGFRB,1
breast carcinoma,DOVITINIB,1,Terminated,FGFR3,1
breast carcinoma,DOVITINIB,1,Terminated,FLT1,1
breast carcinoma,DECITABINE,1,Terminated,DNMT1,1
breast carcinoma,DECITABINE,1,"Active, not recruiting",DNMT1,1
breast carcinoma,DURVALUMAB,0,Recruiting,CD274,1
breast carcinoma,DACTOLISIB,1,Completed,MTOR,1
breast carcinoma,CYCLOSPORINE,2,Terminated,PPIA,1
breast carcinoma,CYCLOSPORINE,3,Completed,PPIA,1
breast carcinoma,CYTARABINE,3,"Active, not recruiting",POLA1,1
breast carcinoma,CYTARABINE,3,"Active, not recruiting",POLA2,1
breast carcinoma,CYTARABINE,3,"Active, not recruiting",POLD1,1
breast carcinoma,CYTARABINE,3,"Active, not recruiting",POLD2,1
breast carcinoma,CYTARABINE,3,"Active, not recruiting",POLD3,1
breast carcinoma,CYTARABINE,3,"Active, not recruiting",POLD4,1
breast carcinoma,CYTARABINE,3,"Active, not recruiting",POLE,1
breast carcinoma,CYTARABINE,3,"Active, not recruiting",POLE2,1
breast carcinoma,CYTARABINE,3,"Active, not recruiting",POLE3,1
breast carcinoma,CYTARABINE,3,"Active, not recruiting",PRIM1,1
breast carcinoma,CYTARABINE,3,"Active, not recruiting",PRIM2,1
breast carcinoma,DACTOLISIB,1,Completed,PIK3CA,1
breast carcinoma,CUDC-101,1,Completed,HDAC9,1
breast carcinoma,DACTOLISIB,1,Completed,PIK3CB,1
breast carcinoma,DACTOLISIB,1,Completed,PIK3CD,1
breast carcinoma,DACTOLISIB,1,Completed,PIK3CG,1
breast carcinoma,DACTOLISIB,1,Completed,PIK3R1,1
breast carcinoma,DACTOLISIB,1,Completed,PIK3R2,1
breast carcinoma,DACTOLISIB,1,Completed,PIK3R3,1
breast carcinoma,DACTOLISIB,1,Completed,PIK3R5,1
breast carcinoma,DACTOLISIB,2,Withdrawn,MTOR,1
breast carcinoma,DACTOLISIB,2,Withdrawn,PIK3CA,1
breast carcinoma,DACTOLISIB,2,Withdrawn,PIK3CB,1
breast carcinoma,DACTOLISIB,2,Withdrawn,PIK3CD,1
breast carcinoma,DACTOLISIB,2,Withdrawn,PIK3CG,1
breast carcinoma,DACTOLISIB,2,Withdrawn,PIK3R1,1
breast carcinoma,CYCLOSPORINE,1,Completed,PPIA,1
breast carcinoma,CUDC-101,1,Completed,HDAC8,1
breast carcinoma,DAUNORUBICIN,1,Unknown status,TOP2A,1
breast carcinoma,COPANLISIB,2,Withdrawn,PIK3R3,1
breast carcinoma,COBIMETINIB,2,"Active, not recruiting",MAP2K2,1
breast carcinoma,COBIMETINIB,2,Recruiting,MAP2K1,1
breast carcinoma,COBIMETINIB,2,Recruiting,MAP2K2,1
breast carcinoma,COPANLISIB,1,Not yet recruiting,PIK3CB,1
breast carcinoma,COPANLISIB,1,Not yet recruiting,PIK3CG,1
breast carcinoma,COPANLISIB,1,Not yet recruiting,PIK3R1,1
breast carcinoma,COPANLISIB,1,Not yet recruiting,PIK3R2,1
breast carcinoma,COPANLISIB,1,Not yet recruiting,PIK3R3,1
breast carcinoma,COPANLISIB,1,Not yet recruiting,PIK3R5,1
breast carcinoma,COPANLISIB,2,Withdrawn,PIK3CB,1
breast carcinoma,COPANLISIB,2,Withdrawn,PIK3CG,1
breast carcinoma,COPANLISIB,2,Withdrawn,PIK3R1,1
breast carcinoma,COPANLISIB,2,Withdrawn,PIK3R2,1
breast carcinoma,COPANLISIB,2,Withdrawn,PIK3R5,1
breast carcinoma,CUDC-101,1,Completed,HDAC7,1
breast carcinoma,CP-724714,1,Completed,ERBB2,1
breast carcinoma,CRIZOTINIB,1,Terminated,ALK,1
breast carcinoma,CRIZOTINIB,1,Terminated,MET,1
breast carcinoma,CUDC-101,1,Completed,EGFR,1
breast carcinoma,CUDC-101,1,Completed,ERBB2,1
breast carcinoma,CUDC-101,1,Completed,HDAC1,1
breast carcinoma,CUDC-101,1,Completed,HDAC10,1
breast carcinoma,CUDC-101,1,Completed,HDAC11,1
breast carcinoma,CUDC-101,1,Completed,HDAC2,1
breast carcinoma,CUDC-101,1,Completed,HDAC3,1
breast carcinoma,CUDC-101,1,Completed,HDAC4,1
breast carcinoma,CUDC-101,1,Completed,HDAC5,1
breast carcinoma,CUDC-101,1,Completed,HDAC6,1
breast carcinoma,DACTOLISIB,2,Withdrawn,PIK3R2,1
breast carcinoma,DACTOLISIB,2,Withdrawn,PIK3R3,1
breast carcinoma,DACTOLISIB,2,Withdrawn,PIK3R5,1
breast carcinoma,DASATINIB,2,"Active, not recruiting",YES1,1
breast carcinoma,DASATINIB,2,"Active, not recruiting",ABL1,1
breast carcinoma,DASATINIB,2,"Active, not recruiting",BLK,1
breast carcinoma,DASATINIB,2,"Active, not recruiting",EPHA2,1
breast carcinoma,DASATINIB,2,"Active, not recruiting",FGR,1
breast carcinoma,DASATINIB,2,"Active, not recruiting",FRK,1
breast carcinoma,DASATINIB,2,"Active, not recruiting",FYN,1
breast carcinoma,DASATINIB,2,"Active, not recruiting",HCK,1
breast carcinoma,DASATINIB,2,"Active, not recruiting",KIT,1
breast carcinoma,DASATINIB,2,"Active, not recruiting",LCK,1
breast carcinoma,DASATINIB,2,"Active, not recruiting",LYN,1
breast carcinoma,DASATINIB,2,"Active, not recruiting",PDGFRB,1
breast carcinoma,DASATINIB,2,"Active, not recruiting",SRC,1
breast carcinoma,DASATINIB,2,"Active, not recruiting",SRMS,1
breast carcinoma,DASATINIB,2,Withdrawn,ABL1,1
breast carcinoma,DALOTUZUMAB,1,Terminated,IGF1R,1
breast carcinoma,DASATINIB,2,Withdrawn,BLK,1
breast carcinoma,DASATINIB,2,Withdrawn,EPHA2,1
breast carcinoma,DASATINIB,2,Withdrawn,FGR,1
breast carcinoma,DASATINIB,2,Withdrawn,FRK,1
breast carcinoma,DASATINIB,2,Withdrawn,FYN,1
breast carcinoma,DASATINIB,2,Withdrawn,HCK,1
breast carcinoma,DASATINIB,2,Withdrawn,KIT,1
breast carcinoma,DASATINIB,2,Withdrawn,LCK,1
breast carcinoma,DASATINIB,2,Withdrawn,LYN,1
breast carcinoma,DASATINIB,2,Withdrawn,PDGFRB,1
breast carcinoma,DASATINIB,2,Withdrawn,SRC,1
breast carcinoma,DASATINIB,2,Withdrawn,SRMS,1
breast carcinoma,DASATINIB,2,Withdrawn,YES1,1
breast carcinoma,DASATINIB,1,Terminated,YES1,1
breast carcinoma,DASATINIB,1,Terminated,SRMS,1
breast carcinoma,DASATINIB,1,Terminated,SRC,1
breast carcinoma,DASATINIB,1,Terminated,PDGFRB,1
breast carcinoma,DALOTUZUMAB,2,Completed,IGF1R,1
breast carcinoma,DALTEPARIN SODIUM,3,Completed,SERPINC1,1
breast carcinoma,DARBEPOETIN ALFA,3,Completed,EPOR,1
breast carcinoma,DASATINIB,1,"Active, not recruiting",ABL1,1
breast carcinoma,DASATINIB,1,"Active, not recruiting",BLK,1
breast carcinoma,DASATINIB,1,"Active, not recruiting",EPHA2,1
breast carcinoma,DASATINIB,1,"Active, not recruiting",FGR,1
breast carcinoma,DASATINIB,1,"Active, not recruiting",FRK,1
breast carcinoma,DASATINIB,1,"Active, not recruiting",FYN,1
breast carcinoma,DASATINIB,1,"Active, not recruiting",HCK,1
breast carcinoma,DASATINIB,1,"Active, not recruiting",KIT,1
breast carcinoma,DASATINIB,1,"Active, not recruiting",LCK,1
breast carcinoma,DASATINIB,1,"Active, not recruiting",LYN,1
breast carcinoma,DASATINIB,1,"Active, not recruiting",PDGFRB,1
breast carcinoma,DASATINIB,1,"Active, not recruiting",SRC,1
breast carcinoma,DASATINIB,1,"Active, not recruiting",SRMS,1
breast carcinoma,DASATINIB,1,"Active, not recruiting",YES1,1
breast carcinoma,DASATINIB,1,Terminated,ABL1,1
breast carcinoma,DASATINIB,1,Terminated,BLK,1
breast carcinoma,DASATINIB,1,Terminated,EPHA2,1
breast carcinoma,DASATINIB,1,Terminated,FGR,1
breast carcinoma,DASATINIB,1,Terminated,FRK,1
breast carcinoma,DASATINIB,1,Terminated,FYN,1
breast carcinoma,DASATINIB,1,Terminated,HCK,1
breast carcinoma,DASATINIB,1,Terminated,KIT,1
breast carcinoma,DASATINIB,1,Terminated,LCK,1
breast carcinoma,DASATINIB,1,Terminated,LYN,1
breast carcinoma,DOXORUBICIN,3,Suspended,TOP2A,1
breast carcinoma,DURVALUMAB,0,Unknown status,CD274,1
breast carcinoma,PAMIDRONIC ACID,4,Completed,FDPS,1
breast carcinoma,ERIBULIN,4,"Active, not recruiting",TUBB,1
breast carcinoma,ERIBULIN,3,"Active, not recruiting",TUBB4A,1
breast carcinoma,ERIBULIN,3,"Active, not recruiting",TUBB4B,1
breast carcinoma,ERIBULIN,3,"Active, not recruiting",TUBB6,1
breast carcinoma,ERIBULIN,3,"Active, not recruiting",TUBB8,1
breast carcinoma,ERIBULIN,3,Not yet recruiting,TUBB,1
breast carcinoma,ERIBULIN,3,Not yet recruiting,TUBB1,1
breast carcinoma,ERIBULIN,3,Not yet recruiting,TUBB2A,1
breast carcinoma,ERIBULIN,3,Not yet recruiting,TUBB2B,1
breast carcinoma,ERIBULIN,3,Not yet recruiting,TUBB3,1
breast carcinoma,ERIBULIN,3,Not yet recruiting,TUBB4A,1
breast carcinoma,ERIBULIN,3,Not yet recruiting,TUBB4B,1
breast carcinoma,ERIBULIN,3,Not yet recruiting,TUBB6,1
breast carcinoma,ERIBULIN,3,Not yet recruiting,TUBB8,1
breast carcinoma,ERIBULIN,4,"Active, not recruiting",TUBB1,1
breast carcinoma,ERIBULIN,3,"Active, not recruiting",TUBB2B,1
breast carcinoma,ERIBULIN,4,"Active, not recruiting",TUBB2A,1
breast carcinoma,ERIBULIN,4,"Active, not recruiting",TUBB2B,1
breast carcinoma,ERIBULIN,4,"Active, not recruiting",TUBB3,1
breast carcinoma,ERIBULIN,4,"Active, not recruiting",TUBB4A,1
breast carcinoma,ERIBULIN,4,"Active, not recruiting",TUBB4B,1
breast carcinoma,ERIBULIN,4,"Active, not recruiting",TUBB6,1
breast carcinoma,ERIBULIN,4,"Active, not recruiting",TUBB8,1
breast carcinoma,ERIBULIN,4,Completed,TUBB,1
breast carcinoma,ERIBULIN,4,Completed,TUBB1,1
breast carcinoma,ERIBULIN,4,Completed,TUBB2A,1
breast carcinoma,ERIBULIN,4,Completed,TUBB2B,1
breast carcinoma,ERIBULIN,4,Completed,TUBB3,1
breast carcinoma,ERIBULIN,4,Completed,TUBB4A,1
breast carcinoma,ERIBULIN,3,"Active, not recruiting",TUBB3,1
breast carcinoma,ERIBULIN,3,"Active, not recruiting",TUBB2A,1
breast carcinoma,ERIBULIN,1,Unknown status,TUBB6,1
breast carcinoma,ERIBULIN,2,Unknown status,TUBB3,1
breast carcinoma,ERIBULIN,1,Withdrawn,TUBB,1
breast carcinoma,ERIBULIN,1,Withdrawn,TUBB1,1
breast carcinoma,ERIBULIN,1,Withdrawn,TUBB2A,1
breast carcinoma,ERIBULIN,1,Withdrawn,TUBB2B,1
breast carcinoma,ERIBULIN,1,Withdrawn,TUBB3,1
breast carcinoma,ERIBULIN,1,Withdrawn,TUBB4A,1
breast carcinoma,ERIBULIN,1,Withdrawn,TUBB4B,1
breast carcinoma,ERIBULIN,1,Withdrawn,TUBB6,1
breast carcinoma,ERIBULIN,1,Withdrawn,TUBB8,1
breast carcinoma,ERIBULIN,2,Unknown status,TUBB,1
breast carcinoma,ERIBULIN,2,Unknown status,TUBB1,1
breast carcinoma,ERIBULIN,2,Unknown status,TUBB2A,1
breast carcinoma,ERIBULIN,2,Unknown status,TUBB2B,1
breast carcinoma,ERIBULIN,2,Unknown status,TUBB4A,1
breast carcinoma,ERIBULIN,3,"Active, not recruiting",TUBB1,1
breast carcinoma,ERIBULIN,2,Unknown status,TUBB4B,1
breast carcinoma,ERIBULIN,2,Unknown status,TUBB6,1
breast carcinoma,ERIBULIN,2,Unknown status,TUBB8,1
breast carcinoma,ERIBULIN,2,Withdrawn,TUBB,1
breast carcinoma,ERIBULIN,2,Withdrawn,TUBB1,1
breast carcinoma,ERIBULIN,2,Withdrawn,TUBB2A,1
breast carcinoma,ERIBULIN,2,Withdrawn,TUBB2B,1
breast carcinoma,ERIBULIN,2,Withdrawn,TUBB3,1
breast carcinoma,ERIBULIN,2,Withdrawn,TUBB4A,1
breast carcinoma,ERIBULIN,2,Withdrawn,TUBB4B,1
breast carcinoma,ERIBULIN,2,Withdrawn,TUBB6,1
breast carcinoma,ERIBULIN,2,Withdrawn,TUBB8,1
breast carcinoma,ERIBULIN,3,"Active, not recruiting",TUBB,1
breast carcinoma,ERIBULIN,4,Completed,TUBB4B,1
breast carcinoma,ERIBULIN,4,Completed,TUBB6,1
breast carcinoma,ERIBULIN,4,Completed,TUBB8,1
breast carcinoma,FILGRASTIM,3,Terminated,CSF3R,1
breast carcinoma,EXEMESTANE,2,Not yet recruiting,CYP19A1,1
breast carcinoma,EXEMESTANE,4,Recruiting,CYP19A1,1
breast carcinoma,EXEMESTANE,4,Withdrawn,CYP19A1,1
breast carcinoma,F16IL2,1,Terminated,TNC,1
breast carcinoma,FENTANYL,2,Recruiting,OPRM1,1
breast carcinoma,FENTANYL,4,Unknown status,OPRM1,1
breast carcinoma,FIGITUMUMAB,1,Withdrawn,IGF1R,1
breast carcinoma,FIGITUMUMAB,2,Withdrawn,IGF1R,1
breast carcinoma,FILGRASTIM,1,"Active, not recruiting",CSF3R,1
breast carcinoma,FILGRASTIM,1,Withdrawn,CSF3R,1
breast carcinoma,FILGRASTIM,2,"Active, not recruiting",CSF3R,1
breast carcinoma,FILGRASTIM,2,Suspended,CSF3R,1
breast carcinoma,FILGRASTIM,3,Recruiting,CSF3R,1
breast carcinoma,FILGRASTIM,4,"Active, not recruiting",CSF3R,1
breast carcinoma,ERIBULIN,4,n/a,TUBB,1
breast carcinoma,FILGRASTIM,4,Completed,CSF3R,1
breast carcinoma,FILGRASTIM,4,Recruiting,CSF3R,1
breast carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLA1,1
breast carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLA2,1
breast carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLD1,1
breast carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLD2,1
breast carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLD3,1
breast carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLD4,1
breast carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLE,1
breast carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLE2,1
breast carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,POLE3,1
breast carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,PRIM1,1
breast carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,PRIM2,1
breast carcinoma,EXEMESTANE,1,Withdrawn,CYP19A1,1
breast carcinoma,EXEMESTANE,1,Unknown status,CYP19A1,1
breast carcinoma,EVEROLIMUS,4,n/a,FKBP1A,1
breast carcinoma,EVEROLIMUS,3,Unknown status,FKBP1A,1
breast carcinoma,ERIBULIN,4,n/a,TUBB1,1
breast carcinoma,ERIBULIN,4,n/a,TUBB2A,1
breast carcinoma,ERIBULIN,4,n/a,TUBB2B,1
breast carcinoma,ERIBULIN,4,n/a,TUBB3,1
breast carcinoma,ERIBULIN,4,n/a,TUBB4A,1
breast carcinoma,ERIBULIN,4,n/a,TUBB4B,1
breast carcinoma,ERIBULIN,4,n/a,TUBB6,1
breast carcinoma,ERIBULIN,4,n/a,TUBB8,1
breast carcinoma,ERLOTINIB,1,"Active, not recruiting",EGFR,1
breast carcinoma,ERLOTINIB,2,Unknown status,EGFR,1
breast carcinoma,ERLOTINIB,2,Withdrawn,EGFR,1
breast carcinoma,ESTRAMUSTINE PHOSPHATE,2,Unknown status,ESR2,1
breast carcinoma,"ESTROGENS, CONJUGATED",3,Terminated,ESR1,1
breast carcinoma,"ESTROGENS, CONJUGATED",3,Terminated,ESR2,1
breast carcinoma,"ESTROGENS, ESTERIFIED",2,Terminated,ESR1,1
breast carcinoma,"ESTROGENS, ESTERIFIED",2,Terminated,ESR2,1
breast carcinoma,ETHINYL ESTRADIOL,3,Terminated,ESR1,1
breast carcinoma,ETIRINOTECAN PEGOL,2,Completed,TOP1,1
breast carcinoma,ETIRINOTECAN PEGOL,3,Completed,TOP1,1
breast carcinoma,ETOPOSIDE,1,Completed,TOP2A,1
breast carcinoma,ETOPOSIDE,1,Completed,TOP2B,1
breast carcinoma,ETOPOSIDE,2,Recruiting,TOP2A,1
breast carcinoma,ETOPOSIDE,2,Recruiting,TOP2B,1
breast carcinoma,ETOPOSIDE,3,Completed,TOP2A,1
breast carcinoma,ETOPOSIDE,3,Completed,TOP2B,1
breast carcinoma,EVEROLIMUS,3,Suspended,FKBP1A,1
breast carcinoma,EVEROLIMUS,3,Terminated,FKBP1A,1
breast carcinoma,ERIBULIN,1,Unknown status,TUBB8,1
breast carcinoma,ERIBULIN,1,Unknown status,TUBB4B,1
breast carcinoma,DURVALUMAB,1,"Active, not recruiting",CD274,1
breast carcinoma,ENTINOSTAT,0,Recruiting,HDAC8,1
breast carcinoma,ENMD-981693,2,Completed,YES1,1
breast carcinoma,ENOBOSARM,2,"Active, not recruiting",AR,1
breast carcinoma,ENOBOSARM,2,Recruiting,AR,1
breast carcinoma,ENOBOSARM,2,Terminated,AR,1
breast carcinoma,ENTINOSTAT,0,Recruiting,HDAC1,1
breast carcinoma,ENTINOSTAT,0,Recruiting,HDAC10,1
breast carcinoma,ENTINOSTAT,0,Recruiting,HDAC11,1
breast carcinoma,ENTINOSTAT,0,Recruiting,HDAC2,1
breast carcinoma,ENTINOSTAT,0,Recruiting,HDAC3,1
breast carcinoma,ENTINOSTAT,0,Recruiting,HDAC4,1
breast carcinoma,ENTINOSTAT,0,Recruiting,HDAC5,1
breast carcinoma,ENTINOSTAT,0,Recruiting,HDAC6,1
breast carcinoma,ENTINOSTAT,0,Recruiting,HDAC7,1
breast carcinoma,ENTINOSTAT,0,Recruiting,HDAC9,1
breast carcinoma,ENMD-981693,2,Completed,SRC,1
breast carcinoma,ENTINOSTAT,1,Withdrawn,HDAC1,1
breast carcinoma,ENTINOSTAT,1,Withdrawn,HDAC10,1
breast carcinoma,ENTINOSTAT,1,Withdrawn,HDAC11,1
breast carcinoma,ENTINOSTAT,1,Withdrawn,HDAC2,1
breast carcinoma,ENTINOSTAT,1,Withdrawn,HDAC3,1
breast carcinoma,ENTINOSTAT,1,Withdrawn,HDAC4,1
breast carcinoma,ENTINOSTAT,1,Withdrawn,HDAC5,1
breast carcinoma,ENTINOSTAT,1,Withdrawn,HDAC6,1
breast carcinoma,ENTINOSTAT,1,Withdrawn,HDAC7,1
breast carcinoma,ENTINOSTAT,1,Withdrawn,HDAC8,1
breast carcinoma,ENTINOSTAT,1,Withdrawn,HDAC9,1
breast carcinoma,ENTINOSTAT,2,"Active, not recruiting",HDAC1,1
breast carcinoma,ENTINOSTAT,2,"Active, not recruiting",HDAC10,1
breast carcinoma,ENMD-981693,2,Completed,SRMS,1
breast carcinoma,ENMD-981693,2,Completed,PDGFRB,1
breast carcinoma,ERIBULIN,1,Unknown status,TUBB4A,1
breast carcinoma,ENMD-2076,2,Completed,KIT,1
breast carcinoma,DURVALUMAB,2,"Active, not recruiting",CD274,1
breast carcinoma,DUSIGITUMAB,2,"Active, not recruiting",IGF1,1
breast carcinoma,DUSIGITUMAB,2,"Active, not recruiting",IGF2,1
breast carcinoma,EFAPROXIRAL,3,Completed,HBA2,1
breast carcinoma,EFAPROXIRAL,3,Completed,HBB,1
breast carcinoma,ENALAPRIL,3,Recruiting,ACE,1
breast carcinoma,ENILURACIL,2,Unknown status,DPYD,1
breast carcinoma,ENMD-2076,2,Completed,AURKA,1
breast carcinoma,ENMD-2076,2,Completed,AURKB,1
breast carcinoma,ENMD-2076,2,Completed,CSF1R,1
breast carcinoma,ENMD-2076,2,Completed,FGFR3,1
breast carcinoma,ENMD-2076,2,Completed,FLT3,1
breast carcinoma,ENMD-2076,2,Completed,KDR,1
breast carcinoma,ENMD-981693,2,Completed,AURKA,1
breast carcinoma,ENMD-981693,2,Completed,PDGFRA,1
breast carcinoma,ENMD-981693,2,Completed,BLK,1
breast carcinoma,ENMD-981693,2,Completed,FGFR1,1
breast carcinoma,ENMD-981693,2,Completed,FGFR2,1
breast carcinoma,ENMD-981693,2,Completed,FGFR3,1
breast carcinoma,ENMD-981693,2,Completed,FGFR4,1
breast carcinoma,ENMD-981693,2,Completed,FGR,1
breast carcinoma,ENMD-981693,2,Completed,FLT3,1
breast carcinoma,ENMD-981693,2,Completed,FRK,1
breast carcinoma,ENMD-981693,2,Completed,FYN,1
breast carcinoma,ENMD-981693,2,Completed,HCK,1
breast carcinoma,ENMD-981693,2,Completed,KDR,1
breast carcinoma,ENMD-981693,2,Completed,LCK,1
breast carcinoma,ENMD-981693,2,Completed,LYN,1
breast carcinoma,ENTINOSTAT,2,"Active, not recruiting",HDAC11,1
breast carcinoma,ENTINOSTAT,2,"Active, not recruiting",HDAC2,1
breast carcinoma,ENTINOSTAT,2,"Active, not recruiting",HDAC3,1
breast carcinoma,ERGOCALCIFEROL,3,Unknown status,VDR,1
breast carcinoma,EPINEPHRINE,2,Unknown status,ADRA1A,1
breast carcinoma,EPINEPHRINE,2,Unknown status,ADRA1B,1
breast carcinoma,EPINEPHRINE,2,Unknown status,ADRA1D,1
breast carcinoma,EPINEPHRINE,2,Unknown status,ADRA2A,1
breast carcinoma,EPINEPHRINE,2,Unknown status,ADRA2B,1
breast carcinoma,EPINEPHRINE,2,Unknown status,ADRA2C,1
breast carcinoma,EPINEPHRINE,2,Unknown status,ADRB1,1
breast carcinoma,EPINEPHRINE,2,Unknown status,ADRB2,1
breast carcinoma,EPINEPHRINE,2,Unknown status,ADRB3,1
breast carcinoma,EPLERENONE,2,Terminated,NR3C2,1
breast carcinoma,ERGOCALCIFEROL,1,Recruiting,VDR,1
breast carcinoma,ERGOCALCIFEROL,2,Terminated,VDR,1
breast carcinoma,ERGOCALCIFEROL,3,Completed,VDR,1
breast carcinoma,ERIBULIN,1,Terminated,TUBB,1
breast carcinoma,ENTINOSTAT,2,"Active, not recruiting",HDAC4,1
breast carcinoma,ERIBULIN,1,Terminated,TUBB1,1
breast carcinoma,ERIBULIN,1,Terminated,TUBB2A,1
breast carcinoma,ERIBULIN,1,Terminated,TUBB2B,1
breast carcinoma,ERIBULIN,1,Terminated,TUBB3,1
breast carcinoma,ERIBULIN,1,Terminated,TUBB4A,1
breast carcinoma,ERIBULIN,1,Terminated,TUBB4B,1
breast carcinoma,ERIBULIN,1,Terminated,TUBB6,1
breast carcinoma,ERIBULIN,1,Terminated,TUBB8,1
breast carcinoma,ERIBULIN,1,Unknown status,TUBB,1
breast carcinoma,ERIBULIN,1,Unknown status,TUBB1,1
breast carcinoma,ERIBULIN,1,Unknown status,TUBB2A,1
breast carcinoma,ERIBULIN,1,Unknown status,TUBB2B,1
breast carcinoma,ERIBULIN,1,Unknown status,TUBB3,1
breast carcinoma,ENZASTAURIN,2,Terminated,PRKCB,1
breast carcinoma,ENZALUTAMIDE,3,Withdrawn,AR,1
breast carcinoma,ENZALUTAMIDE,1,Completed,AR,1
breast carcinoma,ENZALUTAMIDE,1,"Active, not recruiting",AR,1
breast carcinoma,ENTINOSTAT,2,"Active, not recruiting",HDAC5,1
breast carcinoma,ENTINOSTAT,2,"Active, not recruiting",HDAC6,1
breast carcinoma,ENTINOSTAT,2,"Active, not recruiting",HDAC7,1
breast carcinoma,ENTINOSTAT,2,"Active, not recruiting",HDAC8,1
breast carcinoma,ENTINOSTAT,2,"Active, not recruiting",HDAC9,1
breast carcinoma,ENTINOSTAT,2,Withdrawn,HDAC1,1
breast carcinoma,ENTINOSTAT,2,Withdrawn,HDAC10,1
breast carcinoma,ENTINOSTAT,2,Withdrawn,HDAC11,1
breast carcinoma,ENTINOSTAT,2,Withdrawn,HDAC2,1
breast carcinoma,ENTINOSTAT,2,Withdrawn,HDAC3,1
breast carcinoma,ENTINOSTAT,2,Withdrawn,HDAC4,1
breast carcinoma,ENTINOSTAT,2,Withdrawn,HDAC5,1
breast carcinoma,ENTINOSTAT,2,Withdrawn,HDAC6,1
breast carcinoma,ENTINOSTAT,2,Withdrawn,HDAC7,1
breast carcinoma,ENTINOSTAT,2,Withdrawn,HDAC8,1
breast carcinoma,ENTINOSTAT,2,Withdrawn,HDAC9,1
breast carcinoma,ENTINOSTAT,3,Recruiting,HDAC1,1
breast carcinoma,ENTINOSTAT,3,Recruiting,HDAC10,1
breast carcinoma,ENTINOSTAT,3,Recruiting,HDAC11,1
breast carcinoma,ENTINOSTAT,3,Recruiting,HDAC2,1
breast carcinoma,ENTINOSTAT,3,Recruiting,HDAC3,1
breast carcinoma,ENTINOSTAT,3,Recruiting,HDAC4,1
breast carcinoma,ENTINOSTAT,3,Recruiting,HDAC5,1
breast carcinoma,ENTINOSTAT,3,Recruiting,HDAC6,1
breast carcinoma,ENTINOSTAT,3,Recruiting,HDAC7,1
breast carcinoma,ENTINOSTAT,3,Recruiting,HDAC8,1
breast carcinoma,ENTINOSTAT,3,Recruiting,HDAC9,1
breast carcinoma,COBIMETINIB,2,"Active, not recruiting",MAP2K1,1
breast carcinoma,CIXUTUMUMAB,2,Completed,IGF1R,1
breast carcinoma,CIXUTUMUMAB,2,"Active, not recruiting",IGF1R,1
breast adenocarcinoma,PACLITAXEL,3,Recruiting,TUBB2A,1
breast adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB6,1
breast adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB8,1
breast adenocarcinoma,PACLITAXEL,3,Not yet recruiting,TUBB,1
breast adenocarcinoma,PACLITAXEL,3,Not yet recruiting,TUBB1,1
breast adenocarcinoma,PACLITAXEL,3,Not yet recruiting,TUBB2A,1
breast adenocarcinoma,PACLITAXEL,3,Not yet recruiting,TUBB2B,1
breast adenocarcinoma,PACLITAXEL,3,Not yet recruiting,TUBB3,1
breast adenocarcinoma,PACLITAXEL,3,Not yet recruiting,TUBB4A,1
breast adenocarcinoma,PACLITAXEL,3,Not yet recruiting,TUBB4B,1
breast adenocarcinoma,PACLITAXEL,3,Not yet recruiting,TUBB6,1
breast adenocarcinoma,PACLITAXEL,3,Not yet recruiting,TUBB8,1
breast adenocarcinoma,PACLITAXEL,3,Recruiting,TUBB,1
breast adenocarcinoma,PACLITAXEL,3,Recruiting,TUBB1,1
breast adenocarcinoma,PACLITAXEL,3,Recruiting,TUBB2B,1
breast adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB4A,1
breast adenocarcinoma,PACLITAXEL,3,Recruiting,TUBB3,1
breast adenocarcinoma,PACLITAXEL,3,Recruiting,TUBB4A,1
breast adenocarcinoma,PACLITAXEL,3,Recruiting,TUBB4B,1
breast adenocarcinoma,PACLITAXEL,3,Recruiting,TUBB6,1
breast adenocarcinoma,PACLITAXEL,3,Recruiting,TUBB8,1
breast adenocarcinoma,PACLITAXEL,3,Suspended,TUBB,1
breast adenocarcinoma,PACLITAXEL,3,Suspended,TUBB1,1
breast adenocarcinoma,PACLITAXEL,3,Suspended,TUBB2A,1
breast adenocarcinoma,PACLITAXEL,3,Suspended,TUBB2B,1
breast adenocarcinoma,PACLITAXEL,3,Suspended,TUBB3,1
breast adenocarcinoma,PACLITAXEL,3,Suspended,TUBB4A,1
breast adenocarcinoma,PACLITAXEL,3,Suspended,TUBB4B,1
breast adenocarcinoma,PACLITAXEL,3,Suspended,TUBB6,1
breast adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB4B,1
breast adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB3,1
breast adenocarcinoma,ENTINOSTAT,3,"Active, not recruiting",HDAC5,1
breast adenocarcinoma,ERIBULIN,3,Suspended,TUBB1,1
breast adenocarcinoma,ENTINOSTAT,3,"Active, not recruiting",HDAC7,1
breast adenocarcinoma,ENTINOSTAT,3,"Active, not recruiting",HDAC8,1
breast adenocarcinoma,ENTINOSTAT,3,"Active, not recruiting",HDAC9,1
breast adenocarcinoma,ERIBULIN,1,Recruiting,TUBB,1
breast adenocarcinoma,ERIBULIN,1,Recruiting,TUBB1,1
breast adenocarcinoma,ERIBULIN,1,Recruiting,TUBB2A,1
breast adenocarcinoma,ERIBULIN,1,Recruiting,TUBB2B,1
breast adenocarcinoma,ERIBULIN,1,Recruiting,TUBB3,1
breast adenocarcinoma,ERIBULIN,1,Recruiting,TUBB4A,1
breast adenocarcinoma,ERIBULIN,1,Recruiting,TUBB4B,1
breast adenocarcinoma,ERIBULIN,1,Recruiting,TUBB6,1
breast adenocarcinoma,ERIBULIN,1,Recruiting,TUBB8,1
breast adenocarcinoma,ERIBULIN,3,Suspended,TUBB,1
breast adenocarcinoma,ERIBULIN,3,Suspended,TUBB2A,1
breast adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB2B,1
breast adenocarcinoma,ERIBULIN,3,Suspended,TUBB2B,1
breast adenocarcinoma,ERIBULIN,3,Suspended,TUBB3,1
breast adenocarcinoma,ERIBULIN,3,Suspended,TUBB4A,1
breast adenocarcinoma,ERIBULIN,3,Suspended,TUBB4B,1
breast adenocarcinoma,ERIBULIN,3,Suspended,TUBB6,1
breast adenocarcinoma,ERIBULIN,3,Suspended,TUBB8,1
breast adenocarcinoma,GOSERELIN,3,"Active, not recruiting",GNRHR,1
breast adenocarcinoma,IPILIMUMAB,1,Recruiting,CTLA4,1
breast adenocarcinoma,LETROZOLE,3,"Active, not recruiting",CYP19A1,1
breast adenocarcinoma,NIVOLUMAB,1,Recruiting,PDCD1,1
breast adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
breast adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB1,1
breast adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB2A,1
breast adenocarcinoma,PACLITAXEL,3,Suspended,TUBB8,1
breast adenocarcinoma,PEMBROLIZUMAB,1,Recruiting,PDCD1,1
breast adenocarcinoma,PEMBROLIZUMAB,2,Recruiting,PDCD1,1
breast carcinoma,ALITRETINOIN,1,Completed,RARB,1
breast carcinoma,ALDESLEUKIN,2,Completed,IL2RA,1
breast carcinoma,ALDESLEUKIN,2,Completed,IL2RB,1
breast carcinoma,ALDESLEUKIN,3,Completed,IL2RA,1
breast carcinoma,ALDESLEUKIN,3,Completed,IL2RB,1
breast carcinoma,ALDOXORUBICIN,1,Recruiting,TOP2A,1
breast carcinoma,ALDOXORUBICIN,2,Not yet recruiting,TOP2A,1
breast carcinoma,ALENDRONIC ACID,3,Completed,FDPS,1
breast carcinoma,ALISERTIB,1,Completed,AURKA,1
breast carcinoma,ALISERTIB,1,Recruiting,AURKA,1
breast carcinoma,ALISERTIB,2,"Active, not recruiting",AURKA,1
breast carcinoma,ALISERTIB,2,Completed,AURKA,1
breast carcinoma,ALISERTIB,2,Recruiting,AURKA,1
breast carcinoma,ALITRETINOIN,1,Completed,RARA,1
breast carcinoma,ALITRETINOIN,1,Completed,RARG,1
breast adenocarcinoma,PERTUZUMAB,3,Not yet recruiting,ERBB2,1
breast carcinoma,ALITRETINOIN,1,Completed,RXRA,1
breast carcinoma,ALITRETINOIN,1,Completed,RXRB,1
breast carcinoma,ALITRETINOIN,1,Completed,RXRG,1
breast carcinoma,ALPELISIB,1,Recruiting,PIK3CA,1
breast carcinoma,ALPELISIB,2,Completed,PIK3CA,1
breast carcinoma,ALPELISIB,2,Unknown status,PIK3CA,1
breast carcinoma,ALPELISIB,3,"Active, not recruiting",PIK3CA,1
breast carcinoma,AMG-888,1,Terminated,ERBB3,1
breast carcinoma,AMINOGLUTETHIMIDE,3,Completed,CYP11A1,1
breast carcinoma,AMINOGLUTETHIMIDE,3,Completed,CYP19A1,1
breast carcinoma,AMLODIPINE,1,Recruiting,CACNA1C,1
breast carcinoma,AMLODIPINE,1,Recruiting,CACNA1D,1
breast carcinoma,AMLODIPINE,1,Recruiting,CACNA1F,1
breast carcinoma,ALDESLEUKIN,1,Withdrawn,IL2RB,1
breast carcinoma,ALDESLEUKIN,1,Withdrawn,IL2RA,1
breast carcinoma,ALDESLEUKIN,1,Suspended,IL2RB,1
breast carcinoma,ALDESLEUKIN,1,Suspended,IL2RA,1
breast adenocarcinoma,REBASTINIB,1,Recruiting,ABL1,1
breast adenocarcinoma,TRASTUZUMAB,3,"Active, not recruiting",ERBB2,1
breast adenocarcinoma,TRASTUZUMAB,3,Not yet recruiting,ERBB2,1
breast adenocarcinoma,TRICIRIBINE PHOSPHATE,1,Recruiting,AKT1,1
breast adenocarcinoma,TRICIRIBINE PHOSPHATE,1,Recruiting,AKT2,1
breast adenocarcinoma,TRICIRIBINE PHOSPHATE,1,Recruiting,AKT3,1
breast carcinoma,ABEMACICLIB,1,Not yet recruiting,CDK4,1
breast carcinoma,ABEMACICLIB,1,Not yet recruiting,CDK6,1
breast carcinoma,ABEMACICLIB,4,n/a,CDK4,1
breast carcinoma,ABEMACICLIB,4,n/a,CDK6,1
breast carcinoma,ABIRATERONE ACETATE,1,Completed,CYP17A1,1
breast carcinoma,ABIRATERONE ACETATE,2,"Active, not recruiting",CYP17A1,1
breast carcinoma,ABIRATERONE ACETATE,2,Completed,CYP17A1,1
breast carcinoma,ABIRATERONE ACETATE,2,Withdrawn,CYP17A1,1
breast carcinoma,ACOLBIFENE,2,Completed,ESR1,1
breast carcinoma,ACOLBIFENE,2,Completed,ESR2,1
breast carcinoma,AFATINIB,2,Completed,EGFR,1
breast carcinoma,AFATINIB,2,Completed,ERBB2,1
breast carcinoma,AFATINIB,2,Completed,ERBB4,1
breast carcinoma,AFATINIB,2,Unknown status,EGFR,1
breast carcinoma,AFATINIB,2,Unknown status,ERBB2,1
breast carcinoma,AFATINIB,2,Unknown status,ERBB4,1
breast carcinoma,AFIMOXIFENE,2,Completed,ESR1,1
breast carcinoma,AFIMOXIFENE,2,Completed,ESR2,1
breast carcinoma,AFIMOXIFENE,2,Completed,ESRRG,1
breast carcinoma,AFLIBERCEPT,2,Completed,PGF,1
breast carcinoma,AFLIBERCEPT,2,Completed,VEGFA,1
breast adenocarcinoma,ENTINOSTAT,3,"Active, not recruiting",HDAC6,1
breast adenocarcinoma,ENTINOSTAT,3,"Active, not recruiting",HDAC4,1
breast carcinoma,CI-1040,2,Completed,MAP2K2,1
Hereditary breast and ovarian cancer syndrome,OLAPARIB,1,Not yet recruiting,PARP2,1
Hereditary breast and ovarian cancer syndrome,GEMCITABINE,1,Completed,POLD2,1
Hereditary breast and ovarian cancer syndrome,GEMCITABINE,1,Completed,POLD3,1
Hereditary breast and ovarian cancer syndrome,GEMCITABINE,1,Completed,POLD4,1
Hereditary breast and ovarian cancer syndrome,GEMCITABINE,1,Completed,POLE,1
Hereditary breast and ovarian cancer syndrome,GEMCITABINE,1,Completed,POLE2,1
Hereditary breast and ovarian cancer syndrome,GEMCITABINE,1,Completed,POLE3,1
Hereditary breast and ovarian cancer syndrome,GEMCITABINE,1,Completed,PRIM1,1
Hereditary breast and ovarian cancer syndrome,GEMCITABINE,1,Completed,PRIM2,1
Hereditary breast and ovarian cancer syndrome,GEMCITABINE,1,Completed,RRM1,1
Hereditary breast and ovarian cancer syndrome,LETROZOLE,3,"Active, not recruiting",CYP19A1,1
Hereditary breast and ovarian cancer syndrome,NIRAPARIB,1,Recruiting,PARP3,1
Hereditary breast and ovarian cancer syndrome,NIRAPARIB,3,"Active, not recruiting",PARP3,1
Hereditary breast and ovarian cancer syndrome,OLAPARIB,1,Not yet recruiting,PARP1,1
Hereditary breast and ovarian cancer syndrome,OLAPARIB,1,Not yet recruiting,PARP3,1
Hereditary breast and ovarian cancer syndrome,GEMCITABINE,1,Completed,POLA2,1
Hereditary breast and ovarian cancer syndrome,OLAPARIB,2,Recruiting,PARP1,1
Hereditary breast and ovarian cancer syndrome,OLAPARIB,2,Recruiting,PARP2,1
Hereditary breast and ovarian cancer syndrome,OLAPARIB,2,Recruiting,PARP3,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Completed,TUBB,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Completed,TUBB1,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Completed,TUBB2A,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Completed,TUBB2B,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Completed,TUBB3,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Completed,TUBB4A,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Completed,TUBB4B,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Completed,TUBB6,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Completed,TUBB8,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Recruiting,TUBB,1
Hereditary breast and ovarian cancer syndrome,GEMCITABINE,1,Completed,POLD1,1
Hereditary breast and ovarian cancer syndrome,GEMCITABINE,1,Completed,POLA1,1
breast adenocarcinoma,ENTINOSTAT,3,"Active, not recruiting",HDAC3,1
Hereditary breast and ovarian cancer syndrome,DOCETAXEL,2,Completed,TUBB4B,1
Hereditary breast and ovarian cancer syndrome,ATEZOLIZUMAB,2,Recruiting,CD274,1
Hereditary breast and ovarian cancer syndrome,CHOLECALCIFEROL,2,"Active, not recruiting",VDR,1
Hereditary breast and ovarian cancer syndrome,CHORIOGONADOTROPIN ALFA,4,Recruiting,LHCGR,1
Hereditary breast and ovarian cancer syndrome,DINACICLIB,1,Recruiting,CDK1,1
Hereditary breast and ovarian cancer syndrome,DINACICLIB,1,Recruiting,CDK2,1
Hereditary breast and ovarian cancer syndrome,DINACICLIB,1,Recruiting,CDK5,1
Hereditary breast and ovarian cancer syndrome,DINACICLIB,1,Recruiting,CDK9,1
Hereditary breast and ovarian cancer syndrome,DOCETAXEL,2,Completed,TUBB,1
Hereditary breast and ovarian cancer syndrome,DOCETAXEL,2,Completed,TUBB1,1
Hereditary breast and ovarian cancer syndrome,DOCETAXEL,2,Completed,TUBB2A,1
Hereditary breast and ovarian cancer syndrome,DOCETAXEL,2,Completed,TUBB2B,1
Hereditary breast and ovarian cancer syndrome,DOCETAXEL,2,Completed,TUBB3,1
Hereditary breast and ovarian cancer syndrome,DOCETAXEL,2,Completed,TUBB4A,1
Hereditary breast and ovarian cancer syndrome,DOCETAXEL,2,Completed,TUBB6,1
Hereditary breast and ovarian cancer syndrome,FULVESTRANT,1,Not yet recruiting,ESR2,1
Hereditary breast and ovarian cancer syndrome,DOCETAXEL,2,Completed,TUBB8,1
Hereditary breast and ovarian cancer syndrome,DOXORUBICIN,2,Recruiting,TOP2A,1
Hereditary breast and ovarian cancer syndrome,ERIBULIN,2,Withdrawn,TUBB,1
Hereditary breast and ovarian cancer syndrome,ERIBULIN,2,Withdrawn,TUBB1,1
Hereditary breast and ovarian cancer syndrome,ERIBULIN,2,Withdrawn,TUBB2A,1
Hereditary breast and ovarian cancer syndrome,ERIBULIN,2,Withdrawn,TUBB2B,1
Hereditary breast and ovarian cancer syndrome,ERIBULIN,2,Withdrawn,TUBB3,1
Hereditary breast and ovarian cancer syndrome,ERIBULIN,2,Withdrawn,TUBB4A,1
Hereditary breast and ovarian cancer syndrome,ERIBULIN,2,Withdrawn,TUBB4B,1
Hereditary breast and ovarian cancer syndrome,ERIBULIN,2,Withdrawn,TUBB6,1
Hereditary breast and ovarian cancer syndrome,ERIBULIN,2,Withdrawn,TUBB8,1
Hereditary breast and ovarian cancer syndrome,ESTRADIOL,2,"Active, not recruiting",ESR1,1
Hereditary breast and ovarian cancer syndrome,FULVESTRANT,1,Not yet recruiting,ESR1,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Recruiting,TUBB1,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Recruiting,TUBB2A,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Recruiting,TUBB2B,1
breast adenocarcinoma,ENTINOSTAT,1,Recruiting,HDAC1,1
Hereditary breast and ovarian cancer syndrome,VELIPARIB,2,Withdrawn,PARP3,1
breast adenocarcinoma,ANASTROZOLE,3,"Active, not recruiting",CYP19A1,1
breast adenocarcinoma,ATEZOLIZUMAB,3,Not yet recruiting,CD274,1
breast adenocarcinoma,BINIMETINIB,1,Recruiting,MAP2K1,1
breast adenocarcinoma,BINIMETINIB,1,Recruiting,MAP2K2,1
breast adenocarcinoma,CR 1447,2,"Active, not recruiting",AR,1
breast adenocarcinoma,CR 1447,2,"Active, not recruiting",ESR2,1
breast adenocarcinoma,DECITABINE,2,Recruiting,DNMT1,1
breast adenocarcinoma,DECITABINE,2,Recruiting,DNMT3A,1
breast adenocarcinoma,DOXORUBICIN,1,Recruiting,TOP2A,1
breast adenocarcinoma,DOXORUBICIN,2,Recruiting,TOP2A,1
breast adenocarcinoma,DOXORUBICIN,3,"Active, not recruiting",TOP2A,1
breast adenocarcinoma,DOXORUBICIN,3,Recruiting,TOP2A,1
breast adenocarcinoma,ENTINOSTAT,1,Recruiting,HDAC10,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Recruiting,TUBB3,1
breast adenocarcinoma,ENTINOSTAT,1,Recruiting,HDAC11,1
breast adenocarcinoma,ENTINOSTAT,1,Recruiting,HDAC2,1
breast adenocarcinoma,ENTINOSTAT,1,Recruiting,HDAC3,1
breast adenocarcinoma,ENTINOSTAT,1,Recruiting,HDAC4,1
breast adenocarcinoma,ENTINOSTAT,1,Recruiting,HDAC5,1
breast adenocarcinoma,ENTINOSTAT,1,Recruiting,HDAC6,1
breast adenocarcinoma,ENTINOSTAT,1,Recruiting,HDAC7,1
breast adenocarcinoma,ENTINOSTAT,1,Recruiting,HDAC8,1
breast adenocarcinoma,ENTINOSTAT,1,Recruiting,HDAC9,1
breast adenocarcinoma,ENTINOSTAT,3,"Active, not recruiting",HDAC1,1
breast adenocarcinoma,ENTINOSTAT,3,"Active, not recruiting",HDAC10,1
breast adenocarcinoma,ENTINOSTAT,3,"Active, not recruiting",HDAC11,1
breast adenocarcinoma,ENTINOSTAT,3,"Active, not recruiting",HDAC2,1
Hereditary breast and ovarian cancer syndrome,VELIPARIB,2,Withdrawn,PARP2,1
Hereditary breast and ovarian cancer syndrome,VELIPARIB,2,Withdrawn,PARP1,1
Hereditary breast and ovarian cancer syndrome,VELIPARIB,2,Recruiting,PARP3,1
Hereditary breast and ovarian cancer syndrome,VELIPARIB,2,Recruiting,PARP2,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Recruiting,TUBB4A,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Recruiting,TUBB4B,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Recruiting,TUBB6,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Recruiting,TUBB8,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,2,Recruiting,TUBB,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,2,Recruiting,TUBB1,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,2,Recruiting,TUBB2A,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,2,Recruiting,TUBB2B,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,2,Recruiting,TUBB3,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,2,Recruiting,TUBB4A,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,2,Recruiting,TUBB4B,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,2,Recruiting,TUBB6,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,2,Recruiting,TUBB8,1
Hereditary breast and ovarian cancer syndrome,PALBOCICLIB,1,Not yet recruiting,CDK4,1
Hereditary breast and ovarian cancer syndrome,PALBOCICLIB,1,Not yet recruiting,CDK6,1
Hereditary breast and ovarian cancer syndrome,PEMBROLIZUMAB,2,Recruiting,PDCD1,1
Hereditary breast and ovarian cancer syndrome,RUCAPARIB,2,Completed,PARP1,1
Hereditary breast and ovarian cancer syndrome,RUCAPARIB,2,Completed,PARP2,1
Hereditary breast and ovarian cancer syndrome,RUCAPARIB,2,Completed,PARP3,1
Hereditary breast and ovarian cancer syndrome,TALAZOPARIB,1,Recruiting,PARP1,1
Hereditary breast and ovarian cancer syndrome,TALAZOPARIB,1,Recruiting,PARP2,1
Hereditary breast and ovarian cancer syndrome,TAMOXIFEN,2,Completed,ESR1,1
Hereditary breast and ovarian cancer syndrome,TESTOSTERONE,2,"Active, not recruiting",AR,1
Hereditary breast and ovarian cancer syndrome,VELIPARIB,1,Recruiting,PARP1,1
Hereditary breast and ovarian cancer syndrome,VELIPARIB,1,Recruiting,PARP2,1
Hereditary breast and ovarian cancer syndrome,VELIPARIB,1,Recruiting,PARP3,1
Hereditary breast and ovarian cancer syndrome,VELIPARIB,2,Recruiting,PARP1,1
breast carcinoma,AMLODIPINE,1,Recruiting,CACNA1S,1
breast carcinoma,AMRUBICIN,1,Completed,TOP2A,1
breast carcinoma,AMRUBICIN,2,Withdrawn,TOP2A,1
breast carcinoma,CABAZITAXEL,2,Completed,TUBB1,1
breast carcinoma,BUPARLISIB,3,Terminated,PIK3CB,1
breast carcinoma,BUPARLISIB,3,Terminated,PIK3CD,1
breast carcinoma,BUPARLISIB,3,Terminated,PIK3CG,1
breast carcinoma,BUPARLISIB,3,Terminated,PIK3R1,1
breast carcinoma,BUPARLISIB,3,Terminated,PIK3R2,1
breast carcinoma,BUPARLISIB,3,Terminated,PIK3R3,1
breast carcinoma,BUPARLISIB,3,Terminated,PIK3R5,1
breast carcinoma,BUPIVACAINE,2,Recruiting,SCN4A,1
breast carcinoma,BUPIVACAINE,2,Unknown status,SCN4A,1
breast carcinoma,BUPIVACAINE,3,Completed,SCN4A,1
breast carcinoma,BUPIVACAINE,3,Recruiting,SCN4A,1
breast carcinoma,BUPIVACAINE,4,Recruiting,SCN4A,1
breast carcinoma,CABAZITAXEL,2,Completed,TUBB,1
breast carcinoma,CABAZITAXEL,2,Completed,TUBB2A,1
breast carcinoma,BUPARLISIB,3,"Active, not recruiting",PIK3R5,1
breast carcinoma,CABAZITAXEL,2,Completed,TUBB2B,1
breast carcinoma,CABAZITAXEL,2,Completed,TUBB3,1
breast carcinoma,CABAZITAXEL,2,Completed,TUBB4A,1
breast carcinoma,CABAZITAXEL,2,Completed,TUBB4B,1
breast carcinoma,CABAZITAXEL,2,Completed,TUBB6,1
breast carcinoma,CABAZITAXEL,2,Completed,TUBB8,1
breast carcinoma,CABAZITAXEL,2,Recruiting,TUBB,1
breast carcinoma,CABAZITAXEL,2,Recruiting,TUBB1,1
breast carcinoma,CABAZITAXEL,2,Recruiting,TUBB2A,1
breast carcinoma,CABAZITAXEL,2,Recruiting,TUBB2B,1
breast carcinoma,CABAZITAXEL,2,Recruiting,TUBB3,1
breast carcinoma,CABAZITAXEL,2,Recruiting,TUBB4A,1
breast carcinoma,CABAZITAXEL,2,Recruiting,TUBB4B,1
breast carcinoma,BUPARLISIB,3,Terminated,PIK3CA,1
breast carcinoma,BUPARLISIB,3,"Active, not recruiting",PIK3R3,1
breast carcinoma,ANAKINRA,1,Unknown status,IL1R1,1
breast carcinoma,BUPARLISIB,0,Completed,PIK3R3,1
breast carcinoma,BOSUTINIB,1,Not yet recruiting,ABL1,1
breast carcinoma,BOSUTINIB,1,Not yet recruiting,HCK,1
breast carcinoma,BOSUTINIB,1,Not yet recruiting,LYN,1
breast carcinoma,BOSUTINIB,1,Not yet recruiting,SRC,1
breast carcinoma,BRE-3 90Y,1,Completed,MFGE8,1
breast carcinoma,BRILANESTRANT,1,Completed,ESR1,1
breast carcinoma,BUDESONIDE,2,Recruiting,NR3C1,1
breast carcinoma,BUPARLISIB,0,Completed,PIK3CA,1
breast carcinoma,BUPARLISIB,0,Completed,PIK3CB,1
breast carcinoma,BUPARLISIB,0,Completed,PIK3CD,1
breast carcinoma,BUPARLISIB,0,Completed,PIK3CG,1
breast carcinoma,BUPARLISIB,0,Completed,PIK3R1,1
breast carcinoma,BUPARLISIB,0,Completed,PIK3R2,1
breast carcinoma,BUPARLISIB,0,Completed,PIK3R5,1
breast carcinoma,BUPARLISIB,3,"Active, not recruiting",PIK3R2,1
breast carcinoma,BUPARLISIB,1,Terminated,PIK3CA,1
breast carcinoma,BUPARLISIB,1,Terminated,PIK3CB,1
breast carcinoma,BUPARLISIB,1,Terminated,PIK3CD,1
breast carcinoma,BUPARLISIB,1,Terminated,PIK3CG,1
breast carcinoma,BUPARLISIB,1,Terminated,PIK3R1,1
breast carcinoma,BUPARLISIB,1,Terminated,PIK3R2,1
breast carcinoma,BUPARLISIB,1,Terminated,PIK3R3,1
breast carcinoma,BUPARLISIB,1,Terminated,PIK3R5,1
breast carcinoma,BUPARLISIB,3,"Active, not recruiting",PIK3CA,1
breast carcinoma,BUPARLISIB,3,"Active, not recruiting",PIK3CB,1
breast carcinoma,BUPARLISIB,3,"Active, not recruiting",PIK3CD,1
breast carcinoma,BUPARLISIB,3,"Active, not recruiting",PIK3CG,1
breast carcinoma,BUPARLISIB,3,"Active, not recruiting",PIK3R1,1
breast carcinoma,CABAZITAXEL,2,Recruiting,TUBB6,1
breast carcinoma,CABAZITAXEL,2,Recruiting,TUBB8,1
breast carcinoma,CABAZITAXEL,2,Terminated,TUBB,1
breast carcinoma,CELECOXIB,0,Recruiting,PTGS2,1
breast carcinoma,CARMUSTINE,2,Recruiting,GSR,1
breast carcinoma,CARMUSTINE,3,Completed,GSR,1
breast carcinoma,CARMUSTINE,3,Terminated,GSR,1
breast carcinoma,CAROTUXIMAB,1,Completed,ENG,1
breast carcinoma,CAROTUXIMAB,1,Recruiting,ENG,1
breast carcinoma,CC-223,1,Completed,MTOR,1
breast carcinoma,CEDIRANIB,2,Completed,FLT1,1
breast carcinoma,CEDIRANIB,2,Completed,FLT4,1
breast carcinoma,CEDIRANIB,2,Completed,KDR,1
breast carcinoma,CEDIRANIB,2,Completed,KIT,1
breast carcinoma,CEDIRANIB,2,Completed,PDGFRA,1
breast carcinoma,CEDIRANIB,2,Completed,PDGFRB,1
breast carcinoma,CELECOXIB,0,"Active, not recruiting",PTGS2,1
breast carcinoma,CELECOXIB,1,Terminated,PTGS2,1
breast carcinoma,CABAZITAXEL,2,Terminated,TUBB1,1
breast carcinoma,CELECOXIB,2,Recruiting,PTGS2,1
breast carcinoma,CELECOXIB,2,Withdrawn,PTGS2,1
breast carcinoma,CELECOXIB,3,"Active, not recruiting",PTGS2,1
breast carcinoma,CELECOXIB,3,Completed,PTGS2,1
breast carcinoma,CETUXIMAB,1,Unknown status,EGFR,1
breast carcinoma,CETUXIMAB,2,"Active, not recruiting",EGFR,1
breast carcinoma,CHOLECALCIFEROL,2,"Active, not recruiting",VDR,1
breast carcinoma,CHOLECALCIFEROL,2,Recruiting,VDR,1
breast carcinoma,CHOLECALCIFEROL,2,Terminated,VDR,1
breast carcinoma,CHOLECALCIFEROL,3,"Active, not recruiting",VDR,1
breast carcinoma,CHOLECALCIFEROL,3,Completed,VDR,1
breast carcinoma,CHOLECALCIFEROL,3,Recruiting,VDR,1
breast carcinoma,CI-1040,2,Completed,MAP2K1,1
breast carcinoma,CARMUSTINE,1,Withdrawn,GSR,1
breast carcinoma,CAPSAICIN,3,Not yet recruiting,TRPV1,1
breast carcinoma,CAPMATINIB,1,Recruiting,MET,1
breast carcinoma,CAPECITABINE,4,Terminated,TYMS,1
breast carcinoma,CABAZITAXEL,2,Terminated,TUBB2A,1
breast carcinoma,CABAZITAXEL,2,Terminated,TUBB2B,1
breast carcinoma,CABAZITAXEL,2,Terminated,TUBB3,1
breast carcinoma,CABAZITAXEL,2,Terminated,TUBB4A,1
breast carcinoma,CABAZITAXEL,2,Terminated,TUBB4B,1
breast carcinoma,CABAZITAXEL,2,Terminated,TUBB6,1
breast carcinoma,CABAZITAXEL,2,Terminated,TUBB8,1
breast carcinoma,CABERGOLINE,0,"Active, not recruiting",DRD2,1
breast carcinoma,CABOZANTINIB,2,"Active, not recruiting",KDR,1
breast carcinoma,CABOZANTINIB,2,"Active, not recruiting",MET,1
breast carcinoma,CABOZANTINIB,2,Completed,KDR,1
breast carcinoma,CABOZANTINIB,2,Completed,MET,1
breast carcinoma,CABOZANTINIB,2,Recruiting,KDR,1
breast carcinoma,CABOZANTINIB,2,Recruiting,MET,1
breast carcinoma,CAFFEINE,2,Not yet recruiting,ADORA1,1
breast carcinoma,CAFFEINE,2,Not yet recruiting,ADORA2A,1
breast carcinoma,CAFFEINE,2,Not yet recruiting,ADORA2B,1
breast carcinoma,CAFFEINE,2,Not yet recruiting,ADORA3,1
breast carcinoma,CAL,1,Completed,PTHLH,1
breast carcinoma,CALCITRIOL,2,"Active, not recruiting",VDR,1
breast carcinoma,CANAKINUMAB,1,Recruiting,IL1B,1
breast carcinoma,CANDESARTAN CILEXETIL,3,Completed,AGTR1,1
breast carcinoma,CAPECITABINE,0,Not yet recruiting,TYMS,1
breast carcinoma,CAPECITABINE,1,Not yet recruiting,TYMS,1
breast carcinoma,CAPECITABINE,1,Unknown status,TYMS,1
breast carcinoma,CAPECITABINE,1,Withdrawn,TYMS,1
breast carcinoma,CAPECITABINE,4,Recruiting,TYMS,1
breast carcinoma,BORTEZOMIB,2,"Active, not recruiting",PSMB5,1
breast carcinoma,BMS-754807,2,Completed,INSR,1
breast carcinoma,BMS-754807,2,Completed,IGF1R,1
breast carcinoma,ASPIRIN,0,Completed,PTGS2,1
breast carcinoma,APITOLISIB,2,Completed,PIK3R1,1
breast carcinoma,APITOLISIB,2,Completed,PIK3R2,1
breast carcinoma,APITOLISIB,2,Completed,PIK3R3,1
breast carcinoma,APITOLISIB,2,Completed,PIK3R5,1
breast carcinoma,APREPITANT,3,"Active, not recruiting",TACR1,1
breast carcinoma,APREPITANT,3,Recruiting,TACR1,1
breast carcinoma,APREPITANT,4,Completed,TACR1,1
breast carcinoma,APRICOXIB,2,Terminated,PTGS2,1
breast carcinoma,APROTININ,1,Terminated,KLKB1,1
breast carcinoma,APROTININ,1,Terminated,PLG,1
breast carcinoma,ARZOXIFENE,1,Completed,ESR1,1
breast carcinoma,ARZOXIFENE,1,Completed,ESR2,1
breast carcinoma,ASPIRIN,0,Completed,PTGS1,1
breast carcinoma,ASPIRIN,0,Unknown status,PTGS1,1
breast carcinoma,ATROPINE,2,Recruiting,CHRM3,1
breast carcinoma,ASPIRIN,0,Unknown status,PTGS2,1
breast carcinoma,ASPIRIN,1,Recruiting,PTGS1,1
breast carcinoma,ASPIRIN,1,Recruiting,PTGS2,1
breast carcinoma,ASPIRIN,3,Recruiting,PTGS1,1
breast carcinoma,ASPIRIN,3,Recruiting,PTGS2,1
breast carcinoma,ATEZOLIZUMAB,0,Recruiting,CD274,1
breast carcinoma,ATEZOLIZUMAB,2,Suspended,CD274,1
breast carcinoma,ATEZOLIZUMAB,3,"Active, not recruiting",CD274,1
breast carcinoma,ATORVASTATIN,0,Recruiting,HMGCR,1
breast carcinoma,ATORVASTATIN,2,"Active, not recruiting",HMGCR,1
breast carcinoma,ATORVASTATIN,2,Completed,HMGCR,1
breast carcinoma,ATORVASTATIN,2,Unknown status,HMGCR,1
breast carcinoma,ATROPINE,2,Recruiting,CHRM1,1
breast carcinoma,APITOLISIB,2,Completed,PIK3CG,1
breast carcinoma,APITOLISIB,2,Completed,PIK3CD,1
breast carcinoma,APITOLISIB,2,Completed,PIK3CB,1
breast carcinoma,APITOLISIB,2,Completed,PIK3CA,1
breast carcinoma,ANASTROZOLE,0,Completed,CYP19A1,1
breast carcinoma,ANASTROZOLE,1,"Active, not recruiting",CYP19A1,1
breast carcinoma,ANASTROZOLE,1,Not yet recruiting,CYP19A1,1
breast carcinoma,ANASTROZOLE,1,Recruiting,CYP19A1,1
breast carcinoma,ANASTROZOLE,3,Suspended,CYP19A1,1
breast carcinoma,ANASTROZOLE,4,Recruiting,CYP19A1,1
breast carcinoma,ANASTROZOLE,4,Unknown status,CYP19A1,1
breast carcinoma,ANASTROZOLE,4,Withdrawn,CYP19A1,1
breast carcinoma,ANLOTINIB,1,Not yet recruiting,FLT4,1
breast carcinoma,ANLOTINIB,1,Not yet recruiting,KDR,1
breast carcinoma,ANLOTINIB,1,Not yet recruiting,KIT,1
breast carcinoma,ANLOTINIB,1,Not yet recruiting,PDGFRB,1
breast carcinoma,APATINIB,2,"Active, not recruiting",KDR,1
breast carcinoma,APATINIB,2,Completed,KDR,1
breast carcinoma,APATINIB,2,Enrolling by invitation,KDR,1
breast carcinoma,APATINIB,2,Not yet recruiting,KDR,1
breast carcinoma,APATINIB,2,Unknown status,KDR,1
breast carcinoma,APITOLISIB,1,Completed,MTOR,1
breast carcinoma,APITOLISIB,1,Completed,PIK3CA,1
breast carcinoma,APITOLISIB,1,Completed,PIK3CB,1
breast carcinoma,APITOLISIB,1,Completed,PIK3CD,1
breast carcinoma,APITOLISIB,1,Completed,PIK3CG,1
breast carcinoma,APITOLISIB,1,Completed,PIK3R1,1
breast carcinoma,APITOLISIB,1,Completed,PIK3R2,1
breast carcinoma,APITOLISIB,1,Completed,PIK3R3,1
breast carcinoma,APITOLISIB,1,Completed,PIK3R5,1
breast carcinoma,APITOLISIB,2,Completed,MTOR,1
breast carcinoma,ATROPINE,2,Recruiting,CHRM2,1
breast carcinoma,AUS-131,0,Recruiting,ESR2,1
breast carcinoma,BMS-754807,1,Completed,INSR,1
breast carcinoma,BGT-226,1,Completed,PIK3R3,1
breast carcinoma,BEXAROTENE,1,Completed,RXRA,1
breast carcinoma,BEXAROTENE,1,Completed,RXRB,1
breast carcinoma,BEXAROTENE,1,Completed,RXRG,1
breast carcinoma,BEXAROTENE,2,Completed,RXRA,1
breast carcinoma,BEXAROTENE,2,Completed,RXRB,1
breast carcinoma,BEXAROTENE,2,Completed,RXRG,1
breast carcinoma,BGT-226,1,Completed,MTOR,1
breast carcinoma,BGT-226,1,Completed,PIK3CA,1
breast carcinoma,BGT-226,1,Completed,PIK3CB,1
breast carcinoma,BGT-226,1,Completed,PIK3CD,1
breast carcinoma,BGT-226,1,Completed,PIK3CG,1
breast carcinoma,BGT-226,1,Completed,PIK3R1,1
breast carcinoma,BGT-226,1,Completed,PIK3R2,1
breast carcinoma,BGT-226,1,Completed,PIK3R5,1
breast carcinoma,AVELUMAB,1,Not yet recruiting,CD274,1
breast carcinoma,BICALUTAMIDE,1,"Active, not recruiting",AR,1
breast carcinoma,BICALUTAMIDE,1,Recruiting,AR,1
breast carcinoma,BICALUTAMIDE,2,"Active, not recruiting",AR,1
breast carcinoma,BICALUTAMIDE,2,Not yet recruiting,AR,1
breast carcinoma,BICALUTAMIDE,2,Terminated,AR,1
breast carcinoma,BICALUTAMIDE,3,Recruiting,AR,1
breast carcinoma,BMS-690514,2,Completed,EGFR,1
breast carcinoma,BMS-690514,2,Completed,ERBB2,1
breast carcinoma,BMS-690514,2,Completed,ERBB4,1
breast carcinoma,BMS-690514,2,Completed,FLT1,1
breast carcinoma,BMS-690514,2,Completed,FLT4,1
breast carcinoma,BMS-690514,2,Completed,KDR,1
breast carcinoma,BMS-754807,1,Completed,IGF1R,1
breast carcinoma,BEVACIZUMAB,3,Unknown status,VEGFA,1
breast carcinoma,BEVACIZUMAB,3,Recruiting,VEGFA,1
breast carcinoma,BEVACIZUMAB,2,Withdrawn,VEGFA,1
breast carcinoma,BEVACIZUMAB,2,Not yet recruiting,VEGFA,1
breast carcinoma,AVELUMAB,1,Recruiting,CD274,1
breast carcinoma,AZACITIDINE,1,Completed,DNMT1,1
breast carcinoma,AZACITIDINE,1,Completed,DNMT3A,1
breast carcinoma,AZD-2014,2,"Active, not recruiting",MTOR,1
breast carcinoma,AZD-2014,2,Recruiting,MTOR,1
breast carcinoma,AZD-4547,1,"Active, not recruiting",FGFR1,1
breast carcinoma,AZD-4547,1,"Active, not recruiting",FGFR2,1
breast carcinoma,AZD-4547,1,"Active, not recruiting",FGFR3,1
breast carcinoma,AZD-4547,1,"Active, not recruiting",FGFR4,1
breast carcinoma,AZD-4547,1,Completed,FGFR1,1
breast carcinoma,AZD-4547,1,Completed,FGFR2,1
breast carcinoma,AZD-4547,1,Completed,FGFR3,1
breast carcinoma,AZD-4547,1,Completed,FGFR4,1
breast carcinoma,AZD-4547,2,Recruiting,FGFR1,1
breast carcinoma,AZD-4547,2,Recruiting,FGFR2,1
breast carcinoma,AZD-4547,2,Recruiting,FGFR3,1
breast carcinoma,AZD-4547,2,Recruiting,FGFR4,1
breast carcinoma,AZD-5363,2,"Active, not recruiting",AKT1,1
breast carcinoma,AZD-5363,2,"Active, not recruiting",AKT2,1
breast carcinoma,AZD-5363,2,"Active, not recruiting",AKT3,1
breast carcinoma,AZD-5363,2,Completed,AKT1,1
breast carcinoma,AZD-5363,2,Completed,AKT2,1
breast carcinoma,AZD-5363,2,Completed,AKT3,1
breast carcinoma,BAZEDOXIFENE,1,"Active, not recruiting",ESR1,1
breast carcinoma,BAZEDOXIFENE,1,"Active, not recruiting",ESR2,1
breast carcinoma,BEVACIZUMAB,0,Completed,VEGFA,1
breast carcinoma,BEVACIZUMAB,1,Not yet recruiting,VEGFA,1
breast carcinoma,FLUDARABINE PHOSPHATE,2,Withdrawn,RRM1,1
breast carcinoma,FLUOCINONIDE,2,Completed,NR3C1,1
breast carcinoma,FLUOROURACIL,1,Completed,TYMS,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFA8,1
breast carcinoma,METFORMIN,2,Unknown status,MT-ND6,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFA1,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFA10,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFA11,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFA12,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFA13,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFA2,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFA3,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFA4,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFA4L2,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFA5,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFA6,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFA7,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFA9,1
breast carcinoma,METFORMIN,2,Unknown status,MT-ND4L,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFAB1,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFAF1,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFAF2,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFAF3,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFAF4,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFB1,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFB10,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFB11,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFB2,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFB3,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFB4,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFB5,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFB6,1
breast carcinoma,METFORMIN,2,Unknown status,MT-ND5,1
breast carcinoma,METFORMIN,2,Unknown status,MT-ND4,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFAF3,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFS1,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFB1,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFB10,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFB11,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFB2,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFB3,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFB4,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFB5,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFB6,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFB7,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFB8,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFB9,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFC1,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFC2,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFS2,1
breast carcinoma,METFORMIN,2,Unknown status,MT-ND3,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFS3,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFS4,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFS5,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFS6,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFS7,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFS8,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFV1,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFV2,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFV3,1
Hereditary breast and ovarian cancer syndrome,ARZOXIFENE,2,Completed,ESR2,1
breast carcinoma,METFORMIN,2,Unknown status,GPD2,1
breast carcinoma,METFORMIN,2,Unknown status,MT-ND1,1
breast carcinoma,METFORMIN,2,Unknown status,MT-ND2,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFB7,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFB8,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFB9,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFB4,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFA7,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFA8,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFA9,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFAB1,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFAF1,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFAF2,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFAF3,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFAF4,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFB1,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFB10,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFB11,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFB2,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFB3,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFB5,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFC1,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFB6,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFB7,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFB8,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFB9,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFC1,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFC2,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFS1,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFS2,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFS3,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFS4,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFS5,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFS6,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFS7,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFA6,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFA5,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFA4L2,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFA4,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFC2,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFS1,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFS2,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFS3,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFS4,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFS5,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFS6,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFS7,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFS8,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFV1,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFV2,1
breast carcinoma,METFORMIN,2,Unknown status,NDUFV3,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",GPD2,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",MT-ND1,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",MT-ND2,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",MT-ND3,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",MT-ND4,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",MT-ND4L,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",MT-ND5,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",MT-ND6,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFA1,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFA10,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFA11,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFA12,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFA13,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFA2,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFA3,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFAF4,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFAF2,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",GPD2,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFS8,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFB6,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFB7,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFB8,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFB9,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFC1,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFC2,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFS1,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFS2,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFS3,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFS4,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFS5,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFS6,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFS7,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFV1,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFB4,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFV2,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFV3,1
breast carcinoma,METFORMIN,1,Completed,GPD2,1
breast carcinoma,METFORMIN,1,Completed,MT-ND1,1
breast carcinoma,METFORMIN,1,Completed,MT-ND2,1
breast carcinoma,METFORMIN,1,Completed,MT-ND3,1
breast carcinoma,METFORMIN,1,Completed,MT-ND4,1
breast carcinoma,METFORMIN,1,Completed,MT-ND4L,1
breast carcinoma,METFORMIN,1,Completed,MT-ND5,1
breast carcinoma,METFORMIN,1,Completed,MT-ND6,1
breast carcinoma,METFORMIN,1,Completed,NDUFA1,1
breast carcinoma,METFORMIN,1,Completed,NDUFA10,1
breast carcinoma,METFORMIN,1,Completed,NDUFA11,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFB5,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFB3,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFAF1,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFA4,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",MT-ND2,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",MT-ND3,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",MT-ND4,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",MT-ND4L,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",MT-ND5,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",MT-ND6,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFA1,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFA10,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFA11,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFA12,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFA13,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFA2,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFA3,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFA4L2,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFB2,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFA5,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFA6,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFA7,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFA8,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFA9,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFAB1,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFAF1,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFAF2,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFAF3,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFAF4,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFB1,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFB10,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",NDUFB11,1
breast carcinoma,METFORMIN,1,Completed,NDUFA12,1
breast carcinoma,METFORMIN,1,Completed,NDUFA13,1
breast carcinoma,METFORMIN,1,Completed,NDUFA2,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFA1,1
breast carcinoma,METFORMIN,1,Completed,NDUFS7,1
breast carcinoma,METFORMIN,1,Completed,NDUFS8,1
breast carcinoma,METFORMIN,1,Completed,NDUFV1,1
breast carcinoma,METFORMIN,1,Completed,NDUFV2,1
breast carcinoma,METFORMIN,1,Completed,NDUFV3,1
breast carcinoma,METFORMIN,1,Recruiting,GPD2,1
breast carcinoma,METFORMIN,1,Recruiting,MT-ND1,1
breast carcinoma,METFORMIN,1,Recruiting,MT-ND2,1
breast carcinoma,METFORMIN,1,Recruiting,MT-ND3,1
breast carcinoma,METFORMIN,1,Recruiting,MT-ND4,1
breast carcinoma,METFORMIN,1,Recruiting,MT-ND4L,1
breast carcinoma,METFORMIN,1,Recruiting,MT-ND5,1
breast carcinoma,METFORMIN,1,Recruiting,MT-ND6,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFA10,1
breast carcinoma,METFORMIN,1,Completed,NDUFA3,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFA11,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFA12,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFA13,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFA2,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFA3,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFA4,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFA4L2,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFA5,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFA6,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFA7,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFA8,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFA9,1
breast carcinoma,METFORMIN,1,Recruiting,NDUFAB1,1
breast carcinoma,METFORMIN,1,Completed,NDUFS6,1
breast carcinoma,METFORMIN,1,Completed,NDUFS5,1
breast carcinoma,METFORMIN,1,Completed,NDUFS4,1
breast carcinoma,METFORMIN,1,Completed,NDUFS3,1
breast carcinoma,METFORMIN,1,Completed,NDUFA4,1
breast carcinoma,METFORMIN,1,Completed,NDUFA4L2,1
breast carcinoma,METFORMIN,1,Completed,NDUFA5,1
breast carcinoma,METFORMIN,1,Completed,NDUFA6,1
breast carcinoma,METFORMIN,1,Completed,NDUFA7,1
breast carcinoma,METFORMIN,1,Completed,NDUFA8,1
breast carcinoma,METFORMIN,1,Completed,NDUFA9,1
breast carcinoma,METFORMIN,1,Completed,NDUFAB1,1
breast carcinoma,METFORMIN,1,Completed,NDUFAF1,1
breast carcinoma,METFORMIN,1,Completed,NDUFAF2,1
breast carcinoma,METFORMIN,1,Completed,NDUFAF3,1
breast carcinoma,METFORMIN,1,Completed,NDUFAF4,1
breast carcinoma,METFORMIN,1,Completed,NDUFB1,1
breast carcinoma,METFORMIN,1,Completed,NDUFB10,1
breast carcinoma,METFORMIN,1,Completed,NDUFB11,1
breast carcinoma,METFORMIN,1,Completed,NDUFB2,1
breast carcinoma,METFORMIN,1,Completed,NDUFB3,1
breast carcinoma,METFORMIN,1,Completed,NDUFB4,1
breast carcinoma,METFORMIN,1,Completed,NDUFB5,1
breast carcinoma,METFORMIN,1,Completed,NDUFB6,1
breast carcinoma,METFORMIN,1,Completed,NDUFB7,1
breast carcinoma,METFORMIN,1,Completed,NDUFB8,1
breast carcinoma,METFORMIN,1,Completed,NDUFB9,1
breast carcinoma,METFORMIN,1,Completed,NDUFC1,1
breast carcinoma,METFORMIN,1,Completed,NDUFC2,1
breast carcinoma,METFORMIN,1,Completed,NDUFS1,1
breast carcinoma,METFORMIN,1,Completed,NDUFS2,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFS8,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFV1,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFV2,1
breast carcinoma,PACLITAXEL,2,Enrolling by invitation,TUBB6,1
breast carcinoma,PACLITAXEL,0,"Active, not recruiting",TUBB2B,1
breast carcinoma,PACLITAXEL,0,"Active, not recruiting",TUBB3,1
breast carcinoma,PACLITAXEL,0,"Active, not recruiting",TUBB4A,1
breast carcinoma,PACLITAXEL,0,"Active, not recruiting",TUBB4B,1
breast carcinoma,PACLITAXEL,0,"Active, not recruiting",TUBB6,1
breast carcinoma,PACLITAXEL,0,"Active, not recruiting",TUBB8,1
breast carcinoma,PACLITAXEL,2,Enrolling by invitation,TUBB,1
breast carcinoma,PACLITAXEL,2,Enrolling by invitation,TUBB1,1
breast carcinoma,PACLITAXEL,2,Enrolling by invitation,TUBB2A,1
breast carcinoma,PACLITAXEL,2,Enrolling by invitation,TUBB2B,1
breast carcinoma,PACLITAXEL,2,Enrolling by invitation,TUBB3,1
breast carcinoma,PACLITAXEL,2,Enrolling by invitation,TUBB4A,1
breast carcinoma,PACLITAXEL,2,Enrolling by invitation,TUBB4B,1
breast carcinoma,PACLITAXEL,2,Enrolling by invitation,TUBB8,1
breast carcinoma,PACLITAXEL,0,"Active, not recruiting",TUBB1,1
breast carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB,1
breast carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB1,1
breast carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB2A,1
breast carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB2B,1
breast carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB3,1
breast carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB4A,1
breast carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB4B,1
breast carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB6,1
breast carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB8,1
breast carcinoma,PACLITAXEL,3,Withdrawn,TUBB,1
breast carcinoma,PACLITAXEL,3,Withdrawn,TUBB1,1
breast carcinoma,PACLITAXEL,3,Withdrawn,TUBB2A,1
breast carcinoma,PACLITAXEL,3,Withdrawn,TUBB2B,1
breast carcinoma,PACLITAXEL,0,"Active, not recruiting",TUBB2A,1
breast carcinoma,PACLITAXEL,0,"Active, not recruiting",TUBB,1
breast carcinoma,METFORMIN,3,"Active, not recruiting",NDUFV3,1
breast carcinoma,OLAPARIB,2,Unknown status,PARP1,1
breast carcinoma,OLANZAPINE,3,"Active, not recruiting",HTR2C,1
breast carcinoma,OLAPARIB,1,"Active, not recruiting",PARP1,1
breast carcinoma,OLAPARIB,1,"Active, not recruiting",PARP2,1
breast carcinoma,OLAPARIB,1,"Active, not recruiting",PARP3,1
breast carcinoma,OLAPARIB,1,Not yet recruiting,PARP1,1
breast carcinoma,OLAPARIB,1,Not yet recruiting,PARP2,1
breast carcinoma,OLAPARIB,1,Not yet recruiting,PARP3,1
breast carcinoma,OLAPARIB,1,Terminated,PARP1,1
breast carcinoma,OLAPARIB,1,Terminated,PARP2,1
breast carcinoma,OLAPARIB,1,Terminated,PARP3,1
breast carcinoma,OLAPARIB,2,"Active, not recruiting",PARP1,1
breast carcinoma,OLAPARIB,2,"Active, not recruiting",PARP2,1
breast carcinoma,OLAPARIB,2,"Active, not recruiting",PARP3,1
breast carcinoma,OLAPARIB,2,Unknown status,PARP2,1
breast carcinoma,ORTERONEL,2,Recruiting,CYP17A1,1
breast carcinoma,OLAPARIB,2,Unknown status,PARP3,1
breast carcinoma,OMEPRAZOLE,1,"Active, not recruiting",ATP4A,1
breast carcinoma,OMEPRAZOLE,2,Recruiting,ATP4A,1
breast carcinoma,ONARTUZUMAB,2,Completed,MET,1
breast carcinoma,ONDANSETRON,2,Unknown status,HTR3A,1
breast carcinoma,ONDANSETRON,3,"Active, not recruiting",HTR3A,1
breast carcinoma,ORANTINIB,1,Unknown status,FGFR1,1
breast carcinoma,ORANTINIB,1,Unknown status,FGFR2,1
breast carcinoma,ORANTINIB,1,Unknown status,FGFR3,1
breast carcinoma,ORANTINIB,1,Unknown status,FGFR4,1
breast carcinoma,ORANTINIB,1,Unknown status,KDR,1
breast carcinoma,ORANTINIB,1,Unknown status,PDGFRA,1
breast carcinoma,ORANTINIB,1,Unknown status,PDGFRB,1
breast carcinoma,PACLITAXEL,3,Withdrawn,TUBB3,1
breast carcinoma,PACLITAXEL,3,Withdrawn,TUBB4A,1
breast carcinoma,PACLITAXEL,3,Withdrawn,TUBB4B,1
breast carcinoma,PALBOCICLIB,2,Completed,CDK4,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBB,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBB1,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBB2A,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBB2B,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBB3,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBB4A,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBB4B,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBB6,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBB8,1
breast carcinoma,PALBOCICLIB,1,Not yet recruiting,CDK4,1
breast carcinoma,PALBOCICLIB,1,Not yet recruiting,CDK6,1
breast carcinoma,PALBOCICLIB,1,Unknown status,CDK4,1
breast carcinoma,PALBOCICLIB,1,Unknown status,CDK6,1
breast carcinoma,PALBOCICLIB,2,Completed,CDK6,1
breast carcinoma,PACLITAXEL,3,Withdrawn,TUBB6,1
breast carcinoma,PALBOCICLIB,2,Withdrawn,CDK4,1
breast carcinoma,PALBOCICLIB,2,Withdrawn,CDK6,1
breast carcinoma,PALBOCICLIB,3,Not yet recruiting,CDK4,1
breast carcinoma,PALBOCICLIB,3,Not yet recruiting,CDK6,1
breast carcinoma,PALBOCICLIB,3,Recruiting,CDK4,1
breast carcinoma,PALBOCICLIB,3,Recruiting,CDK6,1
breast carcinoma,PALBOCICLIB,4,"Active, not recruiting",CDK4,1
breast carcinoma,PALBOCICLIB,4,"Active, not recruiting",CDK6,1
breast carcinoma,PALBOCICLIB,4,Recruiting,CDK4,1
breast carcinoma,PALBOCICLIB,4,Recruiting,CDK6,1
breast carcinoma,PALONOSETRON,3,Recruiting,HTR3A,1
breast carcinoma,PAMIDRONIC ACID,2,Completed,FDPS,1
breast carcinoma,PAMIDRONIC ACID,2,Terminated,FDPS,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBA4A,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBA3E,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBA3C,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBA1C,1
breast carcinoma,PACLITAXEL,3,Withdrawn,TUBB8,1
breast carcinoma,PACLITAXEL,4,Withdrawn,TUBB,1
breast carcinoma,PACLITAXEL,4,Withdrawn,TUBB1,1
breast carcinoma,PACLITAXEL,4,Withdrawn,TUBB2A,1
breast carcinoma,PACLITAXEL,4,Withdrawn,TUBB2B,1
breast carcinoma,PACLITAXEL,4,Withdrawn,TUBB3,1
breast carcinoma,PACLITAXEL,4,Withdrawn,TUBB4A,1
breast carcinoma,PACLITAXEL,4,Withdrawn,TUBB4B,1
breast carcinoma,PACLITAXEL,4,Withdrawn,TUBB6,1
breast carcinoma,PACLITAXEL,4,Withdrawn,TUBB8,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBA1A,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBA1B,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBA1C,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBA3C,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBA3E,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBA4A,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBB,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBB1,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBB2A,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBB2B,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBB3,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBB4A,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBB4B,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBB6,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBB8,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBA1A,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBA1B,1
breast carcinoma,OLANZAPINE,3,"Active, not recruiting",HTR2A,1
breast carcinoma,OLANZAPINE,3,"Active, not recruiting",DRD4,1
breast carcinoma,OLANZAPINE,3,"Active, not recruiting",DRD3,1
breast carcinoma,MK-2206,2,Completed,AKT1,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBA3C,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBA3E,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBA4A,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBB,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBB1,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBB2A,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBB2B,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBB3,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBB4A,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBB4B,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBB6,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBB8,1
breast carcinoma,MITOXANTRONE,2,Recruiting,TOP2A,1
breast carcinoma,MK-2206,2,Completed,AKT2,1
breast carcinoma,MOTESANIB,1,Completed,PDGFRA,1
breast carcinoma,MK-2206,2,Completed,AKT3,1
breast carcinoma,MK-2206,2,Withdrawn,AKT1,1
breast carcinoma,MK-2206,2,Withdrawn,AKT2,1
breast carcinoma,MK-2206,2,Withdrawn,AKT3,1
breast carcinoma,MM-302,1,Unknown status,ERBB2,1
breast carcinoma,MM-302,1,Unknown status,TOP2A,1
breast carcinoma,MM-302,2,Terminated,ERBB2,1
breast carcinoma,MM-302,2,Terminated,TOP2A,1
breast carcinoma,MOMETASONE FUROATE,3,Completed,NR3C1,1
breast carcinoma,MORPHINE,4,Unknown status,OPRM1,1
breast carcinoma,MOTESANIB,1,Completed,FLT1,1
breast carcinoma,MOTESANIB,1,Completed,FLT4,1
breast carcinoma,MOTESANIB,1,Completed,KDR,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBA1C,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBA1B,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBA1A,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,FOLR1,1
breast carcinoma,METHOTREXATE,1,Recruiting,DHFR,1
breast carcinoma,METHOTREXATE,2,"Active, not recruiting",DHFR,1
breast carcinoma,METHOTREXATE,3,Suspended,DHFR,1
breast carcinoma,METHOTREXATE,3,Terminated,DHFR,1
breast carcinoma,METHYLPHENIDATE,2,Recruiting,SLC6A2,1
breast carcinoma,METHYLPHENIDATE,2,Recruiting,SLC6A3,1
breast carcinoma,METHYLPREDNISOLONE,2,Completed,NR3C1,1
breast carcinoma,METOPROLOL,3,Withdrawn,ADRB1,1
breast carcinoma,MIDAZOLAM,1,Recruiting,GABRA1,1
breast carcinoma,MIDAZOLAM,1,Recruiting,GABRA2,1
breast carcinoma,MIDAZOLAM,1,Recruiting,GABRA3,1
breast carcinoma,MIDAZOLAM,1,Recruiting,GABRA5,1
breast carcinoma,MIDAZOLAM,1,Recruiting,GABRG1,1
breast carcinoma,MIDAZOLAM,1,Recruiting,GABRG2,1
breast carcinoma,MIDAZOLAM,1,Recruiting,GABRG3,1
breast carcinoma,MIDAZOLAM,2,Recruiting,GABRA1,1
breast carcinoma,MIDAZOLAM,2,Recruiting,GABRA2,1
breast carcinoma,MIDAZOLAM,2,Recruiting,GABRA3,1
breast carcinoma,MIDAZOLAM,2,Recruiting,GABRA5,1
breast carcinoma,MIDAZOLAM,2,Recruiting,GABRG1,1
breast carcinoma,MIDAZOLAM,2,Recruiting,GABRG2,1
breast carcinoma,MIDAZOLAM,2,Recruiting,GABRG3,1
breast carcinoma,MIRTAZAPINE,3,Recruiting,ADRA2A,1
breast carcinoma,MIRTAZAPINE,3,Recruiting,ADRA2B,1
breast carcinoma,MIRTAZAPINE,3,Recruiting,ADRA2C,1
breast carcinoma,MIRTAZAPINE,3,Recruiting,HTR2A,1
breast carcinoma,MIRTAZAPINE,3,Recruiting,HTR2C,1
breast carcinoma,MOTESANIB,1,Completed,KIT,1
breast carcinoma,MOTESANIB,1,Completed,PDGFRB,1
breast carcinoma,OLANZAPINE,3,"Active, not recruiting",DRD2,1
breast carcinoma,NINTEDANIB,2,Terminated,PDGFRA,1
breast carcinoma,NINTEDANIB,1,Unknown status,FGFR4,1
breast carcinoma,NINTEDANIB,1,Unknown status,FLT1,1
breast carcinoma,NINTEDANIB,1,Unknown status,FLT4,1
breast carcinoma,NINTEDANIB,1,Unknown status,KDR,1
breast carcinoma,NINTEDANIB,1,Unknown status,PDGFRA,1
breast carcinoma,NINTEDANIB,1,Unknown status,PDGFRB,1
breast carcinoma,NINTEDANIB,2,Terminated,FGFR1,1
breast carcinoma,NINTEDANIB,2,Terminated,FGFR2,1
breast carcinoma,NINTEDANIB,2,Terminated,FGFR3,1
breast carcinoma,NINTEDANIB,2,Terminated,FGFR4,1
breast carcinoma,NINTEDANIB,2,Terminated,FLT1,1
breast carcinoma,NINTEDANIB,2,Terminated,FLT4,1
breast carcinoma,NINTEDANIB,2,Terminated,KDR,1
breast carcinoma,NINTEDANIB,2,Terminated,PDGFRB,1
breast carcinoma,MOTESANIB,1,Completed,RET,1
breast carcinoma,NINTEDANIB,2,Unknown status,FGFR1,1
breast carcinoma,NINTEDANIB,2,Unknown status,FGFR2,1
breast carcinoma,NINTEDANIB,2,Unknown status,FGFR3,1
breast carcinoma,NINTEDANIB,2,Unknown status,FGFR4,1
breast carcinoma,NINTEDANIB,2,Unknown status,FLT1,1
breast carcinoma,NINTEDANIB,2,Unknown status,FLT4,1
breast carcinoma,NINTEDANIB,2,Unknown status,KDR,1
breast carcinoma,NINTEDANIB,2,Unknown status,PDGFRA,1
breast carcinoma,NINTEDANIB,2,Unknown status,PDGFRB,1
breast carcinoma,NIRAPARIB,1,"Active, not recruiting",PARP3,1
breast carcinoma,NIRAPARIB,1,Not yet recruiting,PARP3,1
breast carcinoma,NIRAPARIB,2,Recruiting,PARP3,1
breast carcinoma,ODANACATIB,3,Withdrawn,CTSK,1
breast carcinoma,NINTEDANIB,1,Unknown status,FGFR3,1
breast carcinoma,NINTEDANIB,1,Unknown status,FGFR2,1
breast carcinoma,NINTEDANIB,1,Unknown status,FGFR1,1
breast carcinoma,NIMOTUZUMAB,2,Unknown status,EGFR,1
breast carcinoma,MOTESANIB,1,Withdrawn,FLT1,1
breast carcinoma,MOTESANIB,1,Withdrawn,FLT4,1
breast carcinoma,MOTESANIB,1,Withdrawn,KDR,1
breast carcinoma,MOTESANIB,1,Withdrawn,KIT,1
breast carcinoma,MOTESANIB,1,Withdrawn,PDGFRA,1
breast carcinoma,MOTESANIB,1,Withdrawn,PDGFRB,1
breast carcinoma,MOTESANIB,1,Withdrawn,RET,1
breast carcinoma,MOTESANIB,2,Terminated,FLT1,1
breast carcinoma,MOTESANIB,2,Terminated,FLT4,1
breast carcinoma,MOTESANIB,2,Terminated,KDR,1
breast carcinoma,MOTESANIB,2,Terminated,KIT,1
breast carcinoma,MOTESANIB,2,Terminated,PDGFRA,1
breast carcinoma,MOTESANIB,2,Terminated,PDGFRB,1
breast carcinoma,MOTESANIB,2,Terminated,RET,1
breast carcinoma,NALTREXONE,2,Terminated,OPRD1,1
breast carcinoma,NALTREXONE,2,Terminated,OPRK1,1
breast carcinoma,NALTREXONE,2,Terminated,OPRM1,1
breast carcinoma,NAPROXEN,2,Completed,PTGS1,1
breast carcinoma,NAPROXEN,2,Completed,PTGS2,1
breast carcinoma,NEOSTIGMINE,2,Recruiting,ACHE,1
breast carcinoma,NERATINIB,2,Not yet recruiting,ERBB3,1
breast carcinoma,NERATINIB,2,Not yet recruiting,ERBB4,1
breast carcinoma,NERATINIB,4,n/a,ERBB3,1
breast carcinoma,NERATINIB,4,n/a,ERBB4,1
breast carcinoma,NETUPITANT,3,Recruiting,TACR1,1
breast carcinoma,NICOTINE,1,Recruiting,CHRNA4,1
breast carcinoma,NICOTINE,1,Recruiting,CHRNB2,1
breast carcinoma,METFORMIN,1,"Active, not recruiting",MT-ND1,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFV3,1
breast carcinoma,FLUOROURACIL,1,Not yet recruiting,TYMS,1
breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB2A,1
breast carcinoma,IPATASERTIB,2,Completed,AKT1,1
breast carcinoma,IPATASERTIB,2,Completed,AKT2,1
breast carcinoma,IPATASERTIB,2,Completed,AKT3,1
breast carcinoma,IPILIMUMAB,1,Completed,CTLA4,1
breast carcinoma,IRINOTECAN,2,Completed,TOP1,1
breast carcinoma,IRINOTECAN,2,Terminated,TOP1,1
breast carcinoma,IRINOTECAN,3,Unknown status,TOP1,1
breast carcinoma,IROSUSTAT,1,Completed,STS,1
breast carcinoma,IROSUSTAT,2,Completed,STS,1
breast carcinoma,IROSUSTAT,2,Terminated,STS,1
breast carcinoma,ITACITINIB,1,Recruiting,JAK1,1
breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB,1
breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB1,1
breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB2B,1
breast carcinoma,IPATASERTIB,1,Not yet recruiting,AKT2,1
breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB3,1
breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB4A,1
breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB4B,1
breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB6,1
breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB8,1
breast carcinoma,IXABEPILONE,1,Withdrawn,TUBB,1
breast carcinoma,IXABEPILONE,1,Withdrawn,TUBB1,1
breast carcinoma,IXABEPILONE,1,Withdrawn,TUBB2A,1
breast carcinoma,IXABEPILONE,1,Withdrawn,TUBB2B,1
breast carcinoma,IXABEPILONE,1,Withdrawn,TUBB3,1
breast carcinoma,IXABEPILONE,1,Withdrawn,TUBB4A,1
breast carcinoma,IXABEPILONE,1,Withdrawn,TUBB4B,1
breast carcinoma,IXABEPILONE,1,Withdrawn,TUBB6,1
breast carcinoma,IPATASERTIB,1,Not yet recruiting,AKT3,1
breast carcinoma,IPATASERTIB,1,Not yet recruiting,AKT1,1
breast carcinoma,IMATINIB,4,Completed,PDGFRB,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBB2B,1
breast carcinoma,IMETELSTAT SODIUM,2,Completed,TERT,1
breast carcinoma,IMIQUIMOD,1,Completed,TLR7,1
breast carcinoma,IMIQUIMOD,2,Completed,TLR7,1
breast carcinoma,INCB-047986,1,Terminated,JAK1,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBA1A,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBA1B,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBA1C,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBA3C,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBA3E,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBA4A,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBB,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBB1,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBB2A,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBB3,1
breast carcinoma,INTERFERON GAMMA-1B,3,Completed,IFNGR2,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBB4A,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBB4B,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBB6,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBB8,1
breast carcinoma,INDOMETHACIN,1,"Active, not recruiting",PTGS1,1
breast carcinoma,INDOMETHACIN,1,"Active, not recruiting",PTGS2,1
breast carcinoma,INTERFERON ALFA-2B,0,Recruiting,IFNAR1,1
breast carcinoma,INTERFERON ALFA-2B,0,Recruiting,IFNAR2,1
breast carcinoma,INTERFERON ALFA-2B,1,Recruiting,IFNAR1,1
breast carcinoma,INTERFERON ALFA-2B,1,Recruiting,IFNAR2,1
breast carcinoma,INTERFERON GAMMA-1B,1,Recruiting,IFNGR1,1
breast carcinoma,INTERFERON GAMMA-1B,1,Recruiting,IFNGR2,1
breast carcinoma,INTERFERON GAMMA-1B,3,Completed,IFNGR1,1
breast carcinoma,IXABEPILONE,1,Withdrawn,TUBB8,1
breast carcinoma,IXABEPILONE,2,Recruiting,TUBB,1
breast carcinoma,IXABEPILONE,2,Recruiting,TUBB1,1
breast carcinoma,LANSOPRAZOLE,2,Not yet recruiting,ATP4A,1
breast carcinoma,KETAMINE,2,Completed,GRIN3B,1
breast carcinoma,KETAMINE,4,Recruiting,GRIN1,1
breast carcinoma,KETAMINE,4,Recruiting,GRIN2A,1
breast carcinoma,KETAMINE,4,Recruiting,GRIN2B,1
breast carcinoma,KETAMINE,4,Recruiting,GRIN2C,1
breast carcinoma,KETAMINE,4,Recruiting,GRIN2D,1
breast carcinoma,KETAMINE,4,Recruiting,GRIN3A,1
breast carcinoma,KETAMINE,4,Recruiting,GRIN3B,1
breast carcinoma,KETOROLAC,4,Withdrawn,PTGS1,1
breast carcinoma,KETOROLAC,4,Withdrawn,PTGS2,1
breast carcinoma,KW-2450,1,Terminated,IGF1R,1
breast carcinoma,KW-2450,1,Terminated,INSR,1
breast carcinoma,LABETUZUMAB,1,Completed,CEACAM5,1
breast carcinoma,LAPATINIB,0,"Active, not recruiting",EGFR,1
breast carcinoma,IXABEPILONE,2,Recruiting,TUBB2A,1
breast carcinoma,LAPATINIB,0,"Active, not recruiting",ERBB2,1
breast carcinoma,LAPATINIB,1,Recruiting,EGFR,1
breast carcinoma,LAPATINIB,1,Recruiting,ERBB2,1
breast carcinoma,LAPATINIB,1,Suspended,EGFR,1
breast carcinoma,LAPATINIB,1,Suspended,ERBB2,1
breast carcinoma,LAPATINIB,4,n/a,EGFR,1
breast carcinoma,LAPATINIB,4,n/a,ERBB2,1
breast carcinoma,LEFLUNOMIDE,1,Not yet recruiting,DHODH,1
breast carcinoma,LENVATINIB,1,Unknown status,FLT1,1
breast carcinoma,LENVATINIB,1,Unknown status,FLT4,1
breast carcinoma,LENVATINIB,1,Unknown status,KDR,1
breast carcinoma,LENVATINIB,2,Recruiting,FLT1,1
breast carcinoma,LENVATINIB,2,Recruiting,FLT4,1
breast carcinoma,KETAMINE,2,Completed,GRIN3A,1
breast carcinoma,KETAMINE,2,Completed,GRIN2D,1
breast carcinoma,KETAMINE,2,Completed,GRIN2C,1
breast carcinoma,KETAMINE,2,Completed,GRIN2B,1
breast carcinoma,IXABEPILONE,2,Recruiting,TUBB2B,1
breast carcinoma,IXABEPILONE,2,Recruiting,TUBB3,1
breast carcinoma,IXABEPILONE,2,Recruiting,TUBB4A,1
breast carcinoma,IXABEPILONE,2,Recruiting,TUBB4B,1
breast carcinoma,IXABEPILONE,2,Recruiting,TUBB6,1
breast carcinoma,IXABEPILONE,2,Recruiting,TUBB8,1
breast carcinoma,IXABEPILONE,2,Withdrawn,TUBB,1
breast carcinoma,IXABEPILONE,2,Withdrawn,TUBB1,1
breast carcinoma,IXABEPILONE,2,Withdrawn,TUBB2A,1
breast carcinoma,IXABEPILONE,2,Withdrawn,TUBB2B,1
breast carcinoma,IXABEPILONE,2,Withdrawn,TUBB3,1
breast carcinoma,IXABEPILONE,2,Withdrawn,TUBB4A,1
breast carcinoma,IXABEPILONE,2,Withdrawn,TUBB4B,1
breast carcinoma,IXABEPILONE,2,Withdrawn,TUBB6,1
breast carcinoma,IXABEPILONE,2,Withdrawn,TUBB8,1
breast carcinoma,IXABEPILONE,4,n/a,TUBB,1
breast carcinoma,IXABEPILONE,4,n/a,TUBB1,1
breast carcinoma,IXABEPILONE,4,n/a,TUBB2A,1
breast carcinoma,IXABEPILONE,4,n/a,TUBB2B,1
breast carcinoma,IXABEPILONE,4,n/a,TUBB3,1
breast carcinoma,IXABEPILONE,4,n/a,TUBB4A,1
breast carcinoma,IXABEPILONE,4,n/a,TUBB4B,1
breast carcinoma,IXABEPILONE,4,n/a,TUBB6,1
breast carcinoma,IXABEPILONE,4,n/a,TUBB8,1
breast carcinoma,IXAZOMIB CITRATE,1,Recruiting,PSMB5,1
breast carcinoma,KETAMINE,2,Completed,GRIN1,1
breast carcinoma,KETAMINE,2,Completed,GRIN2A,1
breast carcinoma,IMETELSTAT,1,Completed,TERT,1
breast carcinoma,IMATINIB,4,Completed,KIT,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFV2,1
breast carcinoma,GEDATOLISIB,1,Not yet recruiting,MTOR,1
breast carcinoma,FULVESTRANT,4,"Active, not recruiting",ESR2,1
breast carcinoma,FULVESTRANT,4,Not yet recruiting,ESR1,1
breast carcinoma,FULVESTRANT,4,Not yet recruiting,ESR2,1
breast carcinoma,FULVESTRANT,4,Recruiting,ESR1,1
breast carcinoma,FULVESTRANT,4,Recruiting,ESR2,1
breast carcinoma,FULVESTRANT,4,n/a,ESR1,1
breast carcinoma,FULVESTRANT,4,n/a,ESR2,1
breast carcinoma,GABAPENTIN,2,Recruiting,CACNA2D1,1
breast carcinoma,GALUNISERTIB,1,Recruiting,TGFBR1,1
breast carcinoma,GANETESPIB,2,Recruiting,HSP90AA1,1
breast carcinoma,GANETESPIB,2,Recruiting,HSP90AB1,1
breast carcinoma,GANITUMAB,1,Withdrawn,IGF1R,1
breast carcinoma,GANITUMAB,2,Recruiting,IGF1R,1
breast carcinoma,GEDATOLISIB,1,Not yet recruiting,PIK3CA,1
breast carcinoma,FULVESTRANT,3,Suspended,ESR2,1
breast carcinoma,GEDATOLISIB,1,Not yet recruiting,PIK3CB,1
breast carcinoma,GEDATOLISIB,1,Not yet recruiting,PIK3CD,1
breast carcinoma,GEDATOLISIB,1,Not yet recruiting,PIK3CG,1
breast carcinoma,GEDATOLISIB,1,Not yet recruiting,PIK3R1,1
breast carcinoma,GEDATOLISIB,1,Not yet recruiting,PIK3R2,1
breast carcinoma,GEDATOLISIB,1,Not yet recruiting,PIK3R3,1
breast carcinoma,GEDATOLISIB,1,Not yet recruiting,PIK3R5,1
breast carcinoma,GEFITINIB,1,Completed,EGFR,1
breast carcinoma,GEFITINIB,2,Unknown status,EGFR,1
breast carcinoma,GEFITINIB,2,Withdrawn,EGFR,1
breast carcinoma,GEFITINIB,3,Completed,EGFR,1
breast carcinoma,GEMCITABINE,1,"Active, not recruiting",POLA1,1
breast carcinoma,GEMCITABINE,1,"Active, not recruiting",POLA2,1
breast carcinoma,FULVESTRANT,4,"Active, not recruiting",ESR1,1
breast carcinoma,FULVESTRANT,3,Suspended,ESR1,1
breast carcinoma,IMATINIB,4,Completed,ABL1,1
breast carcinoma,FORETINIB,1,Completed,PDGFRB,1
breast carcinoma,FLUOROURACIL,1,Unknown status,TYMS,1
breast carcinoma,FLUOROURACIL,2,Not yet recruiting,TYMS,1
breast carcinoma,FLUOROURACIL,3,Recruiting,TYMS,1
breast carcinoma,FLUOROURACIL,3,Suspended,TYMS,1
breast carcinoma,FLUOXYMESTERONE,2,Terminated,AR,1
breast carcinoma,FLUVASTATIN,2,Completed,HMGCR,1
breast carcinoma,FORETINIB,1,Completed,FLT1,1
breast carcinoma,FORETINIB,1,Completed,FLT3,1
breast carcinoma,FORETINIB,1,Completed,FLT4,1
breast carcinoma,FORETINIB,1,Completed,KDR,1
breast carcinoma,FORETINIB,1,Completed,KIT,1
breast carcinoma,FORETINIB,1,Completed,MET,1
breast carcinoma,FORETINIB,1,Completed,PDGFRA,1
breast carcinoma,FORETINIB,1,Completed,TEK,1
breast carcinoma,FULVESTRANT,2,Not yet recruiting,ESR2,1
breast carcinoma,FORETINIB,2,Completed,FLT1,1
breast carcinoma,FORETINIB,2,Completed,FLT3,1
breast carcinoma,FORETINIB,2,Completed,FLT4,1
breast carcinoma,FORETINIB,2,Completed,KDR,1
breast carcinoma,FORETINIB,2,Completed,KIT,1
breast carcinoma,FORETINIB,2,Completed,MET,1
breast carcinoma,FORETINIB,2,Completed,PDGFRA,1
breast carcinoma,FORETINIB,2,Completed,PDGFRB,1
breast carcinoma,FORETINIB,2,Completed,TEK,1
breast carcinoma,FRESOLIMUMAB,2,Completed,TGFB1,1
breast carcinoma,FRESOLIMUMAB,2,Completed,TGFB2,1
breast carcinoma,FRESOLIMUMAB,2,Completed,TGFB3,1
breast carcinoma,FULVESTRANT,2,Not yet recruiting,ESR1,1
breast carcinoma,GEMCITABINE,1,"Active, not recruiting",POLD1,1
breast carcinoma,GEMCITABINE,1,"Active, not recruiting",POLD2,1
breast carcinoma,GEMCITABINE,1,"Active, not recruiting",POLD3,1
breast carcinoma,HYDROXYCHLOROQUINE,2,Recruiting,TLR9,1
breast carcinoma,GLEMBATUMUMAB VEDOTIN,0,Withdrawn,GPNMB,1
breast carcinoma,GONADORELIN,3,Completed,GNRHR,1
breast carcinoma,"GONADOTROPIN, CHORIONIC",3,Unknown status,LHCGR,1
breast carcinoma,GOSERELIN,1,Recruiting,GNRHR,1
breast carcinoma,GOSERELIN,1,Withdrawn,GNRHR,1
breast carcinoma,GOSERELIN,3,Withdrawn,GNRHR,1
breast carcinoma,GOSERELIN,4,Not yet recruiting,GNRHR,1
breast carcinoma,HUHMFG1,1,Completed,MUC1,1
breast carcinoma,HUHMFG1,1,Unknown status,MUC1,1
breast carcinoma,HUHMFG1,2,Terminated,MUC1,1
breast carcinoma,HYDROXYCHLOROQUINE,1,Recruiting,TLR7,1
breast carcinoma,HYDROXYCHLOROQUINE,1,Recruiting,TLR9,1
breast carcinoma,HYDROXYCHLOROQUINE,2,Recruiting,TLR7,1
breast carcinoma,IBANDRONIC ACID,2,Completed,FDPS,1
breast carcinoma,GEMCITABINE,1,"Active, not recruiting",POLD4,1
breast carcinoma,IBANDRONIC ACID,2,Unknown status,FDPS,1
breast carcinoma,IBANDRONIC ACID,3,"Active, not recruiting",FDPS,1
breast carcinoma,IBANDRONIC ACID,3,Completed,FDPS,1
breast carcinoma,IBANDRONIC ACID,3,Unknown status,FDPS,1
breast carcinoma,IBUPROFEN,0,Completed,PTGS1,1
breast carcinoma,IBUPROFEN,0,Completed,PTGS2,1
breast carcinoma,ICRUCUMAB,2,Completed,FLT1,1
breast carcinoma,IMATINIB,1,Completed,ABL1,1
breast carcinoma,IMATINIB,1,Completed,KIT,1
breast carcinoma,IMATINIB,1,Completed,PDGFRB,1
breast carcinoma,IMATINIB,2,Terminated,ABL1,1
breast carcinoma,IMATINIB,2,Terminated,KIT,1
breast carcinoma,IMATINIB,2,Terminated,PDGFRB,1
breast carcinoma,GLEMBATUMUMAB,1,Completed,GPNMB,1
breast carcinoma,GEMCITABINE,3,Terminated,RRM1,1
breast carcinoma,GEMCITABINE,3,Terminated,PRIM2,1
breast carcinoma,GEMCITABINE,3,Terminated,PRIM1,1
breast carcinoma,GEMCITABINE,1,"Active, not recruiting",POLE,1
breast carcinoma,GEMCITABINE,1,"Active, not recruiting",POLE2,1
breast carcinoma,GEMCITABINE,1,"Active, not recruiting",POLE3,1
breast carcinoma,GEMCITABINE,1,"Active, not recruiting",PRIM1,1
breast carcinoma,GEMCITABINE,1,"Active, not recruiting",PRIM2,1
breast carcinoma,GEMCITABINE,1,"Active, not recruiting",RRM1,1
breast carcinoma,GEMCITABINE,2,Withdrawn,POLA1,1
breast carcinoma,GEMCITABINE,2,Withdrawn,POLA2,1
breast carcinoma,GEMCITABINE,2,Withdrawn,POLD1,1
breast carcinoma,GEMCITABINE,2,Withdrawn,POLD2,1
breast carcinoma,GEMCITABINE,2,Withdrawn,POLD3,1
breast carcinoma,GEMCITABINE,2,Withdrawn,POLD4,1
breast carcinoma,GEMCITABINE,2,Withdrawn,POLE,1
breast carcinoma,GEMCITABINE,2,Withdrawn,POLE2,1
breast carcinoma,GEMCITABINE,2,Withdrawn,POLE3,1
breast carcinoma,GEMCITABINE,2,Withdrawn,PRIM1,1
breast carcinoma,GEMCITABINE,2,Withdrawn,PRIM2,1
breast carcinoma,GEMCITABINE,2,Withdrawn,RRM1,1
breast carcinoma,GEMCITABINE,3,Terminated,POLA1,1
breast carcinoma,GEMCITABINE,3,Terminated,POLA2,1
breast carcinoma,GEMCITABINE,3,Terminated,POLD1,1
breast carcinoma,GEMCITABINE,3,Terminated,POLD2,1
breast carcinoma,GEMCITABINE,3,Terminated,POLD3,1
breast carcinoma,GEMCITABINE,3,Terminated,POLD4,1
breast carcinoma,GEMCITABINE,3,Terminated,POLE,1
breast carcinoma,GEMCITABINE,3,Terminated,POLE2,1
breast carcinoma,GEMCITABINE,3,Terminated,POLE3,1
breast carcinoma,LENVATINIB,2,Recruiting,KDR,1
breast carcinoma,LETROZOLE,0,Completed,CYP19A1,1
breast carcinoma,LETROZOLE,0,Terminated,CYP19A1,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFAB1,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFA10,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFA11,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFA12,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFA13,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFA2,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFA3,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFA4,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFA4L2,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFA5,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFA6,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFA7,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFA8,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFA9,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFAF1,1
breast carcinoma,METFORMIN,0,Recruiting,MT-ND6,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFAF2,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFAF3,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFAF4,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFB1,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFB10,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFB11,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFB2,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFB3,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFB4,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFB5,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFB6,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFB7,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFB8,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFA1,1
breast carcinoma,METFORMIN,0,Recruiting,MT-ND5,1
breast carcinoma,LETROZOLE,1,Not yet recruiting,CYP19A1,1
breast carcinoma,ME-344,0,Unknown status,NDUFS7,1
breast carcinoma,ME-344,0,Unknown status,NDUFB5,1
breast carcinoma,ME-344,0,Unknown status,NDUFB6,1
breast carcinoma,ME-344,0,Unknown status,NDUFB7,1
breast carcinoma,ME-344,0,Unknown status,NDUFB8,1
breast carcinoma,ME-344,0,Unknown status,NDUFB9,1
breast carcinoma,ME-344,0,Unknown status,NDUFC1,1
breast carcinoma,ME-344,0,Unknown status,NDUFC2,1
breast carcinoma,ME-344,0,Unknown status,NDUFS1,1
breast carcinoma,ME-344,0,Unknown status,NDUFS2,1
breast carcinoma,ME-344,0,Unknown status,NDUFS3,1
breast carcinoma,ME-344,0,Unknown status,NDUFS4,1
breast carcinoma,ME-344,0,Unknown status,NDUFS5,1
breast carcinoma,ME-344,0,Unknown status,NDUFS6,1
breast carcinoma,ME-344,0,Unknown status,NDUFS8,1
breast carcinoma,METFORMIN,0,Recruiting,MT-ND4L,1
breast carcinoma,ME-344,0,Unknown status,NDUFV1,1
breast carcinoma,ME-344,0,Unknown status,NDUFV2,1
breast carcinoma,ME-344,0,Unknown status,NDUFV3,1
breast carcinoma,MEGESTROL ACETATE,2,"Active, not recruiting",PGR,1
breast carcinoma,MEGESTROL ACETATE,2,Completed,PGR,1
breast carcinoma,MEGESTROL ACETATE,2,Recruiting,PGR,1
breast carcinoma,MEGESTROL ACETATE,3,Completed,PGR,1
breast carcinoma,MERESTINIB,1,Recruiting,MET,1
breast carcinoma,METFORMIN,0,Recruiting,GPD2,1
breast carcinoma,METFORMIN,0,Recruiting,MT-ND1,1
breast carcinoma,METFORMIN,0,Recruiting,MT-ND2,1
breast carcinoma,METFORMIN,0,Recruiting,MT-ND3,1
breast carcinoma,METFORMIN,0,Recruiting,MT-ND4,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFB9,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFC1,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFC2,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFB6,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFA9,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFAB1,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFAF1,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFAF2,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFAF3,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFAF4,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFB1,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFB10,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFB11,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFB2,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFB3,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFB4,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFB5,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFB7,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFS1,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFB8,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFB9,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFC1,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFC2,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFS1,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFS2,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFS3,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFS4,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFS5,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFS6,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFS7,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFS8,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFV1,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFA8,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFA7,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFA6,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFA5,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFS2,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFS3,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFS4,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFS5,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFS6,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFS7,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFS8,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFV1,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFV2,1
breast carcinoma,METFORMIN,0,Recruiting,NDUFV3,1
breast carcinoma,METFORMIN,0,Withdrawn,GPD2,1
breast carcinoma,METFORMIN,0,Withdrawn,MT-ND1,1
breast carcinoma,METFORMIN,0,Withdrawn,MT-ND2,1
breast carcinoma,METFORMIN,0,Withdrawn,MT-ND3,1
breast carcinoma,METFORMIN,0,Withdrawn,MT-ND4,1
breast carcinoma,METFORMIN,0,Withdrawn,MT-ND4L,1
breast carcinoma,METFORMIN,0,Withdrawn,MT-ND5,1
breast carcinoma,METFORMIN,0,Withdrawn,MT-ND6,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFA1,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFA10,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFA11,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFA12,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFA13,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFA2,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFA3,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFA4,1
breast carcinoma,METFORMIN,0,Withdrawn,NDUFA4L2,1
breast carcinoma,ME-344,0,Unknown status,NDUFB4,1
breast carcinoma,ME-344,0,Unknown status,NDUFB3,1
breast carcinoma,ME-344,0,Unknown status,NDUFB2,1
breast carcinoma,LIDOCAINE,3,"Active, not recruiting",SCN2A,1
breast carcinoma,LIDOCAINE,2,Unknown status,SCN10A,1
breast carcinoma,LIDOCAINE,2,Unknown status,SCN11A,1
breast carcinoma,LIDOCAINE,2,Unknown status,SCN1A,1
breast carcinoma,LIDOCAINE,2,Unknown status,SCN2A,1
breast carcinoma,LIDOCAINE,2,Unknown status,SCN3A,1
breast carcinoma,LIDOCAINE,2,Unknown status,SCN4A,1
breast carcinoma,LIDOCAINE,2,Unknown status,SCN5A,1
breast carcinoma,LIDOCAINE,2,Unknown status,SCN7A,1
breast carcinoma,LIDOCAINE,2,Unknown status,SCN8A,1
breast carcinoma,LIDOCAINE,2,Unknown status,SCN9A,1
breast carcinoma,LIDOCAINE,3,"Active, not recruiting",SCN10A,1
breast carcinoma,LIDOCAINE,3,"Active, not recruiting",SCN11A,1
breast carcinoma,LIDOCAINE,3,"Active, not recruiting",SCN1A,1
breast carcinoma,LIDOCAINE,3,"Active, not recruiting",SCN3A,1
breast carcinoma,LINSITINIB,2,Withdrawn,IGF1R,1
breast carcinoma,LIDOCAINE,3,"Active, not recruiting",SCN4A,1
breast carcinoma,LIDOCAINE,3,"Active, not recruiting",SCN5A,1
breast carcinoma,LIDOCAINE,3,"Active, not recruiting",SCN7A,1
breast carcinoma,LIDOCAINE,3,"Active, not recruiting",SCN8A,1
breast carcinoma,LIDOCAINE,3,"Active, not recruiting",SCN9A,1
breast carcinoma,LINIFANIB,2,Completed,CSF1R,1
breast carcinoma,LINIFANIB,2,Completed,FLT1,1
breast carcinoma,LINIFANIB,2,Completed,FLT3,1
breast carcinoma,LINIFANIB,2,Completed,FLT4,1
breast carcinoma,LINIFANIB,2,Completed,KDR,1
breast carcinoma,LINIFANIB,2,Completed,PDGFRA,1
breast carcinoma,LINIFANIB,2,Completed,PDGFRB,1
breast carcinoma,LINSITINIB,2,Terminated,IGF1R,1
breast carcinoma,LIDOCAINE,2,Recruiting,SCN9A,1
breast carcinoma,LIDOCAINE,2,Recruiting,SCN8A,1
breast carcinoma,LIDOCAINE,2,Recruiting,SCN7A,1
breast carcinoma,LIDOCAINE,2,Recruiting,SCN5A,1
breast carcinoma,LETROZOLE,3,Withdrawn,CYP19A1,1
breast carcinoma,LETROZOLE,4,"Active, not recruiting",CYP19A1,1
breast carcinoma,LETROZOLE,4,Recruiting,CYP19A1,1
breast carcinoma,LETROZOLE,4,Withdrawn,CYP19A1,1
breast carcinoma,LEUPROLIDE,1,Not yet recruiting,GNRHR,1
breast carcinoma,LEUPROLIDE,1,Recruiting,GNRHR,1
breast carcinoma,LEUPROLIDE,2,Completed,GNRHR,1
breast carcinoma,LEUPROLIDE,2,Terminated,GNRHR,1
breast carcinoma,LEUPROLIDE,2,Withdrawn,GNRHR,1
breast carcinoma,LEUPROLIDE,3,Recruiting,GNRHR,1
breast carcinoma,LEVOBUPIVACAINE,4,Recruiting,SCN4A,1
breast carcinoma,LIDOCAINE,1,Completed,SCN10A,1
breast carcinoma,LIDOCAINE,1,Completed,SCN11A,1
breast carcinoma,LIDOCAINE,1,Completed,SCN1A,1
breast carcinoma,LIDOCAINE,1,Completed,SCN2A,1
breast carcinoma,LIDOCAINE,1,Completed,SCN3A,1
breast carcinoma,LIDOCAINE,1,Completed,SCN4A,1
breast carcinoma,LIDOCAINE,1,Completed,SCN5A,1
breast carcinoma,LIDOCAINE,1,Completed,SCN7A,1
breast carcinoma,LIDOCAINE,1,Completed,SCN8A,1
breast carcinoma,LIDOCAINE,1,Completed,SCN9A,1
breast carcinoma,LIDOCAINE,2,Recruiting,SCN10A,1
breast carcinoma,LIDOCAINE,2,Recruiting,SCN11A,1
breast carcinoma,LIDOCAINE,2,Recruiting,SCN1A,1
breast carcinoma,LIDOCAINE,2,Recruiting,SCN2A,1
breast carcinoma,LIDOCAINE,2,Recruiting,SCN3A,1
breast carcinoma,LIDOCAINE,2,Recruiting,SCN4A,1
breast carcinoma,LINSITINIB,2,Terminated,INSR,1
breast carcinoma,LINSITINIB,2,Withdrawn,INSR,1
breast carcinoma,ME-344,0,Unknown status,NDUFB11,1
breast carcinoma,ME-344,0,Unknown status,NDUFA3,1
breast carcinoma,ME-344,0,Unknown status,MT-ND1,1
breast carcinoma,ME-344,0,Unknown status,MT-ND2,1
breast carcinoma,ME-344,0,Unknown status,MT-ND3,1
breast carcinoma,ME-344,0,Unknown status,MT-ND4,1
breast carcinoma,ME-344,0,Unknown status,MT-ND4L,1
breast carcinoma,ME-344,0,Unknown status,MT-ND5,1
breast carcinoma,ME-344,0,Unknown status,MT-ND6,1
breast carcinoma,ME-344,0,Unknown status,NDUFA1,1
breast carcinoma,ME-344,0,Unknown status,NDUFA10,1
breast carcinoma,ME-344,0,Unknown status,NDUFA11,1
breast carcinoma,ME-344,0,Unknown status,NDUFA12,1
breast carcinoma,ME-344,0,Unknown status,NDUFA13,1
breast carcinoma,ME-344,0,Unknown status,NDUFA2,1
breast carcinoma,ME-344,0,Unknown status,NDUFA4,1
breast carcinoma,LIOTHYRONINE,2,Not yet recruiting,THRA,1
breast carcinoma,ME-344,0,Unknown status,NDUFA4L2,1
breast carcinoma,ME-344,0,Unknown status,NDUFA5,1
breast carcinoma,ME-344,0,Unknown status,NDUFA6,1
breast carcinoma,ME-344,0,Unknown status,NDUFA7,1
breast carcinoma,ME-344,0,Unknown status,NDUFA8,1
breast carcinoma,ME-344,0,Unknown status,NDUFA9,1
breast carcinoma,ME-344,0,Unknown status,NDUFAB1,1
breast carcinoma,ME-344,0,Unknown status,NDUFAF1,1
breast carcinoma,ME-344,0,Unknown status,NDUFAF2,1
breast carcinoma,ME-344,0,Unknown status,NDUFAF3,1
breast carcinoma,ME-344,0,Unknown status,NDUFAF4,1
breast carcinoma,ME-344,0,Unknown status,NDUFB1,1
breast carcinoma,ME-344,0,Unknown status,NDUFB10,1
breast carcinoma,MARIMASTAT,3,Completed,MMP9,1
breast carcinoma,MARIMASTAT,3,Completed,MMP7,1
breast carcinoma,MARIMASTAT,3,Completed,MMP3,1
breast carcinoma,MARIMASTAT,3,Completed,MMP2,1
breast carcinoma,LIOTHYRONINE,2,Not yet recruiting,THRB,1
breast carcinoma,LITRONESIB,2,Completed,KIF11,1
breast carcinoma,LONAFARNIB,1,Completed,FNTA,1
breast carcinoma,LONAFARNIB,1,Completed,FNTB,1
breast carcinoma,LONAFARNIB,2,Completed,FNTA,1
breast carcinoma,LONAFARNIB,2,Completed,FNTB,1
breast carcinoma,LONAFARNIB,2,Terminated,FNTA,1
breast carcinoma,LONAFARNIB,2,Terminated,FNTB,1
breast carcinoma,LONAPRISAN,2,Completed,PGR,1
breast carcinoma,LOPERAMIDE,2,"Active, not recruiting",OPRM1,1
breast carcinoma,LOPERAMIDE,2,Completed,OPRM1,1
breast carcinoma,LORATADINE,2,Completed,HRH1,1
breast carcinoma,LOVASTATIN,1,Terminated,HMGCR,1
breast carcinoma,LUMRETUZUMAB,1,Completed,ERBB3,1
breast carcinoma,LY-2606368,2,Recruiting,CHEK1,1
breast carcinoma,LY-3023414,1,Recruiting,MTOR,1
breast carcinoma,LY-3023414,1,Recruiting,PIK3CA,1
breast carcinoma,LY-3023414,1,Recruiting,PIK3CB,1
breast carcinoma,LY-3023414,1,Recruiting,PIK3CD,1
breast carcinoma,LY-3023414,1,Recruiting,PIK3CG,1
breast carcinoma,LY-3023414,1,Recruiting,PIK3R1,1
breast carcinoma,LY-3023414,1,Recruiting,PIK3R2,1
breast carcinoma,LY-3023414,1,Recruiting,PIK3R3,1
breast carcinoma,LY-3023414,1,Recruiting,PIK3R5,1
breast carcinoma,MARGETUXIMAB,2,Completed,ERBB2,1
breast carcinoma,MARIMASTAT,3,Completed,MMP1,1
breast carcinoma,MARIMASTAT,3,Completed,MMP12,1
triple-negative breast cancer,VELIPARIB,2,Completed,PARP3,1
